10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

OR

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission file number: 001-39392

TREAN INSURANCE GROUP, INC.

(Exact name of registrant as specified in its charter)

Delaware	84-4512647
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

150 Lake Street West

Wayzata, MN 55391

(Address of principal executive offices and zip code)

 (952) 974-2200

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value per share	TIG	The Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒    No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes ☒    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," a "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒	Non-accelerated filer	☐	Smaller reporting company	☐
						Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐ 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes ☐    No ☒ 

As of November 4, 2022, there were 51,220,485 shares of the registrant's common stock outstanding.

TREAN INSURANCE GROUP, INC.

TABLE OF CONTENTS

		Page
PART I - FINANCIAL INFORMATION
Item 1	Financial Statements
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Operations	4
	Condensed Consolidated Statements of Comprehensive Income	5
	Condensed Consolidated Statements of Stockholders’ Equity	6
	Condensed Consolidated Statements of Cash Flows	8
	Notes to the Condensed Consolidated Financial Statements	10
Item 2	Management's Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3	Quantitative and Qualitative Disclosures About Market Risk	50
Item 4	Controls and Procedures	50
PART II - OTHER INFORMATION
Item 1	Legal Proceedings	51
Item 1A	Risk Factors	51
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	51
Item 3	Defaults Upon Senior Securities	51
Item 4	Mine Safety Disclosures	51
Item 5	Other Information	51
Item 6	Exhibits	52
Signatures		53

2

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

Trean Insurance Group, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

	September 30, 2022		December 31, 2021
Assets	(unaudited)
Fixed maturities, at fair value (amortized cost of $581,935 and $465,459, respectively)	$	530,118	$	471,061
Equity securities, at fair value (cost $39,838 and $984, respectively)	35,296		969
Total investments	565,414		472,030
Cash and cash equivalents	81,489		129,577
Restricted cash	16,320		407
Accrued investment income	3,441		2,344
Premiums and other receivables	153,440		141,920
Income taxes receivable	1,584		460
Reinsurance recoverable	384,204		377,241
Prepaid reinsurance premiums	119,389		129,411
Deferred policy acquisition cost, net	15,011		13,344
Property and equipment, net	7,369		7,632
Right of use asset	3,292		4,530
Deferred tax asset	3,454		—
Goodwill	142,347		142,347
Intangible assets, net	68,616		73,114
Other assets	16,205		8,658
Total assets	$	1,581,575	$	1,503,015
Liabilities
Unpaid loss and loss adjustment expenses	$	578,751	$	544,320
Unearned premiums	220,891		219,940
Funds held under reinsurance agreements	204,828		199,410
Reinsurance premiums payable	49,512		45,130
Accounts payable, accrued expenses and other liabilities	43,449		29,448
Lease liability	3,629		4,976
Deferred tax liability	—		7,520
Debt	77,459		30,362
Total liabilities	1,178,519		1,081,106
Commitments and contingencies
Stockholders' equity
Common stock, $0.01 par value per share (600,000,000 authorized; 51,220,485 and 51,176,887 issued and outstanding as of September 30, 2022 and December 31, 2021, respectively)	512		512
Additional paid-in capital	289,618		288,623
Retained earnings	153,795		128,390
Accumulated other comprehensive income (loss)	(40,869)		4,384
Total stockholders' equity	403,056		421,909
Total liabilities and stockholders' equity	$	1,581,575	$	1,503,015

See accompanying notes to the condensed consolidated financial statements.

3

Trean Insurance Group, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

(unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Revenues
Gross written premiums	$	162,183	$	177,624	$	477,775	$	480,905
Increase in gross unearned premiums	(1,061)		(28,478)		(972)		(64,836)
Gross earned premiums	161,122		149,146		476,803		416,069
Ceded earned premiums	(89,741)		(97,191)		(275,235)		(275,037)
Net earned premiums	71,381		51,955		201,568		141,032
Net investment income	2,951		2,187		5,136		6,562
Net realized gains	9		49		311		72
Other revenue	2,140		2,799		7,145		8,683
Total revenue	76,481		56,990		214,160		156,349
Expenses
Losses and loss adjustment expenses	45,647		32,129		125,727		86,735
General and administrative expenses	23,256		13,788		63,235		40,946
Other expenses	—		—		268		845
Intangible asset amortization	1,499		1,499		4,498		4,326
Noncash stock compensation	460		468		1,019		1,098
Interest expense	931		419		1,806		1,271
Total expenses	71,793		48,303		196,553		135,221
Gains (losses) on embedded derivatives	4,871		(121)		14,463		1,869
Other income	29		35		76		191
Income before taxes	9,588		8,601		32,146		23,188
Income tax expense	2,014		2,083		6,741		5,102
Net income	$	7,574	$	6,518	$	25,405	$	18,086
Earnings per share:
Basic	$	0.15	$	0.13	$	0.50	$	0.35
Diluted	$	0.15	$	0.13	$	0.50	$	0.35
Weighted average shares outstanding:
Basic	51,216,869		51,171,416		51,197,296		51,157,726
Diluted	51,217,005		51,171,416		51,197,482		51,172,602

See accompanying notes to the condensed consolidated financial statements.

4

Trean Insurance Group, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (Loss)

(in thousands)

(unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net income	$	7,574	$	6,518	$	25,405	$	18,086
Other comprehensive loss, net of tax:
Unrealized investment losses:
Unrealized investment losses arising during the period	(19,059)		(2,419)		(58,333)		(8,670)
Income tax benefit	(3,996)		(508)		(12,243)		(1,821)
Unrealized investment losses, net of tax	(15,063)		(1,911)		(46,090)		(6,849)
Less reclassification adjustments to:
Net realized investment gains (losses) included in net realized gains (losses)	21		49		(1,060)		72
Income tax expense (benefit)	4		10		(223)		15
Total reclassifications included in net income, net of tax	17		39		(837)		57
Other comprehensive loss	(15,080)		(1,950)		(45,253)		(6,906)
Total comprehensive income (loss)	$	(7,506)	$	4,568	$	(19,848)	$	11,180

See accompanying notes to the condensed consolidated financial statements.

5

Trean Insurance Group, Inc. and Subsidiaries

Condensed Consolidated Statements of Stockholders' Equity

For the Three and Nine Months Ended September 30, 2022 and 2021

(in thousands, except share and unit data)

(unaudited)

	Common Stock			Additional Paid in Capital		Accumulated Other Comprehensive Income (Loss)		Retained Earnings		Total Stockholders' Equity
	Shares	Amount
Balance at June 30, 2022	51,202,136	$	512	$	289,174	$	(25,789)	$	146,221	$	410,118
Stock compensation expense	—	—		460		—		—		460
Common stock issued pursuant to equity compensation awards, net of shares repurchased	18,349	—		(16)		—		—		(16)
Other comprehensive loss	—	—		—		(15,080)		—		(15,080)
Net income	—	—		—		—		7,574		7,574
Balance at September 30, 2022	51,220,485	$	512	$	289,618	$	(40,869)	$	153,795	$	403,056

Balance at June 30, 2021	51,157,004	$	511	$	287,734	$	8,470	$	120,628	$	417,343
Stock compensation expense	—	—		468		—		—		468
Common stock issuances pursuant to equity compensation awards, net of shares repurchased	17,883	1		(88)		—		—		(87)
Other comprehensive loss	—	—		—		(1,950)		—		(1,950)
Net income	—	—		—		—		6,518		6,518
Balance at September 30, 2021	51,174,887	$	512	$	288,114	$	6,520	$	127,146	$	422,292

Balance at December 31, 2021	51,176,887	$	512	$	288,623	$	4,384	$	128,390	$	421,909
Stock compensation expense	—	—		1,019		—		—		1,019
Common stock issuances pursuant to equity compensation awards, net of shares repurchased	43,598	—		(24)		—		—		(24)
Other comprehensive loss	—	—		—		(45,253)		—		(45,253)
Net income	—	—		—		—		25,405		25,405
Balance at September 30, 2022	51,220,485	$	512	$	289,618	$	(40,869)	$	153,795	$	403,056

See accompanying notes to the condensed consolidated financial statements.

6

Balance at December 31, 2020	51,148,782	$	511	$	287,110	$	13,426	$	109,060	$	410,107
Stock compensation expense	—	—		1,098		—		—		1,098
Common stock issuances pursuant to equity compensation awards, net of shares repurchased	26,105	1		(94)		—		—		(93)
Other comprehensive loss	—	—		—		(6,906)		—		(6,906)
Net income	—	—		—		—		18,086		18,086
Balance at September 30, 2021	51,174,887	$	512	$	288,114	$	6,520	$	127,146	$	422,292

See accompanying notes to the condensed consolidated financial statements.

7

Trean Insurance Group, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

	Nine Months Ended September 30,
	2022		2021
Operating activities
Net income	$	25,405	$	18,086
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	5,100		5,123
Stock compensation	1,019		1,098
Unrealized gains on embedded derivatives	(16,848)		(3,761)
Net gains on investments	(311)		(72)
Unrealized losses on equity securities	4,542		—
Bond amortization and accretion	996		1,715
Deferred income taxes	1,046		(2,259)
Amortization of debt discount and deferred financing costs	131		126
Changes in operating assets and liabilities:
Accrued investment income	(1,097)		80
Premiums and other receivables	(11,520)		(25,167)
Reinsurance recoverable on paid and unpaid losses	(6,963)		(18,460)
Prepaid reinsurance premiums	10,022		(30,252)
Right of use asset	1,238		1,444
Other assets	(9,040)		(10,863)
Unpaid loss and loss adjustment expenses	34,431		52,975
Unearned premiums	951		64,879
Funds held under reinsurance agreements	25,016		19,585
Reinsurance premiums payable	4,382		(7,829)
Accounts payable, accrued expenses and other liabilities	10,518		(11,430)
Lease liability	(1,347)		(1,537)
Income taxes payable and receivable	(1,124)		(71)
Net cash provided by operating activities	76,547		53,410
Investing activities
Payments for capital expenditures	(339)		(92)
Return of capital on equity method investment	—		232
Purchase of investments, available for sale	(257,929)		(129,474)
Proceeds from investments sold, matured or repaid	103,526		61,998
Acquisition of subsidiary, net of cash received	—		(3,795)
Net cash used in investing activities	(154,742)		(71,131)
Financing activities
Shares redeemed for payroll taxes	(23)		(94)
Proceeds from surplus notes	48,455		—
Principal payments on debt	(1,238)		(1,031)
Payment for deferred financing costs	(251)		—
Payment for interest rate cap	(173)		—
Payment for acquisition of subsidiary	(750)		—
Net cash provided by (used in) financing activities	46,020		(1,125)
Net decrease in cash, cash equivalents and restricted cash	(32,175)		(18,846)
Cash, cash equivalents and restricted cash – beginning of period	129,984		157,234
Cash, cash equivalents and restricted cash – end of period	$	97,809	$	138,388

See accompanying notes to the condensed consolidated financial statements.

8

Trean Insurance Group, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

Disaggregation of cash and restricted cash:	September 30, 2022		December 31, 2021
Cash and cash equivalents	$	81,489	$	129,577
Restricted cash	16,320		407
Total cash, cash equivalents and restricted cash	$	97,809	$	129,984

	Nine Months Ended September 30,
Supplemental disclosure of cash flow information:	2022		2021
Cash paid during the year for:
Interest	$	1,319	$	1,145
Income taxes	7,081		7,395
Non-cash investing and financing activity:
Right-of-use assets obtained in exchange for new operating lease liabilities	307		319
Non-cash transfer of investments to settle funds held for reinsurance	2,750		13,562
Non-cash transfer of investments to settle amounts held for others in accounts payable	—		26,211
Contingent consideration for the acquisition of subsidiary	—		1,500
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	1,890		1,824

See accompanying notes to the condensed consolidated financial statements.

9

Notes to the Condensed Consolidated Financial Statements

Note 1. Business and Basis of Presentation

Trean Insurance Group, Inc. (together with its wholly owned subsidiaries, the "Company") provides products and services to the specialty insurance market. Historically, the Company has focused on specialty casualty markets management believes are under-served and where the Company’s expertise allows the Company to achieve higher rates, such as niche workers' compensation markets and small- to medium-sized specialty casualty insurance programs. The Company underwrites specialty-casualty insurance products both through programs where the Company partners with other organizations ("Program Partners") and also through Company owned managing general agencies ("Owned MGAs"). Additionally, the Company provides Program Partners with a variety of services, including issuing carrier services, claims administration, and reinsurance brokerage from which the Company generates fee-based revenues.

The Company's wholly owned subsidiaries include: (i) Benchmark Holding Company, a property and casualty insurance holding company, which owns Benchmark Insurance Company ("Benchmark"), a property and casualty insurance company domiciled in the state of Kansas, American Liberty Insurance Company ("ALIC"), a property and casualty insurance company domiciled in the state of Utah, 7710 Insurance Company ("7710"), a property and casualty insurance company domiciled in the state of South Carolina and Benchmark Specialty Insurance Company ("BSIC"), a property and casualty insurance company domiciled in the state of Arkansas; (ii) Compstar Insurance Services LLC, a California-based general agency; and (iii) Trean Corporation ("Trean Corp"), a reinsurance intermediary manager and a managing general agent, which consists of the following wholly owned subsidiaries: (a) Trean Reinsurance Services, LLC ("TRS"), a reinsurance intermediary broker; Benchmark Administrators LLC ("BIC Admin"), a claims third-party administrator; (b) Western Integrated Care, LLC ("WIC"), a managed care organization; and (c) Westcap Insurance Services, LLC ("Westcap"), a managing general agent based in California.

The accompanying condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with the instructions to the Quarterly Report on Form 10-Q under the Securities Exchange Act of 1934, as amended. Accordingly, they do not contain all of the information included in the Company's annual consolidated financial statements and notes. In the opinion of management, all adjustments (consisting of normal, recurring adjustments) necessary for a fair presentation of the Company’s condensed consolidated financial position and results of operations for the periods presented have been included. Although management believes the disclosures and information presented are adequate, these interim condensed consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2021 (the "2021 Form 10-K"). Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022.

Use of estimates

While preparing the condensed consolidated financial statements, the Company has made certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements, as well as reported amounts of revenue and expenses during the reporting period. Accordingly, actual results could differ from those estimates. Reported amounts that require extensive use of estimates include the reserves for unpaid losses and loss adjustment expenses ("LAE"), reinsurance recoverables, investments, goodwill, and other intangible assets. Except for the captions on the condensed consolidated balance sheets and condensed consolidated statements of comprehensive income, generally, the term loss(es) is used to collectively refer to both losses and LAE.

The Company tests for goodwill impairment at the reporting unit level during the fourth quarter of each year and between annual tests if a triggering event indicates the possibility of an impairment. The Company monitors changing business conditions as well as industry and economic factors, among others, for events which could trigger the need for an interim impairment analysis. The declining share price of the Company’s stock has caused the market capitalization to fall below the book value as of September 30, 2022. As a result of the decrease in share price, the Company performed an interim impairment analysis at September 30, 2022 and concluded that no impairment relating to goodwill existed as of September 30, 2022.

10

Accounting pronouncements

Recently adopted policies

In January 2020, the Financial Accounting Standards Board ("FASB") issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivative and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323 and Topic 815 ("ASU 2020-01"). This update addresses the accounting for certain equity securities upon the application or discontinuation of the equity method of accounting. Further, the update addresses scope considerations for forward contracts and purchased options on certain securities. ASU 2020-01 is effective for annual periods beginning after December 15, 2021, including interim periods thereafter. The Company adopted this standard effective January 1, 2022. Adoption of this standard did not have a material impact on the condensed consolidated financial statements.

Pending policies

The Company completed its initial public offering in July 2020, and is an emerging growth company as defined under federal securities laws. As such, the Company has elected to adopt pending accounting policies under the dates required for private companies. Therefore, the dates included within this section reflect the effective dates for the adoption of new accounting policies required by private companies.

In March 2020, the FASB issued ASU No. 2020-03, Codification Improvements to Financial Instruments ("ASU 2020-03"). This update represents changes to clarify and improve the codification to allow for easier application by eliminating inconsistencies and providing clarification on items such as (i) the application of fair value option disclosures; (ii) the accounting for fees related to modifications of debt; and (iii) aligning the contractual term of a net investment in a lease in accordance with ASC Topic 326, Financial Instruments - Credit Losses, and the lease term determined in accordance with ASC Topic 842, Leases. The Company adopted items (i) and (ii) effective January 1, 2020 and will adopt item (iii) on January 1, 2023. Adoption of this standard has not had, and is not expected to have, a material impact on the condensed consolidated financial statements.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). This update requires financial assets measured at amortized cost to be presented at the net amount expected to be collected by means of an allowance for credit losses that runs through net income. Additionally, credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses, with the amount of the allowance limited to the amount by which the fair value is below the amortized cost. ASU 2016-13 is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years. The Company will adopt this standard effective January 1, 2023. The Company is currently evaluating the impact of this standard on the condensed consolidated financial statements.

Note 2. Acquisitions

Western Integrated Care

Effective July 6, 2021, Trean Corp acquired 100% ownership of WIC for a total purchase price of $5,500, which includes $1,500 that is contingent on WIC's future earnings, as defined in the agreement. WIC is a managed care organization that offers services to workers' compensation insurers to enable employees who are injured on the job to access qualified medical treatment. The Company recorded $1,501 of goodwill and intangible assets of $3,624 associated with the business combination. The Company made an earn-out payment of $750 during the three months ended September 30, 2022.

Note 3. Fair Value Measurements

The Company’s financial instruments include assets and liabilities carried at fair value. The inputs to valuation techniques used to measure fair value are prioritized into a three level hierarchy. The fair value hierarchy is as follows:

Level 1: Fair values primarily based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

11

Level 2: Fair values primarily based on observable inputs, other than quoted prices included in Level 1, or based on prices for similar assets and liabilities.

Level 3: Fair values primarily based on valuations derived when one or more of the significant inputs are unobservable. With little or no observable market, the determination of fair value uses considerable judgment and represents the Company’s best estimate of an amount that could be realized in a market exchange for the asset or liability.

The Company classifies the financial asset or liability by level based upon the lowest level input that is significant to the determination of the fair value. The following tables present the estimated fair value of the Company’s significant financial instruments.

	September 30, 2022
	Level 1		Level 2		Level 3		Total
Fixed maturities:
U.S. government and government securities	$	56,899	$	—	$	—	$	56,899
Foreign governments	—		392		—		392
States, territories and possessions	—		14,380		—		14,380
Political subdivisions of states territories and possessions	—		33,863		—		33,863
Special revenue and special assessment obligations	—		103,318		—		103,318
Industrial and public utilities	—		118,252		—		118,252
Commercial mortgage-backed securities	—		123,478		—		123,478
Residential mortgage-backed securities	—		24,171		—		24,171
Other loan-backed securities	—		50,339		—		50,339
Hybrid securities	—		5,026		—		5,026
Total fixed maturities	56,899		473,219		—		530,118
Equity securities	12,180		23,116		—		35,296
Total investments	$	69,079	$	496,335	$	—	$	565,414
Embedded derivatives on funds held under reinsurance agreements	$	(2,103)	$	(14,474)	$	—	$	(16,577)
Interest rate cap agreement	—		173		—		173
Debt	—		79,700		—		79,700

12

	December 31, 2021
	Level 1		Level 2		Level 3		Total
Fixed maturities:
U.S. government and government securities	$	2,392	$	39,042	$	—	$	41,434
Foreign governments	—		2,490		—		2,490
States, territories and possessions	—		10,766		—		10,766
Political subdivisions of states, territories and possessions	—		40,002		—		40,002
Special revenue and special assessment obligations	—		95,991		—		95,991
Industrial and public utilities	—		103,257		—		103,257
Commercial mortgage-backed securities	—		118,218		—		118,218
Residential mortgage-backed securities	—		17,368		—		17,368
Other loan-backed securities	—		41,425		—		41,425
Hybrid securities	—		110		—		110
Total fixed maturities	2,392		468,669		—		471,061
Equity securities	—		969		—		969
Total investments	$	2,392	$	469,638	$	—	$	472,030
Embedded derivatives on funds held under reinsurance agreements	$	(4)	$	275	$	—	$	271
Debt	—		30,938		—		30,938

Fixed maturities and equity securities: The Company, through its third-party pricing service provider, uses a variety of sources to estimate the fair value of investments such as Refinitiv (formerly Reuters), PricingDirect, ICE Data Services, and for equities, Bloomberg or S&P Capital IQ Pro. Equity securities are generally valued at the closing price on the exchange on which they are primarily traded as provided by a third-party pricing service. Fixed income securities are generally valued at an evaluated bid as provided by a third-party pricing service. Securities and other assets generally valued using third-party pricing services may also be valued at broker/dealer indications. Values obtained from third-party pricing services can utilize several market data sources for inputs such as transaction data, yield, quality, coupon rate, maturity, issue type, trading characteristics, and other market activity. To validate the reasonableness of the prices, the Company performs various qualitative and quantitative procedures such as analysis of recent trading activity, analytical review of fair values and an evaluation of the underlying pricing methodologies. Based on these procedures, the Company did not adjust the prices or quotes from the third-party pricing service.

Embedded derivatives: The Company enters into funds held contracts under reinsurance agreements, which create embedded derivatives on the underlying investments. These embedded derivatives are valued based upon the unrealized gain or loss position of the funds held portfolio, which is determined consistent with other investments using third-party pricing services. To validate the reasonableness of the quoted prices, the Company performs various qualitative and quantitative procedures such as analysis of recent activity, analytical review of fair values and an evaluation of the underlying pricing methodologies. Based on these procedures, the Company did not adjust the prices or quotes from the third-party pricing service.

Interest rate cap agreement: The Company entered into an interest cap agreement to hedge cash flows associated with interest rate fluctuations on variable rate debt. The fair value of the interest rate cap agreement is based on the terms of the agreement and commonly quoted data for forward interest rate curves and an implied market volatility. The Company also assessed the significance of credit valuation adjustments to appropriately reflect the respective nonperformance risk in the fair value measurement and determined the credit valuation adjustment is not significant to the overall valuation of the interest rate cap.

Debt: The Company holds debt related to its secured credit facility and surplus notes. The Company has determined that the remaining balance of the debt reflected its fair value as this would represent the total amount to repay the debt.

13

Note 4. Investments

Fixed income securities include bonds, asset-backed securities, and redeemable preferred securities. Fixed income securities, which may be sold prior to their contractual maturity, are designated as available-for-sale and are carried at fair value. Equity securities primarily include common stocks, mutual funds, and non-redeemable preferred stocks, which are carried at fair value.

The cost or amortized cost, gross unrealized gains, gross unrealized losses, and estimated fair value of the Company's fixed maturities investments are as follows:

	September 30, 2022
	Cost or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Fixed maturities:
U.S. government and government securities	$	59,974	$	14	$	(3,089)	$	56,899
Foreign governments	400		—		(8)		392
States, territories and possessions	16,088		—		(1,708)		14,380
Political subdivisions of states, territories and possessions	38,614		1		(4,752)		33,863
Special revenue and special assessment obligations	116,311		5		(12,998)		103,318
Industrial and public utilities	125,572		—		(7,320)		118,252
Commercial mortgage-backed securities	141,552		20		(18,094)		123,478
Residential mortgage-backed securities	25,769		16		(1,614)		24,171
Other loan-backed securities	51,857		—		(1,518)		50,339
Hybrid securities	5,798		—		(772)		5,026
Total fixed maturities available for sale	$	581,935	$	56	$	(51,873)	$	530,118

	December 31, 2021
	Cost or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Fixed maturities:
U.S. government and government securities	$	41,490	$	113	$	(169)	$	41,434
Foreign governments	2,500		—		(10)		2,490
States, territories and possessions	10,593		189		(16)		10,766
Political subdivisions of states, territories and possessions	39,170		975		(143)		40,002
Special revenue and special assessment obligations	93,664		2,920		(593)		95,991
Industrial and public utilities	100,774		2,835		(352)		103,257
Commercial mortgage-backed securities	119,378		591		(1,751)		118,218
Residential mortgage-backed securities	16,549		843		(24)		17,368
Other loan-backed securities	41,236		248		(59)		41,425
Hybrid securities	105		5		—		110
Total fixed maturities available for sale	$	465,459	$	8,719	$	(3,117)	$	471,061

14

The following table illustrates the Company’s gross unrealized losses and fair value of fixed maturities, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:

	September 30, 2022
	Less Than 12 Months				12 Months or More				Total
	Fair Value		Unrealized Loss		Fair Value		Unrealized Loss		Fair Value		Unrealized Loss
Fixed maturities:
U.S. government and government securities	$	47,377	$	(2,691)	$	4,623	$	(398)	$	52,000	$	(3,089)
Foreign governments	392		(8)		—		—		392		(8)
States, territories and possessions	14,150		(1,612)		229		(96)		14,379		(1,708)
Political subdivisions of states, territories and possessions	27,617		(3,574)		5,725		(1,178)		33,342		(4,752)
Special revenue and special assessment obligations	86,592		(8,560)		15,668		(4,438)		102,260		(12,998)
Industrial and public utilities	107,179		(5,541)		11,074		(1,779)		118,253		(7,320)
Commercial mortgage-backed securities	72,893		(7,836)		44,600		(10,258)		117,493		(18,094)
Residential mortgage-backed securities	19,794		(1,551)		1,437		(63)		21,231		(1,614)
Other loan-backed securities	46,109		(1,316)		4,231		(202)		50,340		(1,518)
Hybrid securities	5,026		(772)		—		—		5,026		(772)
Total fixed maturities	$	427,129	$	(33,461)	$	87,587	$	(18,412)	$	514,716	$	(51,873)

	December 31, 2021
	Less Than 12 Months				12 Months or More				Total
	Fair Value		Unrealized Loss		Fair Value		Unrealized Loss		Fair Value		Unrealized Loss
Fixed maturities:
U.S. government and government securities	$	26,935	$	(168)	$	23	$	(1)	$	26,958	$	(169)
Foreign governments	2,490		(10)		—		—		2,490		(10)
States, territories and possessions	935		(16)		—		—		935		(16)
Political subdivisions of states, territories and possessions	11,115		(143)		—		—		11,115		(143)
Special revenue and special assessment obligations	29,917		(593)		—		—		29,917		(593)
Industrial and public utilities	24,042		(286)		1,058		(66)		25,100		(352)
Commercial mortgage-backed securities	80,126		(1,565)		6,212		(186)		86,338		(1,751)
Residential mortgage-backed securities	4,539		(24)		—		—		4,539		(24)
Other loan-backed securities	20,153		(36)		2,477		(23)		22,630		(59)
Hybrid securities	—		—		—		—		—		—
Total fixed maturities	$	200,252	$	(2,841)	$	9,770	$	(276)	$	210,022	$	(3,117)

The unrealized losses on the Company’s available for sale securities as of September 30, 2022 and December 31, 2021 were primarily attributable to an increase in interest rates, which predominantly impacted fixed maturities acquired since the second quarter of 2020.

15

The amortized cost and estimated fair value of fixed maturities as of September 30, 2022, by contractual maturity, are as follows:

	Cost or Amortized Cost		Fair Value
Available for sale:
Due in one year or less	$	31,666	$	31,433
Due after one year but before five years	162,478		153,776
Due after five years but before ten years	96,488		86,189
Due after ten years	72,125		60,732
Commercial mortgage-backed securities	141,552		123,478
Residential mortgage-backed securities	25,769		24,171
Other loan-backed securities	51,857		50,339
Total	$	581,935	$	530,118

Actual maturities may differ from contractual maturities as issuers may have the right to call or prepay obligations with or without call or prepayment penalties.

Realized gains and losses on investments included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021 are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Fixed maturities:
Gains	$	21	$	52	$	134	$	150
Losses	—		—		(1,194)		(75)
Total fixed maturities	21		52		(1,060)		75
Funds held investments:
Gains	—		110		19		110
Losses	(12)		(1)		(29)		(1)
Total funds held investments	(12)		109		(10)		109
Equity securities:
Equity method investments:
Gains	—		—		1,400		—
Losses	—		(112)		(19)		(112)
Total equity securities	—		(112)		1,381		(112)
Total net realized gains	$	9	$	49	$	311	$	72

Net investment income consists of the following for the three and nine months ended September 30, 2022 and 2021:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Fixed maturities	$	2,628	$	1,597	$	6,189	$	4,734
Income on funds held investments	953		585		2,395		1,783
Equity securities	421		5		1,031		41
Unrealized losses on equity securities	(1,101)		—		(4,542)		—
Interest earned on cash and short-term investments	50		—		63		4
Net investment income	$	2,951	$	2,187	$	5,136	$	6,562

16

Net realized and unrealized gains (losses) on equity securities recognized during the three and nine months ended September 30, 2022 and 2021 are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Equity securities:
Net realized gains (losses) on sales of equity securities	$	—	$	(112)	$	1,381	$	(112)
Change in net unrealized gains (losses) of equity securities still held as of September 30, 2022 and 2021	(1,101)		(6)		(4,542)		11
Net realized and unrealized gains (losses) on equity securities	$	(1,101)	$	(118)	$	(3,161)	$	(101)

Embedded derivatives

The Company enters into funds held contracts under reinsurance agreements, which create embedded derivatives that are measured at fair value. The embedded derivatives within the Company's funds held under reinsurance agreements relate to a total return swap on the underlying investments. These embedded derivatives had no impact on total operating, investing, and financing activities as presented on the Company’s condensed consolidated statements of cash flows during the nine months ended September 30, 2022 and 2021. Total funds held under reinsurance agreements include the following:

	September 30, 2022		December 31, 2021
Funds held under reinsurance agreements, at cost	$	221,405	$	199,139
Embedded derivatives, at fair value	(16,577)		271
Total funds held under reinsurance agreements	$	204,828	$	199,410

Gains (losses) on embedded derivatives consists of the following for the three and nine months ended September 30, 2022 and 2021:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Change in fair value of embedded derivatives	$	5,812	$	573	$	16,848	$	3,761
Effect of net investment income on funds held investments	(953)		(585)		(2,395)		(1,783)
Effect of realized losses (gains) on funds held investments	12		(109)		10		(109)
Total gains (losses) on embedded derivatives	$	4,871	$	(121)	$	14,463	$	1,869

Note 5. Equity Method Investments

On January 3, 2020, the Company sold 15% of its previous 25% ownership in Trean Intermediaries ("TRI") for cash proceeds of $3,000, resulting in a remaining ownership interest of 10%. The Company sold all of its remaining ownership interest in TRI during the third quarter of 2021 for $1,888, resulting in a realized loss of $112, which was included in net realized gains (losses) on the consolidated statements of operations for the three and nine months ended September 30, 2021. The sale agreement included an earn-out that would increase the amount received based on TRI's future performance. The Company received an earn-out payment of $1,400, which was included in net realized gains (losses) on the consolidated statements of operations for the nine months ended September 30, 2022.

17

The Company recorded $0 and $50 of revenue for the three months ended September 30, 2022 and 2021, respectively, and $100 and $150 of revenue for the nine months ended September 30, 2022 and 2021, respectively, for consulting services provided to TRI.

Note 6. Debt

Debt consisted of the following:

	September 30, 2022						December 31, 2021
	Face Value		Unamortized Discount and Issuance Costs		Carrying Value		Face Value		Unamortized Discount and Issuance Costs		Carrying Value
Secured credit facility	$	29,700	$	(449)	$	29,251	$	30,938	$	(576)	$	30,362
Surplus notes	50,000		(1,792)		48,208		—		—		—
Total debt	$	79,700	$	(2,241)	$	77,459	$	30,938	$	(576)	$	30,362

Secured Credit Facility

In July 2020, the Company entered into a Second Amended and Restated Credit Agreement (the "Credit Agreement") that, among other things, extended the Company's credit facility for a period of five years through May 26, 2025, and increased its term loan facility by $11,707, resulting in a total term loan debt amount of $33,000 and a revolving credit facility of $2,000 at the time of closing. The outstanding principal balance of the loan is to be repaid in quarterly installments, which escalate from $206 to $825. All equity securities of the subsidiaries of the Company (other than Benchmark Holding Company and its subsidiaries) have been pledged as collateral.

On May 6, 2022, the Company entered into a First Amendment to the Credit Agreement to, among other things, facilitate the approval of certain internal distributions among the Company and certain of its subsidiaries as part of the Company’s overall capital management strategy.

On September 28, 2022, the Company entered into a Second Amendment to the new Credit Agreement that, among other things, replaced LIBOR as the benchmark rate with Term SOFR (as defined in the Credit Agreement), reduced the applicable margin under the Credit Agreement on Eurodollar loans from 4.50% to 3.50% and on ABR loans from 3.50% to 2.50%, and converted all extant Eurodollar loans under the Credit Agreement to Term SOFR loans. The variable interest rate plus applicable margin was 6.76% and 4.64% as of September 30, 2022 and December 31, 2021, respectively.

During the three months ended September 30, 2022 and 2021, the Company recorded interest expense of $563 and $419, respectively, on its credit facility including amortization of debt issuance costs. During the nine months ended September 30, 2022 and 2021, the Company recorded interest expense of $1,438 and $1,271, respectively, on its credit facility including amortization of debt issuance costs.

The terms of the credit facility require the Company to maintain certain financial covenants and ratios. The Company was in compliance with all covenants and ratios as of September 30, 2022.

Interest Rate Cap Agreement

In September 2022, the Company entered into an interest rate cap agreement that became effective September 30, 2022, to hedge cash flows associated with interest rate fluctuations on its secured credit facility, with a termination date of May 31, 2024 ("Interest Rate Cap Agreement"). The Interest Rate Cap Agreement has a notional amount of $29,700 that effectively converted the outstanding balance of the secured credit facility from variable rate debt to capped variable rate debt, resulting in a change in the applicable interest rate from an interest rate of one-month SOFR plus the applicable margin (as provided by the secured credit facility) to a one-month SOFR interest rate, capped at 5.00%, plus the applicable margin. The notional amount of the Interest Rate Cap Agreement decreases quarterly in proportion to the quarterly principal payments on the secured credit facility. The Interest Rate Cap Agreement is designated as a cash flow hedge and the change in fair value is recorded in accumulated other comprehensive income and is subsequently reclassified to interest expense in the period when

18

the hedged forecasted interest payments affect earnings. The Company paid a fixed amount of $173 for the Interest Rate Cap Agreement.

Surplus Notes

On August 24, 2022, Benchmark, a subsidiary of the Company, issued $50,000 in aggregate principal amount of Benchmark’s 6.75% surplus notes due 2042 (the “Surplus Notes”) in a private placement exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the issuance of the Surplus Notes, Benchmark entered into a fiscal agency agreement, dated as of August 24, 2022 (the “Fiscal Agency Agreement”), with The Bank of New York Mellon, as fiscal agent, paying agent, registrar and transfer agent, providing for the terms of the Surplus Notes.

The Surplus Notes are unsecured, subordinated debt obligations of the Company and are reflected as debt on the condensed consolidated balance sheets of the Company. All principal and interest payments on the Surplus Notes are subject to prior approval by the Commissioner of the Kansas Insurance Department. Interest on the Surplus Notes accrues at the rate of 6.75% per year, and is payable quarterly in arrears on February 24, May 24, August 24 and November 24 of each year, commencing on November 24, 2022.

The Surplus Notes may be redeemed after 10 years, in full or in part, for 100% of the principal amount plus accrued but unpaid interest, and the Company may at any time repurchase Surplus Notes from the underlying holders thereof on the open market, after which such Surplus Notes will be cancelled and not re-issued. In addition, the Surplus Notes may be redeemed before August 24, 2032 upon the occurrence of certain changes in applicable tax laws or regulations that would require the Company to pay additional amounts necessary to reimburse the noteholders for new or changed withholding or deduction obligations.

In addition, pursuant to the Fiscal Agency Agreement, the Company made certain customary representations and warranties and made certain customary covenants. The covenants, among other things, (i) prevent Benchmark from incurring indebtedness exceeding 35% of its total surplus (as set forth in its statutory financial statements, and including the Surplus Notes), and restrict Benchmark’s ability to pay dividends to the Company if such ratio were to exceed 35% or would exceed 35% as a result of such payment; (ii) limit Benchmark’s ability to engage in a merger, sale or consolidation and require it to preserve its corporate existence; and (iii) require it to provide certain financial information and insurance regulatory filings to the noteholders. All of these covenants are subject to a number of important exceptions, limitations and qualifications. Notwithstanding the foregoing, noteholders do not have the right to declare the Surplus Notes to immediately mature or otherwise become immediately payable as a result of any breach of Benchmark’s covenants or under any other circumstances. Benchmark’s obligations under the Surplus Notes will only be accelerated in the event that any state or federal agency were to obtain an order or grant approval for the rehabilitation, liquidation, conservation or dissolution of Benchmark.

During the three and nine months ended September 30, 2022, the Company recorded interest expense of $368 on its Surplus Notes including amortization of debt issuance costs.

Note 7. Revenue from Contracts with Customers

Revenue from contracts with customers, included in other revenue, includes brokerage, management, third-party administrative, and consulting and other fee-based revenue. The following table presents the revenues recognized from contracts with customers included in the condensed consolidated statements of operations.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Brokerage	$	1,581	$	1,989	$	5,396	$	6,214
Managing general agent fees	83		88		251		407
Third-party administrator fees	266		437		838		1,191
Consulting and other fee-based revenue	210		285		660		871
Total revenue from contracts with customers	$	2,140	$	2,799	$	7,145	$	8,683

19

The Company did not have any contract liabilities as of September 30, 2022 or December 31, 2021. The following table provides information related to the contract assets from contracts with customers. Contract assets are included within other assets on the condensed consolidated balance sheets.

	September 30, 2022		December 31, 2021
Contract assets	$	4,878	$	3,353

Note 8. Income Taxes

Income tax expense for interim periods is measured using an estimated effective income tax rate for the annual period. The Company's effective tax rate was 21.0% for the three and nine months ended months ended September 30, 2022.

The Company’s effective tax rate was 24.2% and 22.0% for the three and nine months ended September 30, 2021, respectively, which differed from the statutory rate primarily due the impact of recording the Company's 2020 tax return accrual to return true-up in the third quarter of 2021.

Note 9. Liability for Unpaid Losses and Loss Adjustment Expense

The following table represents a reconciliation of changes in the liability for unpaid losses and LAE.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Unpaid losses and LAE reserves at beginning of period	$	577,686	$	502,560	$	544,320	$	457,817
Less losses ceded through reinsurance	(379,274)		(358,601)		(369,008)		(335,655)
Net unpaid losses and LAE at beginning of period	198,412		143,959		175,312		122,162
Incurred losses and LAE related to:
Current period	45,673		32,947		126,545		88,032
Prior period	(26)		(818)		(818)		(1,297)
Total incurred losses and LAE	45,647		32,129		125,727		86,735
Paid losses and LAE, net of reinsurance, related to:
Current period	19,570		12,638		41,268		25,111
Prior period	12,859		7,092		48,141		27,428
Total paid losses and LAE	32,429		19,730		89,409		52,539
Net unpaid losses and LAE at end of period	211,630		156,358		211,630		156,358
Plus losses ceded through reinsurance	367,121		354,434		367,121		354,434
Unpaid losses and LAE reserves at end of period	$	578,751	$	510,792	$	578,751	$	510,792

As a result of changes in estimates of insured events in prior years, the provision for unpaid losses and LAE decreased by approximately $26 and $818 for the three and nine months ended September 30, 2022, respectively, and $818 and $1,297 for the three and nine months ended September 30, 2021, respectively.

Note 10. Reinsurance

The Company utilizes reinsurance contracts to reduce its exposure to losses in all aspects of its insurance business. Such reinsurance permits recovery of a portion of losses from reinsurers, although it does not relieve the Company from its primary liability to policyholders. Failure of reinsurers to honor their obligations could result in losses to the Company. The Company evaluates the financial strength of potential reinsurers and continually monitors the financial condition of its reinsurers.

A summary of the impact of ceded reinsurance on premiums written and premiums earned is as follows:

20

	Three Months Ended September 30,
	2022								2021
	Gross		Assumed		Ceded		Net		Gross		Assumed		Ceded		Net
Written premiums	$	160,505	$	1,678	$	(93,790)	$	68,393	$	175,516	$	2,108	$	(114,374)	$	63,250
Earned premiums	158,643		2,479		(89,741)		71,381		146,170		2,976		(97,191)		51,955

	Nine Months Ended September 30,
	2022								2021
	Gross		Assumed		Ceded		Net		Gross		Assumed		Ceded		Net
Written premiums	$	470,391	$	7,384	$	(265,234)	$	212,541	$	473,463	$	7,442	$	(305,164)	$	175,741
Earned premiums	469,403		7,400		(275,235)		201,568		408,936		7,133		(275,037)		141,032

Note 11. Leases

The Company's leases consist of operating leases for office space and equipment. The Company determines if an arrangement is a lease at its inception. Leases with an initial term of twelve months or less are not recorded on the balance sheet. Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease. Operating lease right-of-use assets are recognized at commencement date based on the present value of lease payments over the lease term. As the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Some of the Company's leases include options to extend the term, which are only included in the lease liability and right-of-use asset calculation when it is reasonably certain the Company will exercise an option. The Company's leases have remaining terms ranging from one month to 57 months, some of which have options to extend the lease for up to an additional 60 months. As of September 30, 2022, the lease liability and right-of-use assets did not include the impact of any lease extension options as it is not reasonably certain that the Company will exercise the extension options.

Total lease expense for the three months ended September 30, 2022 was $615, inclusive of $17 in variable lease expense. Total lease expense for the three months ended September 30, 2021 was $626, inclusive of $29 in variable lease expense. The Company also sublets some of its leased office space and recorded $27 and $33 of sublease income for the three months ended September 30, 2022 and 2021, respectively, which is included in other income on the condensed consolidated statements of operations.

Total lease expense for the nine months ended September 30, 2022 was $1,855, inclusive of $68 in variable lease expense. Total lease expense for the nine months ended September 30, 2021 was $1,831, inclusive of $56 in variable lease expense. The Company also sublets some of its leased office space and recorded $70 and $74 of sublease income for the nine months ended September 30, 2022 and 2021, respectively, which is included in other income on the condensed consolidated statement of operations.

Supplemental balance sheet information, the weighted average remaining lease term and weighted average discount rate related to leases were as follows:

	September 30, 2022			December 31, 2021
Right of use asset	$	3,292		$	4,530
Lease liability	$	3,629		$	4,976
Weighted average remaining lease term	1.95 years			2.42 years
Weighted average discount rate	6.04		%	6.33		%

21

Future maturities of lease liabilities as of September 30, 2022 are as follows:

	Operating Leases
2022	$	621
2023	1,940
2024	1,064
2025	164
2026	44
Thereafter	2
Total lease payments	3,835
Less: imputed interest	(206)
Total lease liabilities	$	3,629

Note 12. Equity

Common Stock

The Company currently has authorized 600,000,000 shares of common stock with a par value of $0.01. As of September 30, 2022 and December 31, 2021, there were 51,220,485 and 51,176,887 shares of common stock issued and outstanding, respectively.

Note 13. Earnings Per Share

Basic earnings per share ("EPS") is computed by dividing net income by the weighted average number of shares outstanding during reported periods. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock of the Company during reported periods and is calculated using the treasury stock method.

The following table presents the calculation of basic and diluted EPS of common stock:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net income — basic and diluted	$	7,574	$	6,518	$	25,405	$	18,086
Weighted average number of shares outstanding — basic	51,216,869		51,171,416		51,197,296		51,157,726
Effect of dilutive securities:
Restricted stock units	136		—		186		14,876
Dilutive shares	136		—		186		14,876
Weighted average number of shares outstanding — diluted	51,217,005		51,171,416		51,197,482		51,172,602
Earnings per share:
Basic	$	0.15	$	0.13	$	0.50	$	0.35
Diluted	$	0.15	$	0.13	$	0.50	$	0.35

At September 30, 2022 and September 30, 2021, there were restricted stock units and stock options outstanding totaling 561,537 and 396,044, respectively, excluded from the computation of diluted weighted-average shares outstanding because their inclusion would have been anti-dilutive.

22

Note 14. Accumulated Other Comprehensive Income (Loss)

The following table presents the changes in accumulated other comprehensive income (loss) for unrealized gains and losses on available-for-sale securities:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Balance at beginning of period	$	(25,789)	$	8,470	$	4,384	$	13,426
Other comprehensive loss, net of tax:
Unrealized investment losses:
Unrealized investment losses arising during the period	(19,059)		(2,419)		(58,333)		(8,670)
Income tax benefit	(3,996)		(508)		(12,243)		(1,821)
Unrealized investment losses, net of tax	(15,063)		(1,911)		(46,090)		(6,849)
Less reclassification adjustments to:
Net realized investment gains (losses) included in net realized gains (losses)	21		49		(1,060)		72
Income tax expense (benefit)	4		10		(223)		15
Total reclassifications included in net income, net of tax	17		39		(837)		57
Other comprehensive loss	(15,080)		(1,950)		(45,253)		(6,906)
Balance at end of period	$	(40,869)	$	6,520	$	(40,869)	$	6,520

Note 15. Stock Compensation

As of September 30, 2022, the Company has one incentive plan, the Trean Insurance Group, Inc. 2020 Omnibus Incentive Plan (the "2020 Omnibus Plan"). The purposes of the 2020 Omnibus Plan are to provide additional incentive to selected officers, employees, non-employee directors, independent contractors, and consultants of the Company whose contributions are essential to the growth and success of the business of the Company and its affiliates, to strengthen the commitment and motivate such individuals to faithfully and diligently perform their responsibilities and to attract competent and dedicated individuals whose efforts will result in the long-term growth and profitability of the Company and its affiliates. The 2020 Omnibus Plan is administered by the Compensation, Nominating, and Corporate Governance Committee of the Company's board of directors and provides for the issuance of up to 5,058,085 shares of the Company's common stock granted in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, stock bonuses, other stock awards, or any combination of the foregoing.

Stock Options

Stock compensation expense related to stock option awards was $53 and $49 for the three months ended September 30, 2022 and 2021, respectively, and $149 and $118 for the nine months ended September 30, 2022 and 2021, respectively. Actual forfeitures are recognized as they occur.

Employee stock option awards granted set forth, among other things, the option exercise price, the option term, provisions regarding option exercisability, and whether the option is intended to be an incentive stock option ("ISO") or a nonqualified stock option ("NQ"). Stock options may be granted to employees at such exercise prices as the Company’s board of directors may determine but not less than 100% of the fair market value of the underlying stock as of the date of grant. Employee options vest one third annually over a period of three years and have contractual terms of ten years from the date of grant.

The fair value of each time-based vesting option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions noted in the following table. The Company’s expected volatility for the period was based on a weighted average expected volatility of an industry peer group of insurance companies of similar size, life cycle, and lines of business. Expected term is calculated using the simplified method taking into consideration the option's contractual life and vesting terms. The Company’s stock option grants qualify as plain vanilla options and as such the Company uses the simplified method in estimating its expected option term as the Company does not have sufficient historical exercise data to

23

provide a reasonable basis upon which to estimate expected term due to the limited period of time its common shares have been publicly traded. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. Expected dividend yields were not used in the fair value computations as the Company has never declared or paid dividends on its common stock and currently intends to retain earnings for use in operations.

	Fiscal 2022	Fiscal 2021
Expected volatility	29.8%	29.8%
Expected term	6 years	6 years
Risk-free interest rate	1.92%	1.32%

A summary of the status of the Company's stock option activity as of September 30, 2022 and changes during the nine-month period then ended are as follows:

	Stock Options	Weighted Average Exercise Price Per Share		Aggregate Intrinsic Value		Weighted Average Remaining Contract Term
Balance outstanding, December 31, 2021	120,187	$	16.06
Granted	64,694	$	7.04
Forfeited or cancelled	(20,158)	$	14.76
Balance outstanding, September 30, 2022	164,723	$	12.68	$	—	8.59 years
Balance vested and exercisable, September 30, 2022	53,956	$	15.68	$	—	7.98 years

The weighted average grant-date fair value of options granted in the nine months ended September 30, 2022 and 2021 was $2.30 and $5.49, respectively. As of September 30, 2022, total unrecognized compensation cost related to stock options was $304 and is expected to be recognized over a weighted average period of approximately 1.0 years.

Restricted Stock Units

Compensation expense relating to restricted stock unit grants was $407 and $419 for the three months ended September 30, 2022 and 2021, respectively, and $870 and $980 for the nine months ended September 30, 2022 and 2021, respectively. Actual forfeitures are recognized as they occur. As of September 30, 2022, there was $2,453 of total unrecognized compensation cost related to non-vested restricted stock unit grants, which is expected to be recognized over a weighted average life of 1.7 years. The total fair value of restricted stock units vested during the three and nine months ended September 30, 2022 was $113 and $257, respectively, and $342 and $478 during the three and nine months ended September 30, 2021.

The Company has granted time-based restricted stock units ("RSUs"), performance stock units ("PSUs"), and market-based stock units ("MSUs") to certain key employees as part of the Company's long-term incentive program. The estimated fair value of restricted stock units is based on the grant date closing price of the Company's common stock for time-based and performance-based vesting awards. A Monte Carlo valuation model is used to estimate the fair value for market-based vesting awards. RSUs generally vest in three equal annual installments beginning one year from the grant date and are amortized as compensation expense over the three-year vesting period. The Company has also granted time-based restricted stock units to non-employee directors as part of the Company's annual director compensation program. Each time-based restricted stock grant to non-employee directors vests on the day immediately preceding the next annual meeting of stockholders following the date of grant. The grants are amortized as director compensation expense over the vesting period. The Company recognizes compensation expense on PSUs ratably over the requisite performance period of the award and to the extent management views the performance goal attainment as probable. The Company recognizes compensation expense on MSUs ratably over the requisite performance period of the award.

For the 2022 and 2021 fiscal year, the Company granted PSUs to certain key employees pursuant to the Company's 2020 Omnibus Plan. The number of shares earned is based on the Company’s achievement of pre-established target threshold goals for total gross written premiums over a three-year performance measurement period. The performance goals allow for a

24

payout ranging from 0% to 200% of the target award. If performance satisfies minimum requirements to result in shares of Company common stock being awarded, the number of shares will be determined between 50% and 200% of target thresholds, as defined in the applicable award agreements. Any earned PSU will vest if the employee’s service has been continuous through the vesting date. Any PSU not earned because of failure to achieve the minimum performance goal at the end of the performance period will be immediately forfeited. The grant date fair value of the PSUs was determined based on the grant date closing price of the Company’s stock.

For the 2022 and 2021 fiscal year, the Company granted MSUs to certain key employees pursuant to the Company's 2020 Omnibus Plan. The number of restricted stock units earned is based on the Company’s cumulative total shareholder return ("TSR"), as defined in the applicable award agreement, over a three-year performance measurement period. If TSR satisfies minimum requirements to result in shares being awarded, the number of shares will be determined between 50% and 200% shown in the table below. Any MSU not earned because of failure to achieve the minimum performance goal at the end of the performance period will be immediately forfeited. Grant date fair values were determined using a Monte Carlo valuation model based on the following assumptions:

	Fiscal 2022			Fiscal 2021
Total grant date fair value	$	391		$	845
Total grant date fair value per share	$	6.04		$	13.92
Expected volatility	40.0		%	35.0		%
Weighted average expected life	2.81 years			2.77 years
Risk-free interest rate	1.79		%	0.27		%

The percent of the target MSU that will be earned based on the Company’s TSR is as follows:

Cumulative TSR %
Fiscal 2022	Fiscal 2021	Percent of Units Vested
Below 29.2%	Below 25.1%	0%
29.2%	25.1%	50%
52.1%	47.2%	100%
74.9% and above	69.3% and above	200%

A summary of the status of the Company’s non-vested restricted stock unit activity as of September 30, 2022 and changes during the nine-month period then ended is as follows:

	RSUs			MSUs			PSUs			Total
	Shares	Weighted Average Grant Date Fair Value		Shares	Weighted Average Grant Date Fair Value		Shares	Weighted Average Grant Date Fair Value		Shares	Weighted Average Grant Date Fair Value
Non-vested outstanding, December 31, 2021	117,109	$	15.53	50,861	$	13.92	101,748	$	17.50	269,718	$	15.97
Granted	97,808	$	6.67	64,709	$	6.04	64,693	$	7.04	227,210	$	6.60
Vested	(48,236)	$	15.05	—	$	—	—	$	—	(48,236)	$	15.05
Forfeited or cancelled	(17,129)	$	13.43	(9,854)	$	11.67	(16,895)	$	15.76	(43,878)	$	13.93
Non-vested outstanding, September 30, 2022	149,552	$	10.13	105,716	$	9.31	149,546	$	13.17	404,814	$	11.04

25

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of financial condition and results of operations for the three and nine months ended September 30, 2022 is qualified by reference to and should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and the related notes included herein and the audited consolidated financial statements and notes included in our 2021 Form 10-K. The discussion and analysis below are based on comparisons between our historical financial data for different periods and include certain forward-looking statements about our business, operations, and financial performance. These forward-looking statements are subject to risks, uncertainties, assumptions, and other factors described in Item 1A — "Risk Factors" in our 2021 Form 10-K. Our actual results may differ materially from those expressed in, or implied by, those forward-looking statements. See "Forward-Looking Statements."

All references to "we," "us," "our," "the Company," "Trean," or similar terms refer to Trean Insurance Group, Inc. and its subsidiaries, unless the context otherwise requires. The information contained in this quarterly report is not a complete description of our business or the risks associated with an investment in our common stock.

The Company defines increases or decreases greater than 200% as "NM" or not meaningful.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial performance or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "would," "potential," or "continue" or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Forward-looking statements are based on management’s current expectations and assumptions about future events. These statements are only predictions and are not guarantees of future performance. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements if the underlying assumptions prove to be incorrect or as a result of risks, uncertainties, and other factors, including the impact of the COVID-19 pandemic, inflationary pressures and other macroeconomic factors on the business and operations of the Company, our program partners and other business relations. Other factors that may cause such differences include the risks described in the Company’s filings with the U.S. Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. These forward-looking statements speak only as of the date on which they are made. Except as required by applicable securities laws, the Company disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future developments, changes in assumptions or otherwise. Investors are cautioned not to place undue reliance on the forward-looking statements contained in this press release or in other filings and public statements of the Company.

The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and assumptions, which in many cases are beyond our control, as described in "Item 1A — Risk Factors" in our 2021 Form 10-K and in this Quarterly Report on Form 10-Q. Our statements reflecting these risks and uncertainties are not exhaustive, and other risks and uncertainties may currently exist or may arise in the future that could have material effects on our business, operations, and financial condition. We cannot assure you that the results, events, and circumstances reflected in the forward looking statements reflected in this Quarterly Report on Form 10-Q and our other public statements and securities filings will be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward looking statements.

These forward-looking statements speak only as of the date on which such statements are made. We undertake no obligation, and do not intend, to update any forward looking statements after the date of this Quarterly Report on Form 10-Q or to conform such statements to actual results or revised expectations, except as required by applicable securities laws or the rules and regulations of the Securities and Exchange Commission ("SEC").

26

Overview

We are a provider of products and services to the specialty insurance market. We underwrite specialty casualty insurance products both through our Program Partners and also through our Owned MGAs. We also provide our Program Partners with a variety of services, including issuing carrier services, claims administration, and reinsurance brokerage, from which we generate recurring fee-based revenues.

We have one reportable segment. We provide our insurance products and services to our Program Partners and Owned MGAs focused on specialty lines. We target a diversified portfolio of small to medium programs, typically with less than $30 million of premiums, that focus on niche segments of the specialty casualty insurance market and that we believe have strong underwriting track records.

Coronavirus ("COVID-19") Impact

We are monitoring the ongoing COVID-19 pandemic on our business, including how it may impact our premium revenue, loss experience and loss expense, liquidity, and our regulatory capital and surplus, and operations. Significant progress has been made to combat the outbreak of COVID-19; however, the global pandemic, including resulting inflationary pressures and other macroeconomic factors on the business and operations of the Company, has adversely impacted both the domestic and foreign economies and could still have a materially adverse impact on the Company.

Workforce Operations

Following the emergence of the COVID-19 pandemic in early 2020, we took a number of actions to protect the health of the public and our employees and to comply with directives and advice of governmental authorities and public health experts. We responded by developing a Preparedness Plan that outlined both corporate-wide and location-specific modifications to working conditions and operations in our offices.

We continue to navigate through these challenges with a sharp focus on and goal of safeguarding our employees, helping our customers and managing impacts on our business. Despite the unprecedented environment, our teams are executing at a high level and we are advancing our strategy.

Premium Revenue, Claims and Losses

We have not experienced a material impact to our premium revenue as a result of the COVID-19 pandemic. During the nine months ended September 30, 2022, compared to the nine months ended September 30, 2021, gross written premiums decreased by (0.7)% and net earned premiums increased by 42.9%. The decrease in gross written premiums was driven by the Company’s continued focus on maintaining underwriting discipline in an unusually competitive environment. The increase in net earned premiums was primarily driven by increased retention in our existing Program Partner business. Because a majority of our gross written premiums are related to workers’ compensation insurance, revenue trends could be impacted in future periods if the COVID-19 pandemic were to continue or significantly get worse. However, a significant portion of our workers’ compensation premiums are pay-as-you-go programs, which reduces our downside risk from future premium audits or refunds.

We also have not experienced a material impact in our reported claims or incurred losses in the first nine months of 2022 as a specific result of the COVID-19 pandemic.

27

Investment Portfolio

With respect to our investment portfolio, we seek to hold a high-quality, diversified portfolio of investments, which are primarily in fixed maturity and available-for-sale investments and, as such, our investment portfolio has limited exposure to equity market volatility. For the nine months ended September 30, 2022, we experienced a decrease of $58,333 in the fair value of our fixed maturities investment portfolio. The decline in the fair value of our fixed maturity investments is primarily attributable to the recent rise in interest rates driven primarily by changing conditions in the financial markets as compared to the comparatively lower rates that prevailed during the initial part of the COVID-19 pandemic in 2020 and 2021, rather than underlying credit risk within our investment portfolio. If there were to be continued equity and debt financial market volatility, which in turn could create mark-to-market investment valuation decreases, we expect there could be additional or increased unrealized losses recorded or realized losses, if sold, in future reporting periods. However, given the conservative nature of our investment portfolio, we expect that any adverse impact on the value of our investment portfolio, as it relates to COVID-19, will be temporary, and we do not expect a long-term negative impact on our financial condition, results of operations or cash flows.

Other Concerns

Adverse events such as changes in the overall public health environment, changing infection patterns and new variants of COVID-19, health-related concerns about working in our offices, restrictions on travel, the potential impact on our business partners and customers, and other matters affecting our general work and business environment could harm our business and delay the implementation of our business strategy. We cannot anticipate all the ways in which the current global health crisis and financial market conditions could adversely impact our business in the future.

Significant Components of Results of Operations

Gross written premiums: Gross written premiums are the amounts received or to be received for insurance policies written or assumed by us during a specific period of time without reduction for general and administrative expenses (including policy acquisition costs), reinsurance costs or other deductions. The volume of our gross written premiums in any given period is generally influenced by:

•addition and retention of Program Partners;

•new business submissions to our Program Partners;

•binding of new business submissions into policies;

•renewals of existing policies; and

•average size and premium rate of bound policies.

Gross earned premiums: Gross earned premiums are the earned portion of gross written premiums. We earn insurance premiums on a pro rata basis over the term of the policy. Our insurance policies generally have a term of one year.

Ceded earned premiums: Ceded earned premiums are the amount of gross earned premiums ceded to reinsurers. We enter into reinsurance contracts to limit our maximum losses and diversify our exposure and provide statutory surplus relief. The volume of our ceded earned premiums is affected by the level of our gross earned premiums and any decision we make to increase or decrease limits, retention levels, and co-participations.

Net earned premiums: Net earned premiums represent the earned portion of our gross written premiums, less that portion of our gross written premiums that is earned and ceded to third-party reinsurers, including our Program Partners and professional reinsurers, under our reinsurance agreements.

Net investment income: We earn investment income on our portfolio of cash and invested assets. Our cash and invested assets are primarily comprised of fixed maturities, including other equity investments and short-term investments. Our net investment income includes interest income on our invested assets, income on funds held investments as well as unrealized gains and losses on our equity portfolio.

28

Net realized gains/losses: Net realized gains/losses are a function of the difference between the amount received by us on the sale of a security and the security’s recorded value as well as any "other-than-temporary impairments" relating to fixed maturity investments recognized in earnings.

Other revenue: Other revenue includes brokerage, third-party administrative, management, consulting, and other fee-based revenues, which are commonly based on written premiums.

Loss and loss adjustment expenses (LAE): Losses and LAE are net of reinsurance and include claims paid, estimates of future claim payments, changes in those estimates from prior reporting periods and costs associated with investigating, defending, and servicing claims. In general, our losses and LAE are affected by:

•frequency of claims associated with the particular types of insurance contracts that we write;

•trends in the average size of losses incurred on a particular type of business;

•mix of business written by us;

•changes in the legal or regulatory environment related to the business we write;

•trends in legal defense costs;

•wage inflation; and

•inflation in medical costs.

Losses and LAE are based on an actuarial analysis of the estimated losses, including losses incurred during the period and changes in estimates from prior periods. Losses and LAE may be paid out over a period of years.

General and administrative expenses: General and administrative expenses include net commissions, insurance-related expenses, and general and administrative operating expenses. Net commissions consist of policy acquisition costs and other underwriting expenses, net of ceding commissions. Policy acquisition costs are principally comprised of the commissions we pay our brokers and program managers. Policy acquisition costs that are directly related to the successful acquisition or reinsurance of those policies are deferred. All policy acquisition costs are charged to expense in proportion to premium earned over the policy life. We receive ceding commissions on business ceded under our reinsurance contracts. Insurance-related expenses largely consist of state premium taxes. General and administrative operating expenses include employee salaries and benefits, corporate business insurance costs, technology costs, office rent, and professional services fees such as legal, accounting, audit, tax, and actuarial services.

Intangible asset amortization: Intangible asset amortization consists of expenses incurred related to the amortization of intangible assets recorded as a result of business acquisitions and consists of trade names, customer lists and relationships, and non-compete agreements.

Noncash stock compensation: Noncash stock compensation includes expenses related to the fair value and issuance of restricted stock units (time, market and performance-based) and stock options.

Gains (losses) on embedded derivatives: Gains (losses) on embedded derivatives consist of the change in fair value of derivatives, the effect of net investment income on funds held investments, and the effect of realized gains and loss on funds held investments.

Interest expense: Interest expense consists primarily of interest paid on our Secured Credit Facility and Surplus Notes (See "Financial Condition, Liquidity and capital resources — Debt and Credit Agreements").

Other income: Other income consists primarily of sublease revenue and other miscellaneous income items.

Key Metrics

We discuss certain key financial and operating metrics, described below, which provide useful information about our business and the operational factors underlying our financial performance.

29

Underwriting income is a non-GAAP financial measure defined as income before taxes excluding net investment income, investment revaluation gains, net realized gains or losses, intangible asset amortization, noncash stock compensation, noncash changes in fair value of embedded derivatives, interest expense, other revenue, and other income and expenses. See "Reconciliation of Non-GAAP Financial Measures" for a reconciliation of underwriting income to income before taxes in accordance with GAAP.

Adjusted net income is a non-GAAP financial measure defined as net income excluding the impact of certain items, including noncash intangible asset amortization and stock compensation, noncash changes in fair value of embedded derivatives, other expenses, and gains or losses that we believe do not reflect our core operating performance, which items may have a disproportionate effect in a given period, affecting comparability of our results across periods. See "Reconciliation of Non-GAAP Financial Measures" for a reconciliation of adjusted net income to net income in accordance with GAAP.

Loss ratio, expressed as a percentage, is the ratio of losses and LAE to net earned premiums.

Expense ratio, expressed as a percentage, is the ratio of general and administrative expenses to net earned premiums.

Combined ratio is the sum of the loss ratio and the expense ratio. A combined ratio under 100% generally indicates an underwriting profit. A combined ratio over 100% generally indicates an underwriting loss.

Return on equity is net income expressed on an annualized basis as a percentage of average beginning and ending stockholders' equity during the period.

Adjusted return on equity is a non-GAAP financial measure defined as adjusted net income expressed on an annualized basis as a percentage of average beginning and ending stockholders' equity during the period. See "Reconciliation of Non-GAAP Financial Measures" for a reconciliation of adjusted return on equity to return on equity in accordance with GAAP.

Tangible stockholders' equity is defined as stockholders' equity less goodwill and other intangible assets.

Return on tangible equity is a non-GAAP financial measure defined as net income expressed on an annualized basis as a percentage of average beginning and ending tangible stockholders' equity during the period. See "Reconciliation of Non-GAAP Financial Measures" for a reconciliation of return on tangible equity to return on equity in accordance with GAAP.

Adjusted return on tangible equity is a non-GAAP financial measure defined as adjusted net income expressed on an annualized basis as a percentage of average beginning and ending tangible stockholders' equity during the period. See "Reconciliation of Non-GAAP Financial Measures" for a reconciliation of adjusted return on tangible equity to return on equity in accordance with GAAP.

30

Results of Operations

Consolidated Results of Operations for the Three Months Ended September 30, 2022 Compared to September 30, 2021

The following table summarizes our results of operations for the three months ended September 30, 2022 and 2021:

	Three Months Ended September 30,				Change		Percentage Change (1)
(in thousands, except for percentages)	2022		2021
Revenues
Gross written premiums	$	162,183	$	177,624	$	(15,441)	(8.7)%
Increase in gross unearned premiums	(1,061)		(28,478)		27,417		(96.3)%
Gross earned premiums	161,122		149,146		11,976		8.0%
Ceded earned premiums	(89,741)		(97,191)		7,450		(7.7)%
Net earned premiums	71,381		51,955		19,426		37.4%
Net investment income	2,951		2,187		764		34.9%
Net realized gains	9		49		(40)		(81.6)%
Other revenue	2,140		2,799		(659)		(23.5)%
Total revenue	76,481		56,990		19,491		34.2%
Expenses
Losses and loss adjustment expenses	45,647		32,129		13,518		42.1%
General and administrative expenses	23,256		13,788		9,468		68.7%
Intangible asset amortization	1,499		1,499		—		—%
Noncash stock compensation	460		468		(8)		(1.7)%
Interest expense	931		419		512		122.2%
Total expenses	71,793		48,303		23,490		48.6%
Gains (losses) on embedded derivatives	4,871		(121)		4,992		NM
Other income	29		35		(6)		(17.1)%
Income before taxes	9,588		8,601		987		11.5%
Income tax expense	2,014		2,083		(69)		(3.3)%
Net income	$	7,574	$	6,518	$	1,056	16.2%
(1) The Company defines increases or decreases greater than 200% as "NM" or not meaningful.

31

	Three Months Ended September 30,
(in thousands, except for percentages)	2022			2021
Key metrics:
Underwriting income(1)	$	2,478		$	6,038
Adjusted net income(1)	$	5,455		$	7,678
Loss ratio	63.9		%	61.8		%
Expense ratio	32.6		%	26.5		%
Combined ratio	96.5		%	88.3		%
Return on equity	7.5		%	6.2		%
Adjusted return on equity(1)	5.4		%	7.3		%
Return on tangible equity(1)	15.5		%	12.7		%
Adjusted return on tangible equity(1)	11.2		%	15.0		%
(1) This metric represents a non-GAAP financial measure. See 'Reconciliation of Non-GAAP Financial Measures' for a reconciliation of this metric to the applicable GAAP metric.

The table below shows the total premiums earned on a gross and net basis for the respective three-month periods:

	Three Months Ended September 30,				Change		Percentage Change
(in thousands, except for percentages)	2022		2021
Revenues
Gross written premiums	$	162,183	$	177,624	$	(15,441)	(8.7)%
Increase in gross unearned premiums	(1,061)		(28,478)		27,417		(96.3)%
Gross earned premiums	161,122		149,146		11,976		8.0%
Ceded earned premiums	(89,741)		(97,191)		7,450		(7.7)%
Net earned premiums	$	71,381	$	51,955	$	19,426	37.4%

Gross written premiums: Gross written premiums decreased $15,441, or 8.7%, to $162,183 for the three months ended September 30, 2022, compared to $177,624 for the three months ended September 30, 2021. The decrease was primarily driven by the Company’s termination of an underwriting partner in a higher-risk segment at the end of the third quarter of 2021 as the Company focuses on maintaining underwriting discipline in a highly competitive environment.

Workers' compensation represented 54.9% of our gross written premiums for the three months ended September 30, 2022, compared to 54.3% for the three months ended September 30, 2021. For the three months ended September 30, 2022, gross written premiums for workers' compensation decreased by $7,389, or 7.7%, compared to the same period in 2021, reflecting the intentional decrease in California business that resulted from the Company's measures undertaken to exit certain unfavorable risks in 2021 in keeping with our overall strategy to prioritize underwriting discipline, coupled with a recent highly competitive market.

All other non-workers' compensation liability represented 45.1% of our gross written premiums for the three months ended September 30, 2022, compared to 45.7% for the three months ended September 30, 2021. For the three months ended September 30, 2022, gross written premiums for all other non-workers' compensation liability decreased $8,052, or 9.9%, compared to the same period in 2021. The decrease is due primarily to a decline in our other liability line of business, partially offset by growth in our accident & health, commercial and commercial auto lines, a result of continued line of business diversification.

Gross earned premiums: Gross earned premiums increased $11,976, or 8.0%, to $161,122 for the three months ended September 30, 2022, compared to $149,146 for the three months ended September 30, 2021. The increase in gross earned premiums reflects the change in the increase in gross unearned premiums of $27,417 net of a decrease in gross written

32

premiums of $15,441. Gross earned premiums as a percentage of gross written premiums increased to 99.3% for the three months ended September 30, 2022, compared to 84.0% for the three months ended September 30, 2021.

Ceded earned premiums: Ceded earned premiums decreased $7,450, or 7.7%, to $89,741 for the three months ended September 30, 2022, compared to $97,191 for the three months ended September 30, 2021. The decrease in ceded earned premiums is primarily driven by an increase in our retention, partially offset by the growth in gross earned premiums as described above. Ceded earned premiums as a percentage of gross earned premiums decreased to 55.7% for the three months ended September 30, 2022, compared to 65.2% for the three months ended September 30, 2021, reflecting the Company's strategic decision to retain more gross written premiums.

Net earned premiums: Net earned premiums increased $19,426, or 37.4%, to $71,381 for the three months ended September 30, 2022, compared to $51,955 for the three months ended September 30, 2021. The increase is primarily due to the growth in gross earned premiums as described above and the Company's strategic decision to retain more gross written premiums.

Net investment income (loss): Net investment income increased $764, or 34.9%, to $2,951 for the three months ended September 30, 2022, compared to $2,187 for the three months ended September 30, 2021. The increase reflects the investment of the surplus notes proceeds and the reinvestment of funds from lower yielding maturities into higher yielding investments due to higher interest rates. The increase was partially offset by the unrealized losses on equity securities of $1,101. During the first quarter of 2022, we purchased high-yield equity securities, which we believe will improve the yield on our portfolio.

Net realized gains: Net realized gains were $9 for the three months ended September 30, 2022, compared to $49 for the three months ended September 30, 2021.

Other revenue: Other revenue decreased $659, or 23.5%, to $2,140 for the three months ended September 30, 2022, compared to $2,799 for the three months ended September 30, 2021. The decrease is primarily driven by a decrease in brokerage revenue of $408 primarily due to lower placement fees reflecting the Company's increase in retention year over year.

Losses and loss adjustment expenses: Losses and LAE increased $13,518, or 42.1%, to $45,647 for the three months ended September 30, 2022, compared to $32,129 for the three months ended September 30, 2021. The increase is primarily attributable to the growth in earned premiums and increased retention during the three months ended September 30, 2022. This resulted in a loss ratio of 63.9% for the three months ended September 30, 2022 compared to 61.8% for the three months ended September 30, 2021.

General and administrative expenses: General and administrative expenses increased $9,468, or 68.7%, to $23,256 for the three months ended September 30, 2022, compared to $13,788 for the three months ended September 30, 2021. The expense ratio was 32.6% for the three months ended September 30, 2022, compared to 26.5% for the three months ended September 30, 2021.

33

The table below shows the components of general and administrative expenses for the respective three-month periods:

	Three Months Ended September 30,
	2022			2021			Change
Direct commissions	$	28,650		$	27,594		$	1,056
Ceding commissions	(23,916)			(31,655)			7,739
Net commissions	4,734			(4,061)			8,795
Insurance-related expenses	6,038			5,371			667
General and administrative operating expenses	12,484			12,478			6
Total general and administrative expenses	$	23,256		$	13,788		$	9,468
General and administrative expenses — % of gross written premiums	7.7		%	7.0		%
Retention rate (1)	44.3		%	34.8		%
Direct commission rate (2)	17.8		%	18.5		%
Ceding commission rate (3)	26.7		%	32.6		%
(1) Net earned premium as a percentage of gross earned premiums.
(2) Direct commissions as a percentage of gross earned premiums.
(3) Ceding commissions as a percentage of ceded earned premiums.

Direct commissions increased $1,056 primarily due to an increase in gross earned premiums. Ceding commissions decreased $7,739 primarily due to an increase in retention. Insurance-related expenses increased $667 primarily as a result of an increase in gross earned premiums. General and administrative operating expenses increased $6.

Intangible asset amortization: Intangible asset amortization was $1,499 for the three months ended September 30, 2022, compared to $1,499 for the three months ended September 30, 2021.

Noncash stock compensation: Noncash stock compensation was $460 for the three months ended September 30, 2022, compared with $468 for the three months ended September 30, 2021. Expenses incurred during both periods relate to the fair value of restricted stock units and stock options granted under the Company's 2020 Omnibus Plan recognized over the requisite service periods.

Gains (losses) on embedded derivatives:

The table below shows the components of gains (losses) on embedded derivatives for the respective three-month periods:

	Three Months Ended September 30,
	2022		2021		Change
Change in fair value of embedded derivatives	$	5,812	$	573	$	5,239
Effect of net investment income on funds held investments	(953)		(585)		(368)
Effect of realized losses (gains) on funds held investments	12		(109)		121
Total gains (losses) on embedded derivatives	$	4,871	$	(121)	$	4,992

Gains on embedded derivatives increased $4,992 to $4,871 for the three months ended September 30, 2022, compared to a loss of $121 for the three months ended September 30, 2021. The gain reflected an increase in the fair value of embedded derivatives of $5,239, the effect of investment income on funds held investments of $368 and the effect of realized losses on funds held investments of $121. The increase in fair value of the embedded derivatives resulted primarily from the increase in interest rates between periods, which has reduced the fair value of the underlying funds held under reinsurance agreements.

34

Income tax expense: Income tax expense was $2,014 for the three months ended September 30, 2022, which resulted in an effective tax rate of 21.0%. The effective tax rate equaled the statutory rate of 21% since the impact of state taxes were offset by the impact of tax-exempt municipal income on the Company's investments. For the three months ended September 30, 2021, income tax expense was $2,083, which resulted in an effective tax rate of 24.2%. The increase in the effective tax rate from the statutory rate of 21% is due primarily to the impact of recording our 2020 tax return accrual to return true-up in the third quarter of 2021.

Owned MGAs and Program Partner Premiums:

The following table shows the total premiums earned on a gross and net basis for Owned MGAs and Program Partners:

	Three Months Ended September 30, 2022
	Owned MGAs		Program Partner		Total
Gross written premiums	$	58,567	$	103,616	$	162,183
Increase in gross unearned premiums	2,627		(3,688)		(1,061)
Gross earned premiums	61,194		99,928		161,122
Ceded earned premiums	(20,454)		(69,287)		(89,741)
Net earned premiums	$	40,740	$	30,641	$	71,381

We utilize both quota share and catastrophe excess of loss ("XOL") contracts in our reinsurance strategy for our Owned MGAs and Program Partners. For the three months ended September 30, 2022, the Company retained 66.6% of gross earned premiums for Owned MGAs, compared to 30.7% for Program Partners.

35

Consolidated Results of Operations for the Nine Months Ended September 30, 2022 Compared to September 30, 2021

The following table summarizes our results of operations for the nine months ended September 30, 2022 and 2021:

	Nine Months Ended September 30,				Change		Percentage Change (1)
(in thousands, except for percentages)	2022		2021
Revenues
Gross written premiums	$	477,775	$	480,905	$	(3,130)	(0.7)	%
Increase in gross unearned premiums	(972)		(64,836)		63,864		(98.5)	%
Gross earned premiums	476,803		416,069		60,734		14.6	%
Ceded earned premiums	(275,235)		(275,037)		(198)		0.1	%
Net earned premiums	201,568		141,032		60,536		42.9	%
Net investment income	5,136		6,562		(1,426)		(21.7)	%
Net realized gains	311		72		239		NM
Other revenue	7,145		8,683		(1,538)		(17.7)	%
Total revenue	214,160		156,349		57,811		37.0	%
Expenses
Losses and loss adjustment expenses	125,727		86,735		38,992		45.0	%
General and administrative expenses	63,235		40,946		22,289		54.4	%
Other expenses	268		845		(577)		(68.3)	%
Intangible asset amortization	4,498		4,326		172		4.0	%
Noncash stock compensation	1,019		1,098		(79)		(7.2)	%
Interest expense	1,806		1,271		535		42.1	%
Total expenses	196,553		135,221		61,332		45.4	%
Gains on embedded derivatives	14,463		1,869		12,594		NM
Other income	76		191		(115)		(60.2)	%
Income before taxes	32,146		23,188		8,958		38.6	%
Income tax expense	6,741		5,102		1,639		32.1	%
Net income	$	25,405	$	18,086	$	7,319	40.5	%
(1) The Company defines increases or decreases greater than 200% as "NM" or not meaningful.

36

	Nine Months Ended September 30,
(in thousands, except for percentages)	2022			2021
Key metrics:
Underwriting income(1)	$	12,606		$	13,351
Adjusted net income(1)	$	19,305		$	20,103
Loss ratio	62.4		%	61.5		%
Expense ratio	31.4		%	29.0		%
Combined ratio	93.8		%	90.5		%
Return on equity	8.2		%	5.8		%
Adjusted return on equity(1)	6.2		%	6.4		%
Return on tangible equity(1)	17.0		%	12.1		%
Adjusted return on tangible equity(1)	12.9		%	13.4		%
(1) This metric represents a non-GAAP financial measure. See 'Reconciliation of Non-GAAP Financial Measures' for a reconciliation of this metric to the applicable GAAP metric.

The table below shows the total premiums earned on a gross and net basis for the respective nine-month periods:

	Nine Months Ended September 30,				Change		Percentage Change
(in thousands, except for percentages)	2022		2021
Revenues
Gross written premiums	$	477,775	$	480,905	$	(3,130)	(0.7)	%
Increase in gross unearned premiums	(972)		(64,836)		63,864		(98.5)	%
Gross earned premiums	476,803		416,069		60,734		14.6	%
Ceded earned premiums	(275,235)		(275,037)		(198)		0.1	%
Net earned premiums	$	201,568	$	141,032	$	60,536	42.9	%

Gross written premiums: Gross written premiums decreased $3,130, or 0.7%, to $477,775 for the nine months ended September 30, 2022, compared to $480,905 for the nine months ended September 30, 2021. The decrease was primarily driven by the Company’s termination of an underwriting partner in a higher-risk segment at the end of the third quarter of 2021 as the Company focuses on maintaining underwriting discipline in a highly competitive environment.

Workers' compensation represented 58.3% of our gross written premiums for the nine months ended September 30, 2022, compared to 60.2% for the nine months ended September 30, 2021. For the nine months ended September 30, 2022, gross written premiums for workers' compensation decreased by $11,222, or 3.9%, compared to the same period in 2021, reflecting the intentional decrease in California business that resulted from the Company's measures undertaken to reduce certain unfavorable risks in 2021 in keeping with our overall strategy to prioritize underwriting discipline, coupled with a recent highly competitive market.

All other non-workers' compensation liability represented 41.7% of our gross written premiums for the nine months ended September 30, 2022, compared to 39.8% for the nine months ended September 30, 2021. For the nine months ended September 30, 2022, gross written premiums for all other non-workers' compensation liability increased $8,092, or 4.2%, compared to the same period in 2021. The increase is due primarily to growth in our accident & health, commercial, and commercial auto lines, partially offset by decreases in our other liability and homeowners lines, which is a result of continued line of business diversification.

Gross earned premiums: Gross earned premiums increased $60,734, or 14.6%, to $476,803 for the nine months ended September 30, 2022, compared to $416,069 for the nine months ended September 30, 2021. The increase in gross earned premiums reflects the change in the increase in gross unearned premiums of $63,864, slightly offset by a decrease in gross

37

written premiums of $3,130. Gross earned premiums as a percentage of gross written premiums increased to 99.8% for the nine months ended September 30, 2022, compared to 86.5% for the nine months ended September 30, 2021.

Ceded earned premiums: Ceded earned premiums increased $198, or 0.1%, to $275,235 for the nine months ended September 30, 2022, compared to $275,037 for the nine months ended September 30, 2021. The slight increase in ceded earned premiums is primarily driven by the growth in gross earned premiums as described above, mostly offset by an increase in our retention. Ceded earned premiums as a percentage of gross earned premiums decreased to 57.7% for the nine months ended September 30, 2022, compared to 66.1% for the nine months ended September 30, 2021, reflecting the Company's strategic decision to retain more gross written premiums.

Net earned premiums: Net earned premiums increased $60,536, or 42.9%, to $201,568 for the nine months ended September 30, 2022, compared to $141,032 for the nine months ended September 30, 2021. The increase is primarily due to the growth in gross earned premiums as described above and the Company's strategic decision to retain more gross written premiums.

Net investment income: Net investment income decreased $1,426, or 21.7%, to $5,136 for the nine months ended September 30, 2022, compared to $6,562 for the nine months ended September 30, 2021. The decrease reflects unrealized losses of $4,542 on equity securities, partially offset by higher interest and dividend income. During the first quarter of 2022, we purchased high-yield securities, which we believe will improve the yield on our portfolio.

Net realized gains: Net realized gains were $311 for the nine months ended September 30, 2022, compared to net realized gains of $72 for the nine months ended September 30, 2021. Net realized gains for the nine months ended September 30, 2022 includes earn-out proceeds received of $1,400 related to the Company's sale of TRI in 2021. The net realized gain was offset by our repositioning strategy to sell our lower-yielding assets and purchase higher-yielding investments, prior to anticipated interest rate increases. This turnover in our portfolio resulted in realized losses of $1,022 during the first quarter of 2022.

Other revenue: Other revenue decreased $1,538, or 17.7%, to $7,145 for the nine months ended September 30, 2022, compared to $8,683 for the nine months ended September 30, 2021. The decrease is primarily driven by a reduction in brokerage revenue of $818 due to lower placement fees reflecting the Company's increase in retention year over year. In addition, managing general agent fees, third-party administrator fees, consulting and other fee-based revenue were all lower during the period.

Losses and loss adjustment expenses: Losses and LAE increased $38,992, or 45.0%, to $125,727 for the nine months ended September 30, 2022, compared to $86,735 for the nine months ended September 30, 2021. The increase is primarily attributable to the growth in earned premiums and increased retention during the nine months ended September 30, 2022. This resulted in a loss ratio of 62.4% for the nine months ended September 30, 2022, compared to 61.5% for the nine months ended September 30, 2021.

General and administrative expenses: General and administrative expenses increased $22,289, or 54.4%, to $63,235 for the nine months ended September 30, 2022, compared to $40,946 for the nine months ended September 30, 2021. The expense ratio was 31.4% for the nine months ended September 30, 2022, compared to 29.0% for the nine months ended September 30, 2021.

38

The table below shows the components of general and administrative expenses for the respective nine-month periods:

	Nine Months Ended September 30,
	2022			2021			Change
Direct commissions	$	85,691		$	78,304		$	7,387
Ceding commissions	(77,541)			(89,547)			12,006
Net commissions	8,150			(11,243)			19,393
Insurance-related expenses	17,698			14,796			2,902
General and administrative operating expenses	37,387			37,393			(6)
Total general and administrative expenses	$	63,235		$	40,946		$	22,289
General and administrative expenses — % of gross written premiums	7.8		%	7.8		%
Retention rate (1)	42.3		%	33.9		%
Direct commission rate (2)	18.0		%	18.8		%
Ceding commission rate (3)	28.2		%	32.6		%
(1) Net earned premium as a percentage of gross earned premiums.
(2) Direct commissions as a percentage of gross earned premiums.
(3) Ceding commissions as a percentage of ceded earned premiums.

Direct commissions increased $7,387 primarily due to an increase in gross earned premiums. Ceding commissions decreased $12,006 primarily due to an increase in retention. Insurance-related expenses increased $2,902 primarily as a result of an increase in gross earned premiums. General and administrative operating expenses decreased $6. The decrease in general and administrative operating expense reflects an increase in salaries and benefits of $1,295, which related primarily to a general increase in workforce, and a decrease in professional fees of $806 and depreciation expense of $183.

Other expenses: Other expenses were $268 for the nine months ended September 30, 2022 and primarily relates to management and office transition costs. Other expenses were $845 for the nine months ended September 30, 2021 and primarily relates to secondary offering costs of $555 and executive transition costs totaling $290.

Intangible asset amortization: Intangible asset amortization increased $172 to $4,498 for the nine months ended September 30, 2022, compared to $4,326 for the nine months ended September 30, 2021. The increase is primarily driven by the addition of intangible assets acquired in the acquisition of WIC in the third quarter of 2021.

Noncash stock compensation: Noncash stock compensation was $1,019 for the nine months ended September 30, 2022, compared with $1,098 for the nine months ended September 30, 2021. Expenses incurred during both periods relate to the fair value of restricted stock units and stock options granted under the Company's 2020 Omnibus Plan recognized over the requisite service periods.

Gains on embedded derivatives:

The table below shows the components of gains (losses) on embedded derivatives for the respective nine-month periods:

	Nine Months Ended September 30,
	2022		2021		Change
Change in fair value of embedded derivatives	$	16,848	$	3,761	$	13,087
Effect of net investment income on funds held investments	(2,395)		(1,783)		(612)
Effect of realized losses (gains) on funds held investments	10		(109)		119
Total gains on embedded derivatives	$	14,463	$	1,869	$	12,594

39

Gains on embedded derivatives increased $12,594 to $14,463 for the nine months ended September 30, 2022, compared to $1,869 for the nine months ended September 30, 2021. The gain reflected an increase in the fair value of embedded derivatives of $13,087, the effect of investment income on funds held investments of $612 and the effect of realized losses (gains) on funds held investments of $119. The increase in fair value of the embedded derivatives resulted primarily from an increase in interest rates between periods, which has reduced the value of the underlying funds held under reinsurance agreements.

Income tax expense: Income tax expense was $6,741 for the nine months ended September 30, 2022, which resulted in an effective tax rate of 21.0%. The effective tax rate equaled the statutory rate of 21% since the impact of state taxes were offset by the impact of tax-exempt municipal income on the Company's investments. For the nine months ended September 30, 2021, income tax expense was $5,102, which resulted in an effective tax rate of 22.0%. The increase in the effective tax rate from the statutory rate of 21% is due primarily to the impact of recording our 2020 tax return accrual to return true-up in the third quarter of 2021.

Owned MGAs and Program Partner Premiums:

The following table shows the total premiums earned on a gross and net basis for Owned MGAs and Program Partners:

	Nine Months Ended September 30, 2022
	Owned MGAs		Program Partner		Total
Gross written premiums	$	187,050	$	290,725	$	477,775
Increase in gross unearned premiums	(1,732)		760		(972)
Gross earned premiums	185,318		291,485		476,803
Ceded earned premiums	(67,781)		(207,454)		(275,235)
Net earned premiums	$	117,537	$	84,031	$	201,568

We utilize both quota share and XOL contracts in our reinsurance strategy for our Owned MGAs and Program Partners. Direct commissions for Program Partners include third-party agent commissions and MGA service fees, while Owned MGA direct commissions include only third-party agent commissions. For the nine months ended September 30, 2022, the Company retained 63.4% of gross earned premiums for Owned MGAs compared to 28.8% for Program Partners.

40

Reconciliation of Non-GAAP Financial Measures

Underwriting income

We define underwriting income as income before taxes excluding net investment income, investment revaluation gains, net realized gains or losses, intangible asset amortization, noncash stock compensation, noncash changes in fair value of embedded derivatives, interest expense, other revenue, and other income and expenses. Underwriting income represents the pre-tax profitability of our underwriting operations and allows us to evaluate our underwriting performance without regard to investment income, intangible asset amortization, noncash stock compensation, interest expense, other revenue, and other income and expenses. We use this metric because we believe it gives our management and other users of our financial information useful insight into our underwriting business performance by adjusting for these expenses and sources of income. Underwriting income should not be viewed as a substitute for net income calculated in accordance with GAAP, and other companies may define underwriting income differently.

	Three Months Ended September 30,
(in thousands, except percentages)	2022		2021
Net income	$	7,574	$	6,518
Income tax expense	2,014		2,083
Income before taxes	9,588		8,601
Other revenue	(2,140)		(2,799)
(Gains) losses on embedded derivatives	(4,871)		121
Net investment income	(2,951)		(2,187)
Net realized gains	(9)		(49)
Interest expense	931		419
Intangible asset amortization	1,499		1,499
Noncash stock compensation	460		468
Other income	(29)		(35)
Underwriting income	$	2,478	$	6,038

	Nine Months Ended September 30,
(in thousands, except percentages)	2022		2021
Net income	$	25,405	$	18,086
Income tax expense	6,741		5,102
Income before taxes	32,146		23,188
Other revenue	(7,145)		(8,683)
Gains on embedded derivatives	(14,463)		(1,869)
Net investment income	(5,136)		(6,562)
Net realized gains	(311)		(72)
Other expenses	268		845
Interest expense	1,806		1,271
Intangible asset amortization	4,498		4,326
Noncash stock compensation	1,019		1,098
Other income	(76)		(191)
Underwriting income	$	12,606	$	13,351

41

Adjusted net income

We define adjusted net income as net income excluding the impact of certain items, including noncash intangible asset amortization and stock compensation, noncash changes in fair value of embedded derivatives, other expenses and gains or losses that we believe do not reflect our core operating performance, which items may have a disproportionate effect in a given period, affecting comparability of our results across periods. We calculate the tax impact only on adjustments that would be included in calculating our income tax expense using an expected effective tax rate for the applicable years. We use adjusted net income as an internal performance measure in the management of our operations because we believe it gives our management and other users of our financial information useful insight into our results of operations and our underlying business performance by eliminating the effects of these items. Adjusted net income should not be viewed as a substitute for net income calculated in accordance with GAAP, and other companies may define adjusted net income differently.

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except percentages)	2022		2021		2022		2021
Net income	$	7,574	$	6,518	$	25,405	$	18,086
Intangible asset amortization	1,499		1,499		4,498		4,326
Noncash stock compensation	460		468		1,019		1,098
Change in fair value of embedded derivative	(5,812)		(573)		(16,848)		(3,761)
Unrealized losses on equity securities	1,101		—		4,542		—
Realized loss (gain) on sale of investment	—		112		(1,400)		112
Other expenses	—		—		268		845
Total adjustments	(2,752)		1,506		(7,921)		2,620
Tax impact of adjustments	633		(346)		1,821		(603)
Adjusted net income	$	5,455	$	7,678	$	19,305	$	20,103

Adjusted return on equity

We define adjusted return on equity as adjusted net income expressed on an annualized basis as a percentage of average beginning and ending stockholders' equity during the period. We use adjusted return on equity as an internal performance measure in the management of our operations because we believe it gives our management and other users of our financial information useful insight into our results of operations and our underlying business performance by adjusting for items that we believe do not reflect our core operating performance and that may diminish comparability across periods. Adjusted return on equity should not be viewed as a substitute for return on equity calculated in accordance with GAAP, and other companies may define adjusted return on equity differently.

	Three Months Ended September 30,						Nine Months Ended September 30,
(in thousands, except percentages)	2022			2021			2022			2021
Adjusted return on equity calculation:
Numerator: adjusted net income	$	5,455		$	7,678		$	19,305		$	20,103
Denominator: average equity	406,587			419,818			412,483			416,200
Adjusted return on equity	5.4		%	7.3		%	6.2		%	6.4		%
Return on equity	7.5		%	6.2		%	8.2		%	5.8		%

Return on tangible equity and adjusted return on tangible equity

We define tangible stockholders' equity as stockholders' equity less goodwill and other intangible assets. We define return on tangible equity as net income expressed on an annualized basis as a percentage of average beginning and ending tangible stockholders' equity during the period. We define adjusted return on tangible equity as adjusted net income expressed on an annualized basis as a percentage of average beginning and ending tangible stockholders' equity during the period. We regularly evaluate acquisition opportunities and have historically made acquisitions that affect stockholders' equity. We use return on tangible equity and adjusted return on tangible equity as internal performance measures in the management of our

42

operations because we believe they give our management and other users of our financial information useful insight into our results of operations and our underlying business performance by adjusting for the effects of acquisitions on our stockholders' equity and, in the case of adjusted return on tangible equity, by adjusting for the items that we believe do not reflect our core operating performance and that may diminish comparability across periods. Return on tangible equity and adjusted return on tangible equity should not be viewed as a substitute for return on equity or return on tangible equity, respectively, calculated in accordance with GAAP, and other companies may define return on tangible equity and adjusted return on tangible equity differently.

	Three Months Ended September 30,						Nine Months Ended September 30,
(in thousands, except percentages)	2022			2021			2022			2021
Return on tangible equity calculation:
Numerator: net income	$	7,574		$	6,518		$	25,405		$	18,086
Denominator:
Average stockholders' equity	406,587			419,818			412,483			416,200
Less: average goodwill and other intangible assets	211,713			214,942			213,212			216,356
Average tangible stockholders' equity	194,874			204,876			199,271			199,844
Return on tangible equity	15.5		%	12.7		%	17.0		%	12.1		%
Return on equity	7.5		%	6.2		%	8.2		%	5.8		%

	Three Months Ended September 30,						Nine Months Ended September 30,
(in thousands, except percentages)	2022			2021			2022			2021
Adjusted return on tangible equity calculation:
Numerator: adjusted net income	$	5,455		$	7,678		$	19,305		$	20,103
Denominator: average tangible equity	194,874			204,876			199,271			199,844
Adjusted return on tangible equity	11.2		%	15.0		%	12.9		%	13.4		%
Return on equity	7.5		%	6.2		%	8.2		%	5.8		%

Financial Condition, Liquidity and Capital Resources

Sources and Uses of Funds

We are organized as a holding company with our operations conducted through our subsidiaries, including our wholly owned insurance subsidiaries: Benchmark, which is domiciled in Kansas and commercially domiciled in California; ALIC, which is domiciled in Utah; 7710, which is domiciled in South Carolina; and BSIC, which is domiciled in Arkansas. Accordingly, the holding company may receive cash through: (i) loans from banks; (ii) draws on a revolving loan agreement; (iii) issuance of equity and debt securities; (iv) corporate service fees from our operating subsidiaries; (v) payments from our subsidiaries pursuant to our consolidated tax allocation agreement and other transactions; and (vi) dividends from our non-insurance subsidiaries and, subject to certain limitations discussed below, dividends from our insurance subsidiaries. We also may use the proceeds from these sources to contribute funds to the insurance subsidiaries in order to support premium growth, reduce our reliance on reinsurance, pay taxes, and for other general business purposes.

State insurance laws restrict the ability of insurance companies to declare stockholder dividends without prior regulatory approval. State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus.

Under Kansas and California law, dividends payable from Benchmark without the prior approval of the applicable insurance commissioner must not exceed the greater of (i) 10% of Benchmark's surplus as shown on the last statutory financial statement on file with the Kansas Insurance Department and the California Department of Insurance, respectively; or (ii) 100% of net income during the applicable twelve-month period (not including realized gains). Dividends shall not include pro rata distributions of any class of Benchmark's own securities.

43

Under Utah law, dividends payable from ALIC without the prior approval of the applicable insurance commissioner must not exceed the lesser of: (i) 10% of ALIC's surplus as shown on the last statutory financial statement on file with the Utah Insurance Department; or (ii) 100% of net income during the applicable twelve- month period (not including realized gains). Dividends shall not include pro rata distributions of any class of ALIC's own securities.

Under South Carolina law, dividends payable from 7710 without the prior approval of the applicable insurance commissioner are limited to the following during the preceding twelve months: (i) when paid from other than earned surplus must not exceed the lesser of: (a) 10% of 7710's surplus as regards policyholders as shown in 7710's most recent annual statement; or (b) the net income, not including net realized gains or losses as shown in 7710's most recent annual statement; or (ii) when paid from earned surplus must not exceed the greater of: (a) 10% of 7710's surplus as regards policyholders as shown in 7710 Insurance Company's most recent annual statement; or (b) the net income, not including net realized gains or losses as shown in 7710's most recent annual statement. Dividends shall not include pro rata distributions of any class of 7710's own securities.

Under Arkansas law, dividends payable from BSIC without the prior approval of the applicable insurance commissioner must not exceed the lesser of (i) 10% of BSIC’s surplus as shown on the last statutory financial statement on file with the Arkansas Insurance Department; or (ii) 100% of net income during the applicable twelve- month period (not including realized gains). Dividends shall not include pro rata distributions of any class of BSIC's own securities.

The maximum amount of dividends the insurance subsidiaries can pay us during 2022 without regulatory approval is approximately $17,000 based on our wholly-owned insurance subsidiaries' latest filed annual statements. Insurance regulators have broad powers to ensure that statutory surplus remains at adequate levels, and there is no assurance that dividends of the maximum amount calculated under any applicable formula would be permitted. In the future, state insurance regulatory authorities that have jurisdiction over the payment of dividends by the insurance subsidiaries may adopt statutory provisions more restrictive than those currently in effect.

Our insurance subsidiaries are also required by state law to maintain a minimum level of policyholders' surplus. Kansas, Utah, Arkansas, and South Carolina utilize a risk-based capital requirement as promulgated by the National Association of Insurance Commissioners. Such requirements are designed to identify the various business risks (e.g., investment risk, underwriting profitability risk, etc.) of insurance companies and their subsidiaries. As of September 30, 2022 and December 31, 2021, the total adjusted capital of our insurance subsidiaries was in excess of their respective prescribed risk-based capital requirements.

As of September 30, 2022, we had $81,489 in cash and cash equivalents, compared to $129,577 as of December 31, 2021.

Management believes that we have sufficient liquidity available to meet our operating cash needs and obligations and committed capital expenditures for the next twelve months.

Cash Flows

Our most significant source of cash is from premiums received from insureds, net of the related commission amount for the policies. Our most significant cash outflow is for claims that arise when a policyholder incurs an insured loss. Because the payment of claims occurs after the receipt of the premium, often years later, we invest the cash in various investment securities that generally earn interest and dividends. The table below summarizes our net cash flows.

	Nine Months Ended September 30,
	2022		2021
Cash, cash equivalents and restricted cash provided by (used in):
Operating activities	$	76,547	$	53,410
Investing activities	(154,742)		(71,131)
Financing activities	46,020		(1,125)
Net increase (decrease) in cash, cash equivalents and restricted cash	$	(32,175)	$	(18,846)

44

Operating Activities: Net cash provided by operating activities for the nine months ended September 30, 2022 was $76,547, compared to $53,410 for the same period in 2021. Net cash provided by operating activities includes net income as adjusted for depreciation and amortization, stock compensation, unrealized gains and losses on embedded derivatives, net realized gains and losses on investments, unrealized gains and losses on equity securities, bond amortization and accretion, the change in deferred income taxes, and amortization of deferred financing costs. Net cash provided by operating activities for the nine months ended September 30, 2022 primarily reflects increased unpaid loss and loss adjustment expenses of $34,431; increased funds held under reinsurance agreements of $25,016; an increase in accounts payable, accrued expenses and other liabilities of $10,518; decreased prepaid reinsurance premiums of $10,022; partially offset by increases in premiums and other receivables of $11,520; an increase in other assets of $9,040; and an increase in reinsurance recoverables of $6,963. Unpaid loss and loss adjustment expenses increased primarily due to growth in gross earned premiums and an increase in our retention. The decrease in prepaid reinsurance premiums was the result of increased retention. Funds held under reinsurance agreements increased due to a reduction in the derivatives. The increases in premiums and other receivables and reinsurance recoverables were primarily a result of steady gross written premiums during the period and the timing of payments. The increase in accounts payable, accrued expenses and other liabilities is primarily due to an increase in funds held by our reinsurance brokerage services division for insurance contracts not yet executed. Other assets increased primarily as a result of increases in our deferred policy acquisition costs, prepaid software, and brokerage contract asset balances.

Net cash provided by operating activities for the nine months ended September 30, 2021 reflects increases in unpaid loss and loss adjustment expenses of $52,975; unearned premiums of $64,879; and funds held under reinsurance agreements of $19,585; partially offset by increases in premiums and other receivables of $25,167; reinsurance recoverables of $18,460; prepaid reinsurance premiums of $30,252; other assets of $10,863 and decreases in reinsurance premiums payable of $7,829; and accounts payable, accrued expenses and other liabilities of $11,430. Unpaid loss and loss adjustment expenses and unearned premiums increased primarily due to an increase in gross written premiums. The increases in premiums and other receivables and reinsurance recoverables were primarily a result of an increase in gross written premiums during the period. Other assets increased as a result of increases in our deferred acquisition costs and contract asset balances. Funds held under reinsurance agreements decreased due to an arbitration settlement in the fourth quarter of 2020, resulting in the non-cash transfer of certain investments held as collateral. Excluding non-cash transfers, funds held under reinsurance agreements increased as a result of an increase in gross written premium.

Investing Activities: Net cash used in investing activities for the nine months ended September 30, 2022 was $154,742, compared to net cash used in investing activities of $71,131 for the same period in 2021. Net cash used in investing activities for the nine months ended September 30, 2022 includes $154,403 net cash used in the purchase and sale of investments and $339 in capital expenditures. Net cash used in investing activities for the nine months ended September 30, 2021 includes $67,476 net cash used in the purchase and sale of investments, $3,795 in cash used in the acquisition of a subsidiary, net of cash received, $232 in cash received for the sale of equity method investments and $92 in capital expenditures.

Financing Activities: Net cash provided by financing activities for the nine months ended September 30, 2022 was $46,020, compared to net cash used in financing activities of $1,125 for the same period in 2021. Net cash provided by financing activities for the nine months ended September 30, 2022 primarily includes $48,455 of net cash proceeds received from the issuance of surplus notes, partially offset by principal payment made on the Company's debt of $1,238, an earn-out payment of $750 related to our 2021 acquisition of WIC, payments for deferred financing costs of $251 and a payment for our interest rate cap of $173. Net cash used in financing activities for the nine months ended September 30, 2021 primarily includes the principal payments made on the Company's debt.

Debt and Credit Agreements

Secured Credit Facility

On July 16, 2020, we entered into the Credit Agreement with First Horizon Bank, which, among other things, extended our credit facility for a period of five years through May 26, 2025 and increased its term loan facility by $11,707, resulting in a total term loan debt amount of $33,000 and a revolving credit facility of $2,000.

On May 6, 2022, we entered into a First Amendment to the Credit Agreement to, among other things, facilitate the approval of certain internal distributions among the Company and certain of its subsidiaries as part of the Company’s overall capital management strategy.

45

On September 28, 2022, we entered into a Second Amendment to the Second Amended and Restated Credit Agreement that, among other things, replaces LIBOR as the benchmark rate with Term SOFR (as defined in the Credit Agreement), reduces the applicable margin under the Credit Agreement on Eurodollar loans from 4.50% to 3.50% and on ABR loans from 3.50% to 2.50%, and convert all extant Eurodollar loans under the Credit Agreement to Term SOFR loans. The variable interest rate plus applicable margin was 6.76% and 4.64% as of September 30, 2022 and December 31, 2021, respectively. The outstanding principal balance of the loan is to be repaid in quarterly installments that escalate from approximately $206 to $825 until March 2025. All equity securities of the subsidiaries of the Company (other than Benchmark Holding Company and its subsidiaries) have been pledged as collateral.

Hedging Arrangement

In September 2022, we entered into the Interest Rate Cap Agreement that became effective September 30, 2022, to hedge cash flows associated with interest rate fluctuations on our secured credit facility, with a termination date of May 31, 2024. The Interest Rate Cap Agreement has a notional amount of $29,700 that effectively converted the outstanding balance of the secured credit facility from variable rate debt to capped variable rate debt, resulting in a change in the applicable interest rate from an interest rate of one-month SOFR plus the applicable margin (as provided by the secured credit facility) to one-month SOFR interest rate, capped at 5.00%, plus the applicable margin. The notional amount of the Interest Rate Cap Agreement decreases quarterly in proportion to the quarterly principal payments on the secured credit facility. The Interest Rate Cap Agreement is designated as a cash flow hedge and the change in fair value is recorded in accumulated other comprehensive income and is subsequently reclassified to interest expense in the period when the hedged forecasted interest payments affect earnings. The Company paid a fixed amount of $173 for the Interest Rate Cap Agreement.

Surplus Notes

On August 24, 2022, Benchmark issued Surplus Notes which consisted of $50,000 in aggregate principal amount of 6.75% surplus notes due 2042 in a private placement exempt from registration under the Securities Act. In connection with the issuance of the Surplus Notes, Benchmark entered into the Fiscal Agency Agreement with The Bank of New York Mellon, as fiscal agent, paying agent, registrar and transfer agent, providing for the terms of the Surplus Notes.

The Surplus Notes are unsecured, subordinated debt obligations of the Company and are reflected as debt on our condensed consolidated balance sheets. All payments of principal and interest, which accrues at the rate of 6.75% per year and is payable quarterly, on the Surplus Notes are subject to prior approval by the Commissioner of the Kansas Insurance Department.

We recorded $368 of interest expense with its Surplus Notes during the three and nine months ended September 30, 2022.

Reinsurance

We cede a portion of the risk we accept on our balance sheet to third-party reinsurers through a variety of reinsurance arrangements. We manage these arrangements to align risks with our Program Partners, optimize our net retention relative to our financial objectives, balance sheet size and ratings requirements, as well as to limit our maximum loss resulting from a single program or a single event. We utilize both quota share and XOL reinsurance as tools in our overall risk management strategy to achieve these goals, usually in conjunction with each other. Quota share reinsurance involves the proportional sharing of premiums and losses of each defined program. We utilize quota share reinsurance for several purposes, including (i) to cede risk to Program Partners, which allows us to share economics and align incentives, and (ii) to cede risk to third-party reinsurers in order to manage our net written premiums appropriately based on our financial objectives, capital base, A.M. Best financial strength rating, and risk appetite. It is a core pillar of our underwriting philosophy that Program Partners retain a portion of the underwriting risk of their program. We believe this best aligns interests, attracts higher quality programs, and leads to better underwriting results. Under XOL reinsurance, losses in excess of a retention level are paid by the reinsurer, subject to a limit, and are customized per program or across multiple programs. We utilize XOL reinsurance to protect against catastrophic or other unforeseen extreme loss activity that could otherwise negatively impact our profitability and capital base. The majority of our exposure to catastrophe risk stems from the workers’ compensation premium we retain. Potential catastrophic events include an earthquake, terrorism, or another event that could cause more than one covered employee working at the same location to be injured in the event. We believe we mitigate this risk by our focus on small- to mid-sized accounts, which means that we generally do not have concentrated employee counts at single locations that could be exposed to a catastrophic loss. The costs and limits of the reinsurance coverage we purchase vary from year to year based on the availability of quality reinsurance at an acceptable price and our desired level of retention.

46

Ratings

We have a financial strength rating of "A" (Excellent) from A.M. Best. A.M. Best assigns 16 ratings to insurance companies, which currently range from "A++" (Superior) to "S" (Rating Suspended). "A" (Excellent) is the third highest rating issued by A.M. Best. The "A" (Excellent) rating is assigned to insurers that have, in A.M. Best's opinion, an excellent ability to meet their ongoing obligations to policyholders. This rating is intended to provide an independent opinion of an insurer’s ability to meet its obligation to policyholders and is not an evaluation directed at investors. See also "Risk Factors — Risks related to our business and industry — A downgrade in the A.M. Best financial strength ratings of our insurance company subsidiaries may negatively affect our business." in our 2021 Form 10-K.

The financial strength ratings assigned by A.M. Best have an impact on the ability of insurance companies to attract and retain agents and brokers and on the risk profiles of the submissions for insurance that insurance companies receive. The "A" (Excellent) rating obtained by us is consistent with our business plan and allows us to actively pursue relationships with the agents and brokers identified in our marketing plan.

Contractual Obligations

There have been no material changes in the Company's contractual obligations as of September 30, 2022 compared to December 31, 2021.

Financial condition

Stockholders' Equity

As of September 30, 2022, total stockholders' equity was $403,056, compared to $421,909 as of December 31, 2021, a decrease of $18,853. The decrease in stockholders' equity over the period was driven primarily by $19,848 of net comprehensive loss.

We had $2,757 of unrecognized stock compensation as of September 30, 2022 related to non-vested stock compensation granted. The Company recognized $1,019 of stock compensation during the nine months ended September 30, 2022.

Investment Portfolio

Our invested asset portfolio consists of fixed maturities, equity securities, other investments, and short-term investments. The majority of the investment portfolio was comprised of fixed maturity securities of $530,118 at September 30, 2022, that were classified as available-for-sale. Available-for-sale investments are carried at fair value with unrealized gains and losses on these securities, net of applicable taxes, reported as a separate component of accumulated other comprehensive income.

Our investment portfolio objectives are to maintain liquidity, facilitating financial strength and stability and ensuring regulatory and legal compliance. Our investment portfolio consists of available-for-sale fixed maturities and other equity investments, all of which are carried at fair value. We seek to hold a high-quality portfolio of investments that is managed by a professional investment advisory management firm in accordance with the Company's investment policy and routinely reviewed by our management team. Our investments, however, are subject to general economic conditions and market risks as well as risks inherent to particular securities. The Company's investment portfolio has the following objectives:

•meet insurance regulatory requirements with respect to investments under the applicable insurance laws;

•maintain an appropriate level of liquidity to satisfy the cash requirements of current operations and long-term obligations;

•adjust investment risk to offset or complement insurance risk based on our total corporate risk tolerance; and

•realize the highest possible levels of investment income and after-tax total rates of return.

47

The composition of our investment portfolio is shown in the following table as of September 30, 2022 and December 31, 2021.

	September 30, 2022
	Cost or Amortized Cost		Fair Value
Fixed maturities:
U.S. government and government securities	$	59,974	$	56,899
Foreign governments	400		392
States, territories and possessions	16,088		14,380
Political subdivisions of states, territories and possessions	38,614		33,863
Special revenue and special assessment obligations	116,311		103,318
Industrial and public utilities	125,572		118,252
Commercial mortgage-backed securities	141,552		123,478
Residential mortgage-backed securities	25,769		24,171
Other loan-backed securities	51,857		50,339
Hybrid securities	5,798		5,026
Total fixed maturities	581,935		530,118
Equity securities	39,838		35,296
Total investments	$	621,773	$	565,414

	December 31, 2021
	Cost or Amortized Cost		Fair Value
Fixed maturities:
U.S. government and government securities	$	41,490	$	41,434
Foreign governments	2,500		2,490
States, territories and possessions	10,593		10,766
Political subdivisions of states, territories and possessions	39,170		40,002
Special revenue and special assessment obligations	93,664		95,991
Industrial and public utilities	100,774		103,257
Commercial mortgage-backed securities	119,378		118,218
Residential mortgage-backed securities	16,549		17,368
Other loan-backed securities	41,236		41,425
Hybrid securities	105		110
Total fixed maturities	465,459		471,061
Equity securities	984		969
Total investments	$	466,443	$	472,030

The following table shows the percentage of the total estimated fair value of our fixed maturity securities as of September 30, 2022 and December 31, 2021 by credit rating category, using the lower of ratings assigned by Moody's Investor Service or S&P.

48

	September 30, 2022
(in thousands, except percentages)	Fair Value		% of Total
AAA	$	104,952	19.8	%
AA	298,615		56.3	%
A	93,376		17.6	%
BBB	29,651		5.6	%
BB	3,501		0.7	%
Below investment grade	23		0.0	%
Total fixed maturities	$	530,118	100.0	%

	December 31, 2021
(in thousands, except percentages)	Fair Value		% of Total
AAA	$	80,455	17.1	%
AA	278,557		59.1	%
A	77,097		16.4	%
BBB	33,959		7.2	%
BB	947		0.2	%
Below investment grade	46		0.0	%
Total fixed maturities	$	471,061	100.0	%

Critical Accounting Policies and Estimates

The unaudited interim condensed consolidated financial statements included in this Quarterly Report on Form 10-Q include amounts based on the use of estimates and judgments of management.

We identified the accounting estimates that are critical to the understanding of our financial position and results of operations. Critical accounting estimates are defined as those estimates that are both important to the portrayal of our financial condition and results of operations and require us to exercise significant judgment. We use significant judgment concerning future results and developments in applying these critical accounting estimates and in preparing our condensed consolidated financial statements. These judgments and estimates affect our reported amounts of assets, liabilities, revenues and expenses and the disclosure of our material contingent assets and liabilities. Actual results may differ materially from the estimates and assumptions used in preparing the condensed consolidated financial statements. We evaluate our estimates regularly using information that we believe to be relevant. The estimates and judgments that are most critical to the preparation of the condensed consolidated financial statements include: (i) reserves for unpaid loss and LAE; (ii) reinsurance recoveries; (iii) investment fair value measurements; (iv) goodwill and intangible assets; and (v) business combinations. For a detailed discussion of our accounting policies, see the "Notes to the Consolidated and Combined Financial Statements" included in our 2021 Form 10-K.

We test for goodwill impairment at the reporting unit level during the fourth quarter of each year and between annual tests if a triggering event indicates the possibility of an impairment. We monitor changing business conditions as well as industry and economic factors, among others, for events which could trigger the need for an interim impairment analysis. The declining share price our stock has caused the market capitalization to fall below the book value as of September 30, 2022. As a result of the decrease in share price, we performed an interim impairment analysis at September 30, 2022 and concluded that no impairment relating to goodwill existed as of September 30, 2022.

49

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument as the result of changes in interest rates, equity prices, foreign currency exchange rates, and commodity prices. The primary components of market risk affecting us are credit risk, interest rate risk, and equity rate risk, which are described in detail in Item 7A — "Quantitative and Qualitative Disclosures About Market Risk" in our 2021 Form 10-K. During the three months ended September 30, 2022, we entered into an interest rate cap agreement to mitigate our variable interest rate risk on our secured credit facility, as discussed above under "Financial Condition, Liquidity and Capital Resources—Debt and Credit Agreements—Hedging Arrangement." We do not have exposure to foreign currency exchange rate risk or commodity risk.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

As of the end of the period covered by this report, management conducted an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)). Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective as of September 30, 2022 to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms, and to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our chief executive and chief financial officer, as appropriate, to allow timely decisions regarding required disclosures.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

The effectiveness of any system of controls and procedures is subject to certain limitations, and, as a result, there can be no assurance that our controls and procedures will detect all errors or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system will be attained.

50

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

From time-to-time, the Company may be involved in legal proceedings which arise in the ordinary course of business. We believe that the outcome of such matters, individually or in the aggregate, will not have a material adverse effect on our consolidated financial position.

Item 1A. Risk Factors

We have disclosed in our 2021 Form 10-K the most significant risk factors that can impact year-to-year comparisons and that may affect the future performance of the Company's business. On a quarterly basis, we review these disclosures and update the risk factors, as appropriate. As of the date of this report, there have been no material changes to the risk factors from those disclosed in our 2021 Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities

The following table sets forth information concerning purchases of our common stock for the three months ended September 30, 2022:

Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
July 1, 2022 - July 31, 2022	2,491	$	5.39	—	—
August 1, 2022 - August 31, 2022	—	$	—	—	—
September 1, 2022 - September 30, 2022	495	$	4.17	—	—
	2,986			—

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

51

Item 6. Exhibits

Exhibit Number	Description
3.1	Amended and Restated Certificate of Incorporation of Trean Insurance Group, Inc. (filed as Exhibit 3.1 to the Registrant’s Quarterly Report on Form 10-Q filed on August 28, 2020 and incorporated by reference herein)
3.2	Amended and Restated By-Laws of Trean Insurance Group, Inc. (filed as Exhibit 3.2 to the Registrant’s Quarterly Report on Form 10-Q filed on August 28, 2020 and incorporated by reference herein)
10.1	Fiscal Agency Agreement, dated as of August 24, 2022, by and between Benchmark Insurance Company and The Bank of New York Mellon (filed as exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on August 30, 2022 and incorporated by reference herein)
10.2	First Amendment to Second Amended and Restated Credit Agreement by and among Trean Insurance Group, Inc., Trean Corporation, Trean Compstar Holdings LLC, Benchmark Administrators, LLC, the lenders party thereto and First Horizon Bank, N.A., as administrative agent, dated May 6, 2022 (filed as exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on October 4, 2022 and incorporated by reference herein)
10.3	Second Amendment to Second Amended and Restated Credit Agreement by and among Trean Insurance Group, Inc., Trean Corporation, Benchmark Administrators, LLC, the lenders party thereto and First Horizon Bank, N.A., as administrative agent, dated September 28, 2022 (filed as exhibit 10.2 to the Registrant's Current Report on Form 8-K filed on October 4, 2022 and incorporated by reference herein)
31.1+	Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2+	Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*	Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*	Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
* This certification is deemed not filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference to any filing under the Securities Act of 1933, as amended, or the Exchange Act.
+ Filed herewith.

52

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		TREAN INSURANCE GROUP, INC.
Date:	November 8, 2022	By:	/s/ Julie A. Baron
			Julie A. Baron
			Chief Executive Officer and President
			(Principal Executive Officer)
Date:	November 8, 2022	By:	/s/ Nicholas J. Vassallo
			Nicholas J. Vassallo
			Chief Financial Officer
			(Principal Financial and Accounting Officer)

53

EX-31.1

Exhibit 31.1

Certification of Principal Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Julie A. Baron, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Trean Insurance Group, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.[Reserved];

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	November 8, 2022	/s/ Julie A. Baron
		Julie A. Baron
		Chief Executive Officer and President
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Nicholas J. Vassallo, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Trean Insurance Group, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.[Reserved];

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	November 8, 2022	/s/ Nicholas J. Vassallo
		Nicholas J. Vassallo
		Chief Financial Officer
		(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Trean Insurance Group, Inc. (the Company) for the quarter ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned hereby, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

1.the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	November 8, 2022	/s/ Julie A. Baron
		Julie A. Baron
		Chief Executive Officer and President
		(Principal Executive Officer)

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Trean Insurance Group, Inc. (the Company) for the quarter ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned hereby, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to her knowledge:

1.the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	November 8, 2022	/s/ Nicholas J. Vassallo
		Nicholas J. Vassallo
		Chief Financial Officer
		(Principal Financial Officer)

XML

Cover Page - shares	9 Months Ended
	Sep. 30, 2022	Nov. 04, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-39392
Entity Registrant Name	TREAN INSURANCE GROUP, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-4512647
Entity Address, Address Line One	150 Lake Street West
Entity Address, City or Town	Wayzata
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55391
City Area Code	952
Local Phone Number	974-2200
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	TIG
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		51,220,485
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001801754
Current Fiscal Year End Date	--12-31

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Investments [Abstract]
Fixed maturities, at fair value (amortized cost of $581,935 and $465,459, respectively)	$ 530,118	$ 471,061
Equity securities, at fair value (cost $39,838 and $984, respectively)	35,296	969
Total investments	565,414	472,030
Cash and cash equivalents	81,489	129,577
Restricted cash	16,320	407
Accrued investment income	3,441	2,344
Premiums and other receivables	153,440	141,920
Income taxes receivable	1,584	460
Reinsurance recoverable	384,204	377,241
Prepaid reinsurance premiums	119,389	129,411
Deferred policy acquisition cost, net	15,011	13,344
Property and equipment, net	7,369	7,632
Right of use asset	3,292	4,530
Deferred tax asset	3,454	0
Goodwill	142,347	142,347
Intangible assets, net	68,616	73,114
Other assets	16,205	8,658
Total assets	1,581,575	1,503,015
Liabilities
Unpaid loss and loss adjustment expenses	578,751	544,320
Unearned premiums	220,891	219,940
Funds held under reinsurance agreements	204,828	199,410
Reinsurance premiums payable	49,512	45,130
Accounts payable, accrued expenses and other liabilities	43,449	29,448
Lease liability	3,629	4,976
Deferred tax liability	0	7,520
Debt	77,459	30,362
Total liabilities	1,178,519	1,081,106
Commitments and contingencies
Stockholders' equity
Common stock, $0.01 par value per share (600,000,000 authorized; 51,220,485 and 51,176,887 issued and outstanding as of September 30, 2022 and December 31, 2021, respectively)	512	512
Additional paid-in capital	289,618	288,623
Retained earnings	153,795	128,390
Accumulated other comprehensive income (loss)	(40,869)	4,384
Total stockholders' equity	403,056	421,909
Total liabilities and stockholders' equity	$ 1,581,575	$ 1,503,015

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Amortized cost	$ 581,935	$ 465,459
Equity securities, cost	$ 39,838	$ 984
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	600,000,000	600,000,000
Common stock, issued (in shares)	51,220,485	51,176,887
Common stock, outstanding (in shares)	51,220,485	51,176,887

XML

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues
Gross written premiums	$ 162,183	$ 177,624	$ 477,775	$ 480,905
Increase in gross unearned premiums	(1,061)	(28,478)	(972)	(64,836)
Gross earned premiums	161,122	149,146	476,803	416,069
Ceded earned premiums	(89,741)	(97,191)	(275,235)	(275,037)
Net earned premiums	71,381	51,955	201,568	141,032
Net investment income	2,951	2,187	5,136	6,562
Net realized gains	9	49	311	72
Other revenue	2,140	2,799	7,145	8,683
Total revenue	76,481	56,990	214,160	156,349
Expenses
Losses and loss adjustment expenses	45,647	32,129	125,727	86,735
General and administrative expenses	23,256	13,788	63,235	40,946
Other expenses	0	0	268	845
Intangible asset amortization	1,499	1,499	4,498	4,326
Noncash stock compensation	460	468	1,019	1,098
Interest expense	931	419	1,806	1,271
Total expenses	71,793	48,303	196,553	135,221
Gains (losses) on embedded derivatives	4,871	(121)	14,463	1,869
Other income	29	35	76	191
Income before taxes	9,588	8,601	32,146	23,188
Income tax expense	2,014	2,083	6,741	5,102
Net income	$ 7,574	$ 6,518	$ 25,405	$ 18,086
Earnings per share:
Basic (in dollars per share)	$ 0.15	$ 0.13	$ 0.50	$ 0.35
Diluted (in dollars per share)	$ 0.15	$ 0.13	$ 0.50	$ 0.35
Weighted average shares outstanding:
Weighted average number of shares outstanding - basic (in shares)	51,216,869	51,171,416	51,197,296	51,157,726
Weighted average number of shares outstanding - diluted (in shares)	51,217,005	51,171,416	51,197,482	51,172,602

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 7,574	$ 6,518	$ 25,405	$ 18,086
Unrealized investment losses:
Unrealized investment losses arising during the period	(19,059)	(2,419)	(58,333)	(8,670)
Income tax benefit	(3,996)	(508)	(12,243)	(1,821)
Unrealized investment losses, net of tax	(15,063)	(1,911)	(46,090)	(6,849)
Less reclassification adjustments to:
Net realized investment gains (losses) included in net realized gains (losses)	21	49	(1,060)	72
Income tax expense (benefit)	4	10	(223)	15
Total reclassifications included in net income, net of tax	17	39	(837)	57
Other comprehensive loss	(15,080)	(1,950)	(45,253)	(6,906)
Total comprehensive income (loss)	$ (7,506)	$ 4,568	$ (19,848)	$ 11,180

XML

Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common stock	Additional Paid in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning balance (in shares) at Dec. 31, 2020		51,148,782
Shareholders' equity beginning balance at Dec. 31, 2020	$ 410,107	$ 511	$ 287,110	$ 13,426	$ 109,060
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation expense	1,098		1,098
Common stock issued pursuant to equity compensation awards, net of shares repurchased (in shares)		26,105
Common stock issuances pursuant to equity compensation awards, net of shares repurchased	(93)	$ 1	(94)
Other comprehensive loss	(6,906)			(6,906)
Net income	18,086				18,086
Ending balance (in shares) at Sep. 30, 2021		51,174,887
Shareholders' equity ending balance at Sep. 30, 2021	422,292	$ 512	288,114	6,520	127,146
Beginning balance (in shares) at Jun. 30, 2021		51,157,004
Shareholders' equity beginning balance at Jun. 30, 2021	417,343	$ 511	287,734	8,470	120,628
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation expense	468		468
Common stock issued pursuant to equity compensation awards, net of shares repurchased (in shares)		17,883
Common stock issuances pursuant to equity compensation awards, net of shares repurchased	(87)	$ 1	(88)
Other comprehensive loss	(1,950)			(1,950)
Net income	6,518				6,518
Ending balance (in shares) at Sep. 30, 2021		51,174,887
Shareholders' equity ending balance at Sep. 30, 2021	$ 422,292	$ 512	288,114	6,520	127,146
Beginning balance (in shares) at Dec. 31, 2021	51,176,887	51,176,887
Shareholders' equity beginning balance at Dec. 31, 2021	$ 421,909	$ 512	288,623	4,384	128,390
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation expense	1,019		1,019
Common stock issued pursuant to equity compensation awards, net of shares repurchased (in shares)		43,598
Common stock issuances pursuant to equity compensation awards, net of shares repurchased	(24)		(24)
Other comprehensive loss	(45,253)			(45,253)
Net income	$ 25,405				25,405
Ending balance (in shares) at Sep. 30, 2022	51,220,485	51,220,485
Shareholders' equity ending balance at Sep. 30, 2022	$ 403,056	$ 512	289,618	(40,869)	153,795
Beginning balance (in shares) at Jun. 30, 2022		51,202,136
Shareholders' equity beginning balance at Jun. 30, 2022	410,118	$ 512	289,174	(25,789)	146,221
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation expense	460		460
Common stock issued pursuant to equity compensation awards, net of shares repurchased (in shares)		18,349
Common stock issuances pursuant to equity compensation awards, net of shares repurchased	(16)		(16)
Other comprehensive loss	(15,080)			(15,080)
Net income	$ 7,574				7,574
Ending balance (in shares) at Sep. 30, 2022	51,220,485	51,220,485
Shareholders' equity ending balance at Sep. 30, 2022	$ 403,056	$ 512	$ 289,618	$ (40,869)	$ 153,795

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities
Net income	$ 25,405	$ 18,086
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	5,100	5,123
Stock compensation	1,019	1,098
Unrealized gains on embedded derivatives	(16,848)	(3,761)
Net gains on investments	(311)	(72)
Unrealized losses on equity securities	4,542	0
Bond amortization and accretion	996	1,715
Deferred income taxes	1,046	(2,259)
Amortization of debt discount and deferred financing costs	131	126
Changes in operating assets and liabilities:
Accrued investment income	(1,097)	80
Premiums and other receivables	(11,520)	(25,167)
Reinsurance recoverable on paid and unpaid losses	(6,963)	(18,460)
Prepaid reinsurance premiums	10,022	(30,252)
Right of use asset	1,238	1,444
Other assets	(9,040)	(10,863)
Unpaid loss and loss adjustment expenses	34,431	52,975
Unearned premiums	951	64,879
Funds held under reinsurance agreements	25,016	19,585
Reinsurance premiums payable	4,382	(7,829)
Accounts payable, accrued expenses and other liabilities	10,518	(11,430)
Lease liability	(1,347)	(1,537)
Income taxes payable and receivable	(1,124)	(71)
Net cash provided by operating activities	76,547	53,410
Investing activities
Payments for capital expenditures	(339)	(92)
Return of capital on equity method investment	0	232
Purchase of investments, available for sale	(257,929)	(129,474)
Proceeds from investments sold, matured or repaid	103,526	61,998
Acquisition of subsidiary, net of cash received	0	(3,795)
Net cash used in investing activities	(154,742)	(71,131)
Financing activities
Shares redeemed for payroll taxes	(23)	(94)
Proceeds from surplus notes	48,455	0
Principal payments on debt	(1,238)	(1,031)
Payment for deferred financing costs	(251)	0
Payment for interest rate cap	(173)	0
Payment for acquisition of subsidiary	(750)	0
Net cash provided by (used in) financing activities	46,020	(1,125)
Net decrease in cash, cash equivalents and restricted cash	(32,175)	(18,846)
Cash, cash equivalents and restricted cash – beginning of period	129,984	157,234
Cash, cash equivalents and restricted cash – end of period	97,809	138,388
Disaggregation of cash and restricted cash:
Cash and cash equivalents	81,489
Restricted cash	16,320
Total cash, cash equivalents and restricted cash	97,809	138,388
Supplemental disclosure of cash flow information:
Interest	1,319	1,145
Income taxes	7,081	7,395
Non-cash investing and financing activity:
Right-of-use assets obtained in exchange for new operating lease liabilities	307	319
Non-cash transfer of investments to settle funds held for reinsurance	2,750	13,562
Non-cash transfer of investments to settle amounts held for others in accounts payable	0	26,211
Contingent consideration for the acquisition of subsidiary	0	1,500
Operating cash flows from operating leases	$ 1,890	$ 1,824

XML

Business and Basis of Presentation

9 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Business and Basis of Presentation

Business and Basis of Presentation

Trean Insurance Group, Inc. (together with its wholly owned subsidiaries, the "Company") provides products and services to the specialty insurance market. Historically, the Company has focused on specialty casualty markets management believes are under-served and where the Company’s expertise allows the Company to achieve higher rates, such as niche workers' compensation markets and small- to medium-sized specialty casualty insurance programs. The Company underwrites specialty-casualty insurance products both through programs where the Company partners with other organizations ("Program Partners") and also through Company owned managing general agencies ("Owned MGAs"). Additionally, the Company provides Program Partners with a variety of services, including issuing carrier services, claims administration, and reinsurance brokerage from which the Company generates fee-based revenues.

The Company's wholly owned subsidiaries include: (i) Benchmark Holding Company, a property and casualty insurance holding company, which owns Benchmark Insurance Company ("Benchmark"), a property and casualty insurance company domiciled in the state of Kansas, American Liberty Insurance Company ("ALIC"), a property and casualty insurance company domiciled in the state of Utah, 7710 Insurance Company ("7710"), a property and casualty insurance company domiciled in the state of South Carolina and Benchmark Specialty Insurance Company ("BSIC"), a property and casualty insurance company domiciled in the state of Arkansas; (ii) Compstar Insurance Services LLC, a California-based general agency; and (iii) Trean Corporation ("Trean Corp"), a reinsurance intermediary manager and a managing general agent, which consists of the following wholly owned subsidiaries: (a) Trean Reinsurance Services, LLC ("TRS"), a reinsurance intermediary broker; Benchmark Administrators LLC ("BIC Admin"), a claims third-party administrator; (b) Western Integrated Care, LLC ("WIC"), a managed care organization; and (c) Westcap Insurance Services, LLC ("Westcap"), a managing general agent based in California.

The accompanying condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with the instructions to the Quarterly Report on Form 10-Q under the Securities Exchange Act of 1934, as amended. Accordingly, they do not contain all of the information included in the Company's annual consolidated financial statements and notes. In the opinion of management, all adjustments (consisting of normal, recurring adjustments) necessary for a fair presentation of the Company’s condensed consolidated financial position and results of operations for the periods presented have been included. Although management believes the disclosures and information presented are adequate, these interim condensed consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2021 (the "2021 Form 10-K"). Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022.

Use of estimates

While preparing the condensed consolidated financial statements, the Company has made certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements, as well as reported amounts of revenue and expenses during the reporting period. Accordingly, actual results could differ from those estimates. Reported amounts that require extensive use of estimates include the reserves for unpaid losses and loss adjustment expenses ("LAE"), reinsurance recoverables, investments, goodwill, and other intangible assets. Except for the captions on the condensed consolidated balance sheets and condensed consolidated statements of comprehensive income, generally, the term loss(es) is used to collectively refer to both losses and LAE.

The Company tests for goodwill impairment at the reporting unit level during the fourth quarter of each year and between annual tests if a triggering event indicates the possibility of an impairment. The Company monitors changing business conditions as well as industry and economic factors, among others, for events which could trigger the need for an interim impairment analysis. The declining share price of the Company’s stock has caused the market capitalization to fall below the book value as of September 30, 2022. As a result of the decrease in share price, the Company performed an interim impairment analysis at September 30, 2022 and concluded that no impairment relating to goodwill existed as of September 30, 2022.

Accounting pronouncements

Recently adopted policies

In January 2020, the Financial Accounting Standards Board ("FASB") issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivative and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323 and Topic 815 ("ASU 2020-01"). This update addresses the accounting for certain equity securities upon the application or discontinuation of the equity method of accounting. Further, the update addresses scope considerations for forward contracts and purchased options on certain securities. ASU 2020-01 is effective for annual periods beginning after December 15, 2021, including interim periods thereafter. The Company adopted this standard effective January 1, 2022. Adoption of this standard did not have a material impact on the condensed consolidated financial statements.

Pending policies

The Company completed its initial public offering in July 2020, and is an emerging growth company as defined under federal securities laws. As such, the Company has elected to adopt pending accounting policies under the dates required for private companies. Therefore, the dates included within this section reflect the effective dates for the adoption of new accounting policies required by private companies.

In March 2020, the FASB issued ASU No. 2020-03, Codification Improvements to Financial Instruments ("ASU 2020-03"). This update represents changes to clarify and improve the codification to allow for easier application by eliminating inconsistencies and providing clarification on items such as (i) the application of fair value option disclosures; (ii) the accounting for fees related to modifications of debt; and (iii) aligning the contractual term of a net investment in a lease in accordance with ASC Topic 326, Financial Instruments - Credit Losses, and the lease term determined in accordance with ASC Topic 842, Leases. The Company adopted items (i) and (ii) effective January 1, 2020 and will adopt item (iii) on January 1, 2023. Adoption of this standard has not had, and is not expected to have, a material impact on the condensed consolidated financial statements.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). This update requires financial assets measured at amortized cost to be presented at the net amount expected to be collected by means of an allowance for credit losses that runs through net income. Additionally, credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses, with the amount of the allowance limited to the amount by which the fair value is below the amortized cost. ASU 2016-13 is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years. The Company will adopt this standard effective January 1, 2023. The Company is currently evaluating the impact of this standard on the condensed consolidated financial statements.

XML

Acquisitions	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions	AcquisitionsWestern Integrated CareEffective July 6, 2021, Trean Corp acquired 100% ownership of WIC for a total purchase price of $5,500, which includes $1,500 that is contingent on WIC's future earnings, as defined in the agreement. WIC is a managed care organization that offers services to workers' compensation insurers to enable employees who are injured on the job to access qualified medical treatment. The Company recorded $1,501 of goodwill and intangible assets of $3,624 associated with the business combination. The Company made an earn-out payment of $750 during the three months ended September 30, 2022.

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

The Company’s financial instruments include assets and liabilities carried at fair value. The inputs to valuation techniques used to measure fair value are prioritized into a three level hierarchy. The fair value hierarchy is as follows:

Level 1: Fair values primarily based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

Level 2: Fair values primarily based on observable inputs, other than quoted prices included in Level 1, or based on prices for similar assets and liabilities.

Level 3: Fair values primarily based on valuations derived when one or more of the significant inputs are unobservable. With little or no observable market, the determination of fair value uses considerable judgment and represents the Company’s best estimate of an amount that could be realized in a market exchange for the asset or liability.

The Company classifies the financial asset or liability by level based upon the lowest level input that is significant to the determination of the fair value. The following tables present the estimated fair value of the Company’s significant financial instruments.

	September 30, 2022
	Level 1		Level 2		Level 3		Total
Fixed maturities:
U.S. government and government securities	$	56,899	$	—	$	—	$	56,899
Foreign governments	—		392		—		392
States, territories and possessions	—		14,380		—		14,380
Political subdivisions of states territories and possessions	—		33,863		—		33,863
Special revenue and special assessment obligations	—		103,318		—		103,318
Industrial and public utilities	—		118,252		—		118,252
Commercial mortgage-backed securities	—		123,478		—		123,478
Residential mortgage-backed securities	—		24,171		—		24,171
Other loan-backed securities	—		50,339		—		50,339
Hybrid securities	—		5,026		—		5,026
Total fixed maturities	56,899		473,219		—		530,118
Equity securities	12,180		23,116		—		35,296
Total investments	$	69,079	$	496,335	$	—	$	565,414
Embedded derivatives on funds held under reinsurance agreements	$	(2,103)	$	(14,474)	$	—	$	(16,577)
Interest rate cap agreement	—		173		—		173
Debt	—		79,700		—		79,700

	December 31, 2021
	Level 1		Level 2		Level 3		Total
Fixed maturities:
U.S. government and government securities	$	2,392	$	39,042	$	—	$	41,434
Foreign governments	—		2,490		—		2,490
States, territories and possessions	—		10,766		—		10,766
Political subdivisions of states, territories and possessions	—		40,002		—		40,002
Special revenue and special assessment obligations	—		95,991		—		95,991
Industrial and public utilities	—		103,257		—		103,257
Commercial mortgage-backed securities	—		118,218		—		118,218
Residential mortgage-backed securities	—		17,368		—		17,368
Other loan-backed securities	—		41,425		—		41,425
Hybrid securities	—		110		—		110
Total fixed maturities	2,392		468,669		—		471,061
Equity securities	—		969		—		969
Total investments	$	2,392	$	469,638	$	—	$	472,030
Embedded derivatives on funds held under reinsurance agreements	$	(4)	$	275	$	—	$	271
Debt	—		30,938		—		30,938

Fixed maturities and equity securities: The Company, through its third-party pricing service provider, uses a variety of sources to estimate the fair value of investments such as Refinitiv (formerly Reuters), PricingDirect, ICE Data Services, and for equities, Bloomberg or S&P Capital IQ Pro. Equity securities are generally valued at the closing price on the exchange on which they are primarily traded as provided by a third-party pricing service. Fixed income securities are generally valued at an evaluated bid as provided by a third-party pricing service. Securities and other assets generally valued using third-party pricing services may also be valued at broker/dealer indications. Values obtained from third-party pricing services can utilize several market data sources for inputs such as transaction data, yield, quality, coupon rate, maturity, issue type, trading characteristics, and other market activity. To validate the reasonableness of the prices, the Company performs various qualitative and quantitative procedures such as analysis of recent trading activity, analytical review of fair values and an evaluation of the underlying pricing methodologies. Based on these procedures, the Company did not adjust the prices or quotes from the third-party pricing service.

Embedded derivatives: The Company enters into funds held contracts under reinsurance agreements, which create embedded derivatives on the underlying investments. These embedded derivatives are valued based upon the unrealized gain or loss position of the funds held portfolio, which is determined consistent with other investments using third-party pricing services. To validate the reasonableness of the quoted prices, the Company performs various qualitative and quantitative procedures such as analysis of recent activity, analytical review of fair values and an evaluation of the underlying pricing methodologies. Based on these procedures, the Company did not adjust the prices or quotes from the third-party pricing service.

Interest rate cap agreement: The Company entered into an interest cap agreement to hedge cash flows associated with interest rate fluctuations on variable rate debt. The fair value of the interest rate cap agreement is based on the terms of the agreement and commonly quoted data for forward interest rate curves and an implied market volatility. The Company also assessed the significance of credit valuation adjustments to appropriately reflect the respective nonperformance risk in the fair value measurement and determined the credit valuation adjustment is not significant to the overall valuation of the interest rate cap.

Debt: The Company holds debt related to its secured credit facility and surplus notes. The Company has determined that the remaining balance of the debt reflected its fair value as this would represent the total amount to repay the debt.

XML

Investments

9 Months Ended

Sep. 30, 2022

Investments, Debt and Equity Securities [Abstract]

Investments

Investments

Fixed income securities include bonds, asset-backed securities, and redeemable preferred securities. Fixed income securities, which may be sold prior to their contractual maturity, are designated as available-for-sale and are carried at fair value. Equity securities primarily include common stocks, mutual funds, and non-redeemable preferred stocks, which are carried at fair value.

The cost or amortized cost, gross unrealized gains, gross unrealized losses, and estimated fair value of the Company's fixed maturities investments are as follows:

	September 30, 2022
	Cost or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Fixed maturities:
U.S. government and government securities	$	59,974	$	14	$	(3,089)	$	56,899
Foreign governments	400		—		(8)		392
States, territories and possessions	16,088		—		(1,708)		14,380
Political subdivisions of states, territories and possessions	38,614		1		(4,752)		33,863
Special revenue and special assessment obligations	116,311		5		(12,998)		103,318
Industrial and public utilities	125,572		—		(7,320)		118,252
Commercial mortgage-backed securities	141,552		20		(18,094)		123,478
Residential mortgage-backed securities	25,769		16		(1,614)		24,171
Other loan-backed securities	51,857		—		(1,518)		50,339
Hybrid securities	5,798		—		(772)		5,026
Total fixed maturities available for sale	$	581,935	$	56	$	(51,873)	$	530,118

	December 31, 2021
	Cost or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Fixed maturities:
U.S. government and government securities	$	41,490	$	113	$	(169)	$	41,434
Foreign governments	2,500		—		(10)		2,490
States, territories and possessions	10,593		189		(16)		10,766
Political subdivisions of states, territories and possessions	39,170		975		(143)		40,002
Special revenue and special assessment obligations	93,664		2,920		(593)		95,991
Industrial and public utilities	100,774		2,835		(352)		103,257
Commercial mortgage-backed securities	119,378		591		(1,751)		118,218
Residential mortgage-backed securities	16,549		843		(24)		17,368
Other loan-backed securities	41,236		248		(59)		41,425
Hybrid securities	105		5		—		110
Total fixed maturities available for sale	$	465,459	$	8,719	$	(3,117)	$	471,061

The following table illustrates the Company’s gross unrealized losses and fair value of fixed maturities, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:

	September 30, 2022
	Less Than 12 Months				12 Months or More				Total
	Fair Value		Unrealized Loss		Fair Value		Unrealized Loss		Fair Value		Unrealized Loss
Fixed maturities:
U.S. government and government securities	$	47,377	$	(2,691)	$	4,623	$	(398)	$	52,000	$	(3,089)
Foreign governments	392		(8)		—		—		392		(8)
States, territories and possessions	14,150		(1,612)		229		(96)		14,379		(1,708)
Political subdivisions of states, territories and possessions	27,617		(3,574)		5,725		(1,178)		33,342		(4,752)
Special revenue and special assessment obligations	86,592		(8,560)		15,668		(4,438)		102,260		(12,998)
Industrial and public utilities	107,179		(5,541)		11,074		(1,779)		118,253		(7,320)
Commercial mortgage-backed securities	72,893		(7,836)		44,600		(10,258)		117,493		(18,094)
Residential mortgage-backed securities	19,794		(1,551)		1,437		(63)		21,231		(1,614)
Other loan-backed securities	46,109		(1,316)		4,231		(202)		50,340		(1,518)
Hybrid securities	5,026		(772)		—		—		5,026		(772)
Total fixed maturities	$	427,129	$	(33,461)	$	87,587	$	(18,412)	$	514,716	$	(51,873)

	December 31, 2021
	Less Than 12 Months				12 Months or More				Total
	Fair Value		Unrealized Loss		Fair Value		Unrealized Loss		Fair Value		Unrealized Loss
Fixed maturities:
U.S. government and government securities	$	26,935	$	(168)	$	23	$	(1)	$	26,958	$	(169)
Foreign governments	2,490		(10)		—		—		2,490		(10)
States, territories and possessions	935		(16)		—		—		935		(16)
Political subdivisions of states, territories and possessions	11,115		(143)		—		—		11,115		(143)
Special revenue and special assessment obligations	29,917		(593)		—		—		29,917		(593)
Industrial and public utilities	24,042		(286)		1,058		(66)		25,100		(352)
Commercial mortgage-backed securities	80,126		(1,565)		6,212		(186)		86,338		(1,751)
Residential mortgage-backed securities	4,539		(24)		—		—		4,539		(24)
Other loan-backed securities	20,153		(36)		2,477		(23)		22,630		(59)
Hybrid securities	—		—		—		—		—		—
Total fixed maturities	$	200,252	$	(2,841)	$	9,770	$	(276)	$	210,022	$	(3,117)

The unrealized losses on the Company’s available for sale securities as of September 30, 2022 and December 31, 2021 were primarily attributable to an increase in interest rates, which predominantly impacted fixed maturities acquired since the second quarter of 2020.

The amortized cost and estimated fair value of fixed maturities as of September 30, 2022, by contractual maturity, are as follows:

	Cost or Amortized Cost		Fair Value
Available for sale:
Due in one year or less	$	31,666	$	31,433
Due after one year but before five years	162,478		153,776
Due after five years but before ten years	96,488		86,189
Due after ten years	72,125		60,732
Commercial mortgage-backed securities	141,552		123,478
Residential mortgage-backed securities	25,769		24,171
Other loan-backed securities	51,857		50,339
Total	$	581,935	$	530,118

Actual maturities may differ from contractual maturities as issuers may have the right to call or prepay obligations with or without call or prepayment penalties.

Realized gains and losses on investments included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021 are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Fixed maturities:
Gains	$	21	$	52	$	134	$	150
Losses	—		—		(1,194)		(75)
Total fixed maturities	21		52		(1,060)		75
Funds held investments:
Gains	—		110		19		110
Losses	(12)		(1)		(29)		(1)
Total funds held investments	(12)		109		(10)		109
Equity securities:
Equity method investments:
Gains	—		—		1,400		—
Losses	—		(112)		(19)		(112)
Total equity securities	—		(112)		1,381		(112)
Total net realized gains	$	9	$	49	$	311	$	72

Net investment income consists of the following for the three and nine months ended September 30, 2022 and 2021:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Fixed maturities	$	2,628	$	1,597	$	6,189	$	4,734
Income on funds held investments	953		585		2,395		1,783
Equity securities	421		5		1,031		41
Unrealized losses on equity securities	(1,101)		—		(4,542)		—
Interest earned on cash and short-term investments	50		—		63		4
Net investment income	$	2,951	$	2,187	$	5,136	$	6,562

Net realized and unrealized gains (losses) on equity securities recognized during the three and nine months ended September 30, 2022 and 2021 are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Equity securities:
Net realized gains (losses) on sales of equity securities	$	—	$	(112)	$	1,381	$	(112)
Change in net unrealized gains (losses) of equity securities still held as of September 30, 2022 and 2021	(1,101)		(6)		(4,542)		11
Net realized and unrealized gains (losses) on equity securities	$	(1,101)	$	(118)	$	(3,161)	$	(101)

Embedded derivatives

The Company enters into funds held contracts under reinsurance agreements, which create embedded derivatives that are measured at fair value. The embedded derivatives within the Company's funds held under reinsurance agreements relate to a total return swap on the underlying investments. These embedded derivatives had no impact on total operating, investing, and financing activities as presented on the Company’s condensed consolidated statements of cash flows during the nine months ended September 30, 2022 and 2021. Total funds held under reinsurance agreements include the following:

	September 30, 2022		December 31, 2021
Funds held under reinsurance agreements, at cost	$	221,405	$	199,139
Embedded derivatives, at fair value	(16,577)		271
Total funds held under reinsurance agreements	$	204,828	$	199,410

Gains (losses) on embedded derivatives consists of the following for the three and nine months ended September 30, 2022 and 2021:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Change in fair value of embedded derivatives	$	5,812	$	573	$	16,848	$	3,761
Effect of net investment income on funds held investments	(953)		(585)		(2,395)		(1,783)
Effect of realized losses (gains) on funds held investments	12		(109)		10		(109)
Total gains (losses) on embedded derivatives	$	4,871	$	(121)	$	14,463	$	1,869

XML

Equity Method Investments	9 Months Ended
	Sep. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments	Equity Method InvestmentsOn January 3, 2020, the Company sold 15% of its previous 25% ownership in Trean Intermediaries ("TRI") for cash proceeds of $3,000, resulting in a remaining ownership interest of 10%. The Company sold all of its remaining ownership interest in TRI during the third quarter of 2021 for $1,888, resulting in a realized loss of $112, which was included in net realized gains (losses) on the consolidated statements of operations for the three and nine months ended September 30, 2021. The sale agreement included an earn-out that would increase the amount received based on TRI's future performance. The Company received an earn-out payment of $1,400, which was included in net realized gains (losses) on the consolidated statements of operations for the nine months ended September 30, 2022. The Company recorded $0 and $50 of revenue for the three months ended September 30, 2022 and 2021, respectively, and $100 and $150 of revenue for the nine months ended September 30, 2022 and 2021, respectively, for consulting services provided to TRI.

XML

Debt

9 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

Debt

Debt

Debt consisted of the following:

	September 30, 2022						December 31, 2021
	Face Value		Unamortized Discount and Issuance Costs		Carrying Value		Face Value		Unamortized Discount and Issuance Costs		Carrying Value
Secured credit facility	$	29,700	$	(449)	$	29,251	$	30,938	$	(576)	$	30,362
Surplus notes	50,000		(1,792)		48,208		—		—		—
Total debt	$	79,700	$	(2,241)	$	77,459	$	30,938	$	(576)	$	30,362

Secured Credit Facility

In July 2020, the Company entered into a Second Amended and Restated Credit Agreement (the "Credit Agreement") that, among other things, extended the Company's credit facility for a period of five years through May 26, 2025, and increased its term loan facility by $11,707, resulting in a total term loan debt amount of $33,000 and a revolving credit facility of $2,000 at the time of closing. The outstanding principal balance of the loan is to be repaid in quarterly installments, which escalate from $206 to $825. All equity securities of the subsidiaries of the Company (other than Benchmark Holding Company and its subsidiaries) have been pledged as collateral.

On May 6, 2022, the Company entered into a First Amendment to the Credit Agreement to, among other things, facilitate the approval of certain internal distributions among the Company and certain of its subsidiaries as part of the Company’s overall capital management strategy.

On September 28, 2022, the Company entered into a Second Amendment to the new Credit Agreement that, among other things, replaced LIBOR as the benchmark rate with Term SOFR (as defined in the Credit Agreement), reduced the applicable margin under the Credit Agreement on Eurodollar loans from 4.50% to 3.50% and on ABR loans from 3.50% to 2.50%, and converted all extant Eurodollar loans under the Credit Agreement to Term SOFR loans. The variable interest rate plus applicable margin was 6.76% and 4.64% as of September 30, 2022 and December 31, 2021, respectively.

During the three months ended September 30, 2022 and 2021, the Company recorded interest expense of $563 and $419, respectively, on its credit facility including amortization of debt issuance costs. During the nine months ended September 30, 2022 and 2021, the Company recorded interest expense of $1,438 and $1,271, respectively, on its credit facility including amortization of debt issuance costs.

The terms of the credit facility require the Company to maintain certain financial covenants and ratios. The Company was in compliance with all covenants and ratios as of September 30, 2022.

Interest Rate Cap Agreement

In September 2022, the Company entered into an interest rate cap agreement that became effective September 30, 2022, to hedge cash flows associated with interest rate fluctuations on its secured credit facility, with a termination date of May 31, 2024 ("Interest Rate Cap Agreement"). The Interest Rate Cap Agreement has a notional amount of $29,700 that effectively converted the outstanding balance of the secured credit facility from variable rate debt to capped variable rate debt, resulting in a change in the applicable interest rate from an interest rate of one-month SOFR plus the applicable margin (as provided by the secured credit facility) to a one-month SOFR interest rate, capped at 5.00%, plus the applicable margin. The notional amount of the Interest Rate Cap Agreement decreases quarterly in proportion to the quarterly principal payments on the secured credit facility. The Interest Rate Cap Agreement is designated as a cash flow hedge and the change in fair value is recorded in accumulated other comprehensive income and is subsequently reclassified to interest expense in the period when

the hedged forecasted interest payments affect earnings. The Company paid a fixed amount of $173 for the Interest Rate Cap Agreement.

Surplus Notes

On August 24, 2022, Benchmark, a subsidiary of the Company, issued $50,000 in aggregate principal amount of Benchmark’s 6.75% surplus notes due 2042 (the “Surplus Notes”) in a private placement exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the issuance of the Surplus Notes, Benchmark entered into a fiscal agency agreement, dated as of August 24, 2022 (the “Fiscal Agency Agreement”), with The Bank of New York Mellon, as fiscal agent, paying agent, registrar and transfer agent, providing for the terms of the Surplus Notes.

The Surplus Notes are unsecured, subordinated debt obligations of the Company and are reflected as debt on the condensed consolidated balance sheets of the Company. All principal and interest payments on the Surplus Notes are subject to prior approval by the Commissioner of the Kansas Insurance Department. Interest on the Surplus Notes accrues at the rate of 6.75% per year, and is payable quarterly in arrears on February 24, May 24, August 24 and November 24 of each year, commencing on November 24, 2022.

The Surplus Notes may be redeemed after 10 years, in full or in part, for 100% of the principal amount plus accrued but unpaid interest, and the Company may at any time repurchase Surplus Notes from the underlying holders thereof on the open market, after which such Surplus Notes will be cancelled and not re-issued. In addition, the Surplus Notes may be redeemed before August 24, 2032 upon the occurrence of certain changes in applicable tax laws or regulations that would require the Company to pay additional amounts necessary to reimburse the noteholders for new or changed withholding or deduction obligations.

In addition, pursuant to the Fiscal Agency Agreement, the Company made certain customary representations and warranties and made certain customary covenants. The covenants, among other things, (i) prevent Benchmark from incurring indebtedness exceeding 35% of its total surplus (as set forth in its statutory financial statements, and including the Surplus Notes), and restrict Benchmark’s ability to pay dividends to the Company if such ratio were to exceed 35% or would exceed 35% as a result of such payment; (ii) limit Benchmark’s ability to engage in a merger, sale or consolidation and require it to preserve its corporate existence; and (iii) require it to provide certain financial information and insurance regulatory filings to the noteholders. All of these covenants are subject to a number of important exceptions, limitations and qualifications. Notwithstanding the foregoing, noteholders do not have the right to declare the Surplus Notes to immediately mature or otherwise become immediately payable as a result of any breach of Benchmark’s covenants or under any other circumstances. Benchmark’s obligations under the Surplus Notes will only be accelerated in the event that any state or federal agency were to obtain an order or grant approval for the rehabilitation, liquidation, conservation or dissolution of Benchmark.

During the three and nine months ended September 30, 2022, the Company recorded interest expense of $368 on its Surplus Notes including amortization of debt issuance costs.

XML

Revenue from Contracts with Customers

9 Months Ended

Sep. 30, 2022

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

Revenue from Contracts with Customers

Revenue from contracts with customers, included in other revenue, includes brokerage, management, third-party administrative, and consulting and other fee-based revenue. The following table presents the revenues recognized from contracts with customers included in the condensed consolidated statements of operations.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Brokerage	$	1,581	$	1,989	$	5,396	$	6,214
Managing general agent fees	83		88		251		407
Third-party administrator fees	266		437		838		1,191
Consulting and other fee-based revenue	210		285		660		871
Total revenue from contracts with customers	$	2,140	$	2,799	$	7,145	$	8,683

The Company did not have any contract liabilities as of September 30, 2022 or December 31, 2021. The following table provides information related to the contract assets from contracts with customers. Contract assets are included within other assets on the condensed consolidated balance sheets.

	September 30, 2022		December 31, 2021
Contract assets	$	4,878	$	3,353

XML

Income Taxes

9 Months Ended

Sep. 30, 2022

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

Income tax expense for interim periods is measured using an estimated effective income tax rate for the annual period. The Company's effective tax rate was 21.0% for the three and nine months ended months ended September 30, 2022.

The Company’s effective tax rate was 24.2% and 22.0% for the three and nine months ended September 30, 2021, respectively, which differed from the statutory rate primarily due the impact of recording the Company's 2020 tax return accrual to return true-up in the third quarter of 2021.

XML

Liability for Unpaid Losses and Loss Adjustment Expense

9 Months Ended

Sep. 30, 2022

Insurance [Abstract]

Liability for Unpaid Losses and Loss Adjustment Expense

Liability for Unpaid Losses and Loss Adjustment Expense

The following table represents a reconciliation of changes in the liability for unpaid losses and LAE.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Unpaid losses and LAE reserves at beginning of period	$	577,686	$	502,560	$	544,320	$	457,817
Less losses ceded through reinsurance	(379,274)		(358,601)		(369,008)		(335,655)
Net unpaid losses and LAE at beginning of period	198,412		143,959		175,312		122,162
Incurred losses and LAE related to:
Current period	45,673		32,947		126,545		88,032
Prior period	(26)		(818)		(818)		(1,297)
Total incurred losses and LAE	45,647		32,129		125,727		86,735
Paid losses and LAE, net of reinsurance, related to:
Current period	19,570		12,638		41,268		25,111
Prior period	12,859		7,092		48,141		27,428
Total paid losses and LAE	32,429		19,730		89,409		52,539
Net unpaid losses and LAE at end of period	211,630		156,358		211,630		156,358
Plus losses ceded through reinsurance	367,121		354,434		367,121		354,434
Unpaid losses and LAE reserves at end of period	$	578,751	$	510,792	$	578,751	$	510,792

As a result of changes in estimates of insured events in prior years, the provision for unpaid losses and LAE decreased by approximately $26 and $818 for the three and nine months ended September 30, 2022, respectively, and $818 and $1,297 for the three and nine months ended September 30, 2021, respectively.

XML

Reinsurance

9 Months Ended

Sep. 30, 2022

Reinsurance Disclosures [Abstract]

Reinsurance

Reinsurance

The Company utilizes reinsurance contracts to reduce its exposure to losses in all aspects of its insurance business. Such reinsurance permits recovery of a portion of losses from reinsurers, although it does not relieve the Company from its primary liability to policyholders. Failure of reinsurers to honor their obligations could result in losses to the Company. The Company evaluates the financial strength of potential reinsurers and continually monitors the financial condition of its reinsurers.

A summary of the impact of ceded reinsurance on premiums written and premiums earned is as follows:

	Three Months Ended September 30,
	2022								2021
	Gross		Assumed		Ceded		Net		Gross		Assumed		Ceded		Net
Written premiums	$	160,505	$	1,678	$	(93,790)	$	68,393	$	175,516	$	2,108	$	(114,374)	$	63,250
Earned premiums	158,643		2,479		(89,741)		71,381		146,170		2,976		(97,191)		51,955

	Nine Months Ended September 30,
	2022								2021
	Gross		Assumed		Ceded		Net		Gross		Assumed		Ceded		Net
Written premiums	$	470,391	$	7,384	$	(265,234)	$	212,541	$	473,463	$	7,442	$	(305,164)	$	175,741
Earned premiums	469,403		7,400		(275,235)		201,568		408,936		7,133		(275,037)		141,032

XML

Leases

9 Months Ended

Sep. 30, 2022

Leases [Abstract]

Leases

Leases

The Company's leases consist of operating leases for office space and equipment. The Company determines if an arrangement is a lease at its inception. Leases with an initial term of twelve months or less are not recorded on the balance sheet. Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease. Operating lease right-of-use assets are recognized at commencement date based on the present value of lease payments over the lease term. As the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Some of the Company's leases include options to extend the term, which are only included in the lease liability and right-of-use asset calculation when it is reasonably certain the Company will exercise an option. The Company's leases have remaining terms ranging from one month to 57 months, some of which have options to extend the lease for up to an additional 60 months. As of September 30, 2022, the lease liability and right-of-use assets did not include the impact of any lease extension options as it is not reasonably certain that the Company will exercise the extension options.

Total lease expense for the three months ended September 30, 2022 was $615, inclusive of $17 in variable lease expense. Total lease expense for the three months ended September 30, 2021 was $626, inclusive of $29 in variable lease expense. The Company also sublets some of its leased office space and recorded $27 and $33 of sublease income for the three months ended September 30, 2022 and 2021, respectively, which is included in other income on the condensed consolidated statements of operations.

Total lease expense for the nine months ended September 30, 2022 was $1,855, inclusive of $68 in variable lease expense. Total lease expense for the nine months ended September 30, 2021 was $1,831, inclusive of $56 in variable lease expense. The Company also sublets some of its leased office space and recorded $70 and $74 of sublease income for the nine months ended September 30, 2022 and 2021, respectively, which is included in other income on the condensed consolidated statement of operations.

Supplemental balance sheet information, the weighted average remaining lease term and weighted average discount rate related to leases were as follows:

	September 30, 2022			December 31, 2021
Right of use asset	$	3,292		$	4,530
Lease liability	$	3,629		$	4,976
Weighted average remaining lease term	1.95 years			2.42 years
Weighted average discount rate	6.04		%	6.33		%

Future maturities of lease liabilities as of September 30, 2022 are as follows:

	Operating Leases
2022	$	621
2023	1,940
2024	1,064
2025	164
2026	44
Thereafter	2
Total lease payments	3,835
Less: imputed interest	(206)
Total lease liabilities	$	3,629

XML

Equity

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

Equity

Equity

Common Stock

The Company currently has authorized 600,000,000 shares of common stock with a par value of $0.01. As of September 30, 2022 and December 31, 2021, there were 51,220,485 and 51,176,887 shares of common stock issued and outstanding, respectively.

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

Basic earnings per share ("EPS") is computed by dividing net income by the weighted average number of shares outstanding during reported periods. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock of the Company during reported periods and is calculated using the treasury stock method.

The following table presents the calculation of basic and diluted EPS of common stock:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net income — basic and diluted	$	7,574	$	6,518	$	25,405	$	18,086
Weighted average number of shares outstanding — basic	51,216,869		51,171,416		51,197,296		51,157,726
Effect of dilutive securities:
Restricted stock units	136		—		186		14,876
Dilutive shares	136		—		186		14,876
Weighted average number of shares outstanding — diluted	51,217,005		51,171,416		51,197,482		51,172,602
Earnings per share:
Basic	$	0.15	$	0.13	$	0.50	$	0.35
Diluted	$	0.15	$	0.13	$	0.50	$	0.35

At September 30, 2022 and September 30, 2021, there were restricted stock units and stock options outstanding totaling 561,537 and 396,044, respectively, excluded from the computation of diluted weighted-average shares outstanding because their inclusion would have been anti-dilutive.

XML

Accumulated Other Comprehensive Income (Loss)

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

Accumulated Other Comprehensive Income (Loss)

Accumulated Other Comprehensive Income (Loss)

The following table presents the changes in accumulated other comprehensive income (loss) for unrealized gains and losses on available-for-sale securities:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Balance at beginning of period	$	(25,789)	$	8,470	$	4,384	$	13,426
Other comprehensive loss, net of tax:
Unrealized investment losses:
Unrealized investment losses arising during the period	(19,059)		(2,419)		(58,333)		(8,670)
Income tax benefit	(3,996)		(508)		(12,243)		(1,821)
Unrealized investment losses, net of tax	(15,063)		(1,911)		(46,090)		(6,849)
Less reclassification adjustments to:
Net realized investment gains (losses) included in net realized gains (losses)	21		49		(1,060)		72
Income tax expense (benefit)	4		10		(223)		15
Total reclassifications included in net income, net of tax	17		39		(837)		57
Other comprehensive loss	(15,080)		(1,950)		(45,253)		(6,906)
Balance at end of period	$	(40,869)	$	6,520	$	(40,869)	$	6,520

XML

Stock Compensation

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement [Abstract]

Stock Compensation

Stock Compensation

As of September 30, 2022, the Company has one incentive plan, the Trean Insurance Group, Inc. 2020 Omnibus Incentive Plan (the "2020 Omnibus Plan"). The purposes of the 2020 Omnibus Plan are to provide additional incentive to selected officers, employees, non-employee directors, independent contractors, and consultants of the Company whose contributions are essential to the growth and success of the business of the Company and its affiliates, to strengthen the commitment and motivate such individuals to faithfully and diligently perform their responsibilities and to attract competent and dedicated individuals whose efforts will result in the long-term growth and profitability of the Company and its affiliates. The 2020 Omnibus Plan is administered by the Compensation, Nominating, and Corporate Governance Committee of the Company's board of directors and provides for the issuance of up to 5,058,085 shares of the Company's common stock granted in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, stock bonuses, other stock awards, or any combination of the foregoing.

Stock Options

Stock compensation expense related to stock option awards was $53 and $49 for the three months ended September 30, 2022 and 2021, respectively, and $149 and $118 for the nine months ended September 30, 2022 and 2021, respectively. Actual forfeitures are recognized as they occur.

Employee stock option awards granted set forth, among other things, the option exercise price, the option term, provisions regarding option exercisability, and whether the option is intended to be an incentive stock option ("ISO") or a nonqualified stock option ("NQ"). Stock options may be granted to employees at such exercise prices as the Company’s board of directors may determine but not less than 100% of the fair market value of the underlying stock as of the date of grant. Employee options vest one third annually over a period of three years and have contractual terms of ten years from the date of grant.

The fair value of each time-based vesting option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions noted in the following table. The Company’s expected volatility for the period was based on a weighted average expected volatility of an industry peer group of insurance companies of similar size, life cycle, and lines of business. Expected term is calculated using the simplified method taking into consideration the option's contractual life and vesting terms. The Company’s stock option grants qualify as plain vanilla options and as such the Company uses the simplified method in estimating its expected option term as the Company does not have sufficient historical exercise data to

provide a reasonable basis upon which to estimate expected term due to the limited period of time its common shares have been publicly traded. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. Expected dividend yields were not used in the fair value computations as the Company has never declared or paid dividends on its common stock and currently intends to retain earnings for use in operations.

	Fiscal 2022	Fiscal 2021
Expected volatility	29.8%	29.8%
Expected term	6 years	6 years
Risk-free interest rate	1.92%	1.32%

A summary of the status of the Company's stock option activity as of September 30, 2022 and changes during the nine-month period then ended are as follows:

	Stock Options	Weighted Average Exercise Price Per Share		Aggregate Intrinsic Value		Weighted Average Remaining Contract Term
Balance outstanding, December 31, 2021	120,187	$	16.06
Granted	64,694	$	7.04
Forfeited or cancelled	(20,158)	$	14.76
Balance outstanding, September 30, 2022	164,723	$	12.68	$	—	8.59 years
Balance vested and exercisable, September 30, 2022	53,956	$	15.68	$	—	7.98 years

The weighted average grant-date fair value of options granted in the nine months ended September 30, 2022 and 2021 was $2.30 and $5.49, respectively. As of September 30, 2022, total unrecognized compensation cost related to stock options was $304 and is expected to be recognized over a weighted average period of approximately 1.0 years.

Restricted Stock Units

Compensation expense relating to restricted stock unit grants was $407 and $419 for the three months ended September 30, 2022 and 2021, respectively, and $870 and $980 for the nine months ended September 30, 2022 and 2021, respectively. Actual forfeitures are recognized as they occur. As of September 30, 2022, there was $2,453 of total unrecognized compensation cost related to non-vested restricted stock unit grants, which is expected to be recognized over a weighted average life of 1.7 years. The total fair value of restricted stock units vested during the three and nine months ended September 30, 2022 was $113 and $257, respectively, and $342 and $478 during the three and nine months ended September 30, 2021.

The Company has granted time-based restricted stock units ("RSUs"), performance stock units ("PSUs"), and market-based stock units ("MSUs") to certain key employees as part of the Company's long-term incentive program. The estimated fair value of restricted stock units is based on the grant date closing price of the Company's common stock for time-based and performance-based vesting awards. A Monte Carlo valuation model is used to estimate the fair value for market-based vesting awards. RSUs generally vest in three equal annual installments beginning one year from the grant date and are amortized as compensation expense over the three-year vesting period. The Company has also granted time-based restricted stock units to non-employee directors as part of the Company's annual director compensation program. Each time-based restricted stock grant to non-employee directors vests on the day immediately preceding the next annual meeting of stockholders following the date of grant. The grants are amortized as director compensation expense over the vesting period. The Company recognizes compensation expense on PSUs ratably over the requisite performance period of the award and to the extent management views the performance goal attainment as probable. The Company recognizes compensation expense on MSUs ratably over the requisite performance period of the award.

For the 2022 and 2021 fiscal year, the Company granted PSUs to certain key employees pursuant to the Company's 2020 Omnibus Plan. The number of shares earned is based on the Company’s achievement of pre-established target threshold goals for total gross written premiums over a three-year performance measurement period. The performance goals allow for a

payout ranging from 0% to 200% of the target award. If performance satisfies minimum requirements to result in shares of Company common stock being awarded, the number of shares will be determined between 50% and 200% of target thresholds, as defined in the applicable award agreements. Any earned PSU will vest if the employee’s service has been continuous through the vesting date. Any PSU not earned because of failure to achieve the minimum performance goal at the end of the performance period will be immediately forfeited. The grant date fair value of the PSUs was determined based on the grant date closing price of the Company’s stock.

For the 2022 and 2021 fiscal year, the Company granted MSUs to certain key employees pursuant to the Company's 2020 Omnibus Plan. The number of restricted stock units earned is based on the Company’s cumulative total shareholder return ("TSR"), as defined in the applicable award agreement, over a three-year performance measurement period. If TSR satisfies minimum requirements to result in shares being awarded, the number of shares will be determined between 50% and 200% shown in the table below. Any MSU not earned because of failure to achieve the minimum performance goal at the end of the performance period will be immediately forfeited. Grant date fair values were determined using a Monte Carlo valuation model based on the following assumptions:

	Fiscal 2022			Fiscal 2021
Total grant date fair value	$	391		$	845
Total grant date fair value per share	$	6.04		$	13.92
Expected volatility	40.0		%	35.0		%
Weighted average expected life	2.81 years			2.77 years
Risk-free interest rate	1.79		%	0.27		%

The percent of the target MSU that will be earned based on the Company’s TSR is as follows:

Cumulative TSR %
Fiscal 2022	Fiscal 2021	Percent of Units Vested
Below 29.2%	Below 25.1%	0%
29.2%	25.1%	50%
52.1%	47.2%	100%
74.9% and above	69.3% and above	200%

A summary of the status of the Company’s non-vested restricted stock unit activity as of September 30, 2022 and changes during the nine-month period then ended is as follows:

	RSUs			MSUs			PSUs			Total
	Shares	Weighted Average Grant Date Fair Value		Shares	Weighted Average Grant Date Fair Value		Shares	Weighted Average Grant Date Fair Value		Shares	Weighted Average Grant Date Fair Value
Non-vested outstanding, December 31, 2021	117,109	$	15.53	50,861	$	13.92	101,748	$	17.50	269,718	$	15.97
Granted	97,808	$	6.67	64,709	$	6.04	64,693	$	7.04	227,210	$	6.60
Vested	(48,236)	$	15.05	—	$	—	—	$	—	(48,236)	$	15.05
Forfeited or cancelled	(17,129)	$	13.43	(9,854)	$	11.67	(16,895)	$	15.76	(43,878)	$	13.93
Non-vested outstanding, September 30, 2022	149,552	$	10.13	105,716	$	9.31	149,546	$	13.17	404,814	$	11.04

XML

Business and Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Use of estimates

Use of estimates

While preparing the condensed consolidated financial statements, the Company has made certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements, as well as reported amounts of revenue and expenses during the reporting period. Accordingly, actual results could differ from those estimates. Reported amounts that require extensive use of estimates include the reserves for unpaid losses and loss adjustment expenses ("LAE"), reinsurance recoverables, investments, goodwill, and other intangible assets. Except for the captions on the condensed consolidated balance sheets and condensed consolidated statements of comprehensive income, generally, the term loss(es) is used to collectively refer to both losses and LAE.

The Company tests for goodwill impairment at the reporting unit level during the fourth quarter of each year and between annual tests if a triggering event indicates the possibility of an impairment. The Company monitors changing business conditions as well as industry and economic factors, among others, for events which could trigger the need for an interim impairment analysis. The declining share price of the Company’s stock has caused the market capitalization to fall below the book value as of September 30, 2022. As a result of the decrease in share price, the Company performed an interim impairment analysis at September 30, 2022 and concluded that no impairment relating to goodwill existed as of September 30, 2022.

Accounting pronouncements

Accounting pronouncements

Recently adopted policies

In January 2020, the Financial Accounting Standards Board ("FASB") issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivative and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323 and Topic 815 ("ASU 2020-01"). This update addresses the accounting for certain equity securities upon the application or discontinuation of the equity method of accounting. Further, the update addresses scope considerations for forward contracts and purchased options on certain securities. ASU 2020-01 is effective for annual periods beginning after December 15, 2021, including interim periods thereafter. The Company adopted this standard effective January 1, 2022. Adoption of this standard did not have a material impact on the condensed consolidated financial statements.

Pending policies

The Company completed its initial public offering in July 2020, and is an emerging growth company as defined under federal securities laws. As such, the Company has elected to adopt pending accounting policies under the dates required for private companies. Therefore, the dates included within this section reflect the effective dates for the adoption of new accounting policies required by private companies.

In March 2020, the FASB issued ASU No. 2020-03, Codification Improvements to Financial Instruments ("ASU 2020-03"). This update represents changes to clarify and improve the codification to allow for easier application by eliminating inconsistencies and providing clarification on items such as (i) the application of fair value option disclosures; (ii) the accounting for fees related to modifications of debt; and (iii) aligning the contractual term of a net investment in a lease in accordance with ASC Topic 326, Financial Instruments - Credit Losses, and the lease term determined in accordance with ASC Topic 842, Leases. The Company adopted items (i) and (ii) effective January 1, 2020 and will adopt item (iii) on January 1, 2023. Adoption of this standard has not had, and is not expected to have, a material impact on the condensed consolidated financial statements.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). This update requires financial assets measured at amortized cost to be presented at the net amount expected to be collected by means of an allowance for credit losses that runs through net income. Additionally, credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses, with the amount of the allowance limited to the amount by which the fair value is below the amortized cost. ASU 2016-13 is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years. The Company will adopt this standard effective January 1, 2023. The Company is currently evaluating the impact of this standard on the condensed consolidated financial statements.

Fair value measurements

Fair Value Measurements

The Company’s financial instruments include assets and liabilities carried at fair value. The inputs to valuation techniques used to measure fair value are prioritized into a three level hierarchy. The fair value hierarchy is as follows:

Level 1: Fair values primarily based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

Level 2: Fair values primarily based on observable inputs, other than quoted prices included in Level 1, or based on prices for similar assets and liabilities.

Level 3: Fair values primarily based on valuations derived when one or more of the significant inputs are unobservable. With little or no observable market, the determination of fair value uses considerable judgment and represents the Company’s best estimate of an amount that could be realized in a market exchange for the asset or liability.

The Company classifies the financial asset or liability by level based upon the lowest level input that is significant to the determination of the fair value.

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Summary of Fair Value Options

The following tables present the estimated fair value of the Company’s significant financial instruments.

	September 30, 2022
	Level 1		Level 2		Level 3		Total
Fixed maturities:
U.S. government and government securities	$	56,899	$	—	$	—	$	56,899
Foreign governments	—		392		—		392
States, territories and possessions	—		14,380		—		14,380
Political subdivisions of states territories and possessions	—		33,863		—		33,863
Special revenue and special assessment obligations	—		103,318		—		103,318
Industrial and public utilities	—		118,252		—		118,252
Commercial mortgage-backed securities	—		123,478		—		123,478
Residential mortgage-backed securities	—		24,171		—		24,171
Other loan-backed securities	—		50,339		—		50,339
Hybrid securities	—		5,026		—		5,026
Total fixed maturities	56,899		473,219		—		530,118
Equity securities	12,180		23,116		—		35,296
Total investments	$	69,079	$	496,335	$	—	$	565,414
Embedded derivatives on funds held under reinsurance agreements	$	(2,103)	$	(14,474)	$	—	$	(16,577)
Interest rate cap agreement	—		173		—		173
Debt	—		79,700		—		79,700

	December 31, 2021
	Level 1		Level 2		Level 3		Total
Fixed maturities:
U.S. government and government securities	$	2,392	$	39,042	$	—	$	41,434
Foreign governments	—		2,490		—		2,490
States, territories and possessions	—		10,766		—		10,766
Political subdivisions of states, territories and possessions	—		40,002		—		40,002
Special revenue and special assessment obligations	—		95,991		—		95,991
Industrial and public utilities	—		103,257		—		103,257
Commercial mortgage-backed securities	—		118,218		—		118,218
Residential mortgage-backed securities	—		17,368		—		17,368
Other loan-backed securities	—		41,425		—		41,425
Hybrid securities	—		110		—		110
Total fixed maturities	2,392		468,669		—		471,061
Equity securities	—		969		—		969
Total investments	$	2,392	$	469,638	$	—	$	472,030
Embedded derivatives on funds held under reinsurance agreements	$	(4)	$	275	$	—	$	271
Debt	—		30,938		—		30,938

XML

Investments (Tables)

9 Months Ended

Sep. 30, 2022

Investments, Debt and Equity Securities [Abstract]

Schedule of Debt Securities, Available-for-sale

The cost or amortized cost, gross unrealized gains, gross unrealized losses, and estimated fair value of the Company's fixed maturities investments are as follows:

	September 30, 2022
	Cost or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Fixed maturities:
U.S. government and government securities	$	59,974	$	14	$	(3,089)	$	56,899
Foreign governments	400		—		(8)		392
States, territories and possessions	16,088		—		(1,708)		14,380
Political subdivisions of states, territories and possessions	38,614		1		(4,752)		33,863
Special revenue and special assessment obligations	116,311		5		(12,998)		103,318
Industrial and public utilities	125,572		—		(7,320)		118,252
Commercial mortgage-backed securities	141,552		20		(18,094)		123,478
Residential mortgage-backed securities	25,769		16		(1,614)		24,171
Other loan-backed securities	51,857		—		(1,518)		50,339
Hybrid securities	5,798		—		(772)		5,026
Total fixed maturities available for sale	$	581,935	$	56	$	(51,873)	$	530,118

	December 31, 2021
	Cost or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Fixed maturities:
U.S. government and government securities	$	41,490	$	113	$	(169)	$	41,434
Foreign governments	2,500		—		(10)		2,490
States, territories and possessions	10,593		189		(16)		10,766
Political subdivisions of states, territories and possessions	39,170		975		(143)		40,002
Special revenue and special assessment obligations	93,664		2,920		(593)		95,991
Industrial and public utilities	100,774		2,835		(352)		103,257
Commercial mortgage-backed securities	119,378		591		(1,751)		118,218
Residential mortgage-backed securities	16,549		843		(24)		17,368
Other loan-backed securities	41,236		248		(59)		41,425
Hybrid securities	105		5		—		110
Total fixed maturities available for sale	$	465,459	$	8,719	$	(3,117)	$	471,061

Schedule of Continuous Unrealized Loss Position

The following table illustrates the Company’s gross unrealized losses and fair value of fixed maturities, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:

	September 30, 2022
	Less Than 12 Months				12 Months or More				Total
	Fair Value		Unrealized Loss		Fair Value		Unrealized Loss		Fair Value		Unrealized Loss
Fixed maturities:
U.S. government and government securities	$	47,377	$	(2,691)	$	4,623	$	(398)	$	52,000	$	(3,089)
Foreign governments	392		(8)		—		—		392		(8)
States, territories and possessions	14,150		(1,612)		229		(96)		14,379		(1,708)
Political subdivisions of states, territories and possessions	27,617		(3,574)		5,725		(1,178)		33,342		(4,752)
Special revenue and special assessment obligations	86,592		(8,560)		15,668		(4,438)		102,260		(12,998)
Industrial and public utilities	107,179		(5,541)		11,074		(1,779)		118,253		(7,320)
Commercial mortgage-backed securities	72,893		(7,836)		44,600		(10,258)		117,493		(18,094)
Residential mortgage-backed securities	19,794		(1,551)		1,437		(63)		21,231		(1,614)
Other loan-backed securities	46,109		(1,316)		4,231		(202)		50,340		(1,518)
Hybrid securities	5,026		(772)		—		—		5,026		(772)
Total fixed maturities	$	427,129	$	(33,461)	$	87,587	$	(18,412)	$	514,716	$	(51,873)

	December 31, 2021
	Less Than 12 Months				12 Months or More				Total
	Fair Value		Unrealized Loss		Fair Value		Unrealized Loss		Fair Value		Unrealized Loss
Fixed maturities:
U.S. government and government securities	$	26,935	$	(168)	$	23	$	(1)	$	26,958	$	(169)
Foreign governments	2,490		(10)		—		—		2,490		(10)
States, territories and possessions	935		(16)		—		—		935		(16)
Political subdivisions of states, territories and possessions	11,115		(143)		—		—		11,115		(143)
Special revenue and special assessment obligations	29,917		(593)		—		—		29,917		(593)
Industrial and public utilities	24,042		(286)		1,058		(66)		25,100		(352)
Commercial mortgage-backed securities	80,126		(1,565)		6,212		(186)		86,338		(1,751)
Residential mortgage-backed securities	4,539		(24)		—		—		4,539		(24)
Other loan-backed securities	20,153		(36)		2,477		(23)		22,630		(59)
Hybrid securities	—		—		—		—		—		—
Total fixed maturities	$	200,252	$	(2,841)	$	9,770	$	(276)	$	210,022	$	(3,117)

Summary of Investments by Contractual Maturity

The amortized cost and estimated fair value of fixed maturities as of September 30, 2022, by contractual maturity, are as follows:

	Cost or Amortized Cost		Fair Value
Available for sale:
Due in one year or less	$	31,666	$	31,433
Due after one year but before five years	162,478		153,776
Due after five years but before ten years	96,488		86,189
Due after ten years	72,125		60,732
Commercial mortgage-backed securities	141,552		123,478
Residential mortgage-backed securities	25,769		24,171
Other loan-backed securities	51,857		50,339
Total	$	581,935	$	530,118

Summary of Realized Gain (Loss) on Investments

Realized gains and losses on investments included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021 are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Fixed maturities:
Gains	$	21	$	52	$	134	$	150
Losses	—		—		(1,194)		(75)
Total fixed maturities	21		52		(1,060)		75
Funds held investments:
Gains	—		110		19		110
Losses	(12)		(1)		(29)		(1)
Total funds held investments	(12)		109		(10)		109
Equity securities:
Equity method investments:
Gains	—		—		1,400		—
Losses	—		(112)		(19)		(112)
Total equity securities	—		(112)		1,381		(112)
Total net realized gains	$	9	$	49	$	311	$	72

Summary of Net Investment Income

Net investment income consists of the following for the three and nine months ended September 30, 2022 and 2021:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Fixed maturities	$	2,628	$	1,597	$	6,189	$	4,734
Income on funds held investments	953		585		2,395		1,783
Equity securities	421		5		1,031		41
Unrealized losses on equity securities	(1,101)		—		(4,542)		—
Interest earned on cash and short-term investments	50		—		63		4
Net investment income	$	2,951	$	2,187	$	5,136	$	6,562

Summary of Unrealized Gain (Loss) on Investments

Net realized and unrealized gains (losses) on equity securities recognized during the three and nine months ended September 30, 2022 and 2021 are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Equity securities:
Net realized gains (losses) on sales of equity securities	$	—	$	(112)	$	1,381	$	(112)
Change in net unrealized gains (losses) of equity securities still held as of September 30, 2022 and 2021	(1,101)		(6)		(4,542)		11
Net realized and unrealized gains (losses) on equity securities	$	(1,101)	$	(118)	$	(3,161)	$	(101)

Schedule of Funds Held Under Reinsurance Agreements

Total funds held under reinsurance agreements include the following:

	September 30, 2022		December 31, 2021
Funds held under reinsurance agreements, at cost	$	221,405	$	199,139
Embedded derivatives, at fair value	(16,577)		271
Total funds held under reinsurance agreements	$	204,828	$	199,410

Summary of Embedded Derivatives, Gain (Loss)

Gains (losses) on embedded derivatives consists of the following for the three and nine months ended September 30, 2022 and 2021:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Change in fair value of embedded derivatives	$	5,812	$	573	$	16,848	$	3,761
Effect of net investment income on funds held investments	(953)		(585)		(2,395)		(1,783)
Effect of realized losses (gains) on funds held investments	12		(109)		10		(109)
Total gains (losses) on embedded derivatives	$	4,871	$	(121)	$	14,463	$	1,869

XML

Debt (Tables)

9 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

Schedule of Debt

Debt consisted of the following:

	September 30, 2022						December 31, 2021
	Face Value		Unamortized Discount and Issuance Costs		Carrying Value		Face Value		Unamortized Discount and Issuance Costs		Carrying Value
Secured credit facility	$	29,700	$	(449)	$	29,251	$	30,938	$	(576)	$	30,362
Surplus notes	50,000		(1,792)		48,208		—		—		—
Total debt	$	79,700	$	(2,241)	$	77,459	$	30,938	$	(576)	$	30,362

XML

Revenue from Contracts with Customers (Tables)

9 Months Ended

Sep. 30, 2022

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Revenue

The following table presents the revenues recognized from contracts with customers included in the condensed consolidated statements of operations.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Brokerage	$	1,581	$	1,989	$	5,396	$	6,214
Managing general agent fees	83		88		251		407
Third-party administrator fees	266		437		838		1,191
Consulting and other fee-based revenue	210		285		660		871
Total revenue from contracts with customers	$	2,140	$	2,799	$	7,145	$	8,683

Schedule of Contract with Customer, Contract Assets

The following table provides information related to the contract assets from contracts with customers. Contract assets are included within other assets on the condensed consolidated balance sheets.

	September 30, 2022		December 31, 2021
Contract assets	$	4,878	$	3,353

XML

Liability for Unpaid Losses and Loss Adjustment Expense (Tables)

9 Months Ended

Sep. 30, 2022

Insurance [Abstract]

Schedule of Liability for Unpaid Losses and Loss Adjustment Expense

The following table represents a reconciliation of changes in the liability for unpaid losses and LAE.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Unpaid losses and LAE reserves at beginning of period	$	577,686	$	502,560	$	544,320	$	457,817
Less losses ceded through reinsurance	(379,274)		(358,601)		(369,008)		(335,655)
Net unpaid losses and LAE at beginning of period	198,412		143,959		175,312		122,162
Incurred losses and LAE related to:
Current period	45,673		32,947		126,545		88,032
Prior period	(26)		(818)		(818)		(1,297)
Total incurred losses and LAE	45,647		32,129		125,727		86,735
Paid losses and LAE, net of reinsurance, related to:
Current period	19,570		12,638		41,268		25,111
Prior period	12,859		7,092		48,141		27,428
Total paid losses and LAE	32,429		19,730		89,409		52,539
Net unpaid losses and LAE at end of period	211,630		156,358		211,630		156,358
Plus losses ceded through reinsurance	367,121		354,434		367,121		354,434
Unpaid losses and LAE reserves at end of period	$	578,751	$	510,792	$	578,751	$	510,792

XML

Reinsurance (Tables)

9 Months Ended

Sep. 30, 2022

Reinsurance Disclosures [Abstract]

Summary of Effects of Reinsurance

A summary of the impact of ceded reinsurance on premiums written and premiums earned is as follows:

	Three Months Ended September 30,
	2022								2021
	Gross		Assumed		Ceded		Net		Gross		Assumed		Ceded		Net
Written premiums	$	160,505	$	1,678	$	(93,790)	$	68,393	$	175,516	$	2,108	$	(114,374)	$	63,250
Earned premiums	158,643		2,479		(89,741)		71,381		146,170		2,976		(97,191)		51,955

	Nine Months Ended September 30,
	2022								2021
	Gross		Assumed		Ceded		Net		Gross		Assumed		Ceded		Net
Written premiums	$	470,391	$	7,384	$	(265,234)	$	212,541	$	473,463	$	7,442	$	(305,164)	$	175,741
Earned premiums	469,403		7,400		(275,235)		201,568		408,936		7,133		(275,037)		141,032

XML

Leases (Tables)

9 Months Ended

Sep. 30, 2022

Leases [Abstract]

Schedule of Supplemental Balance Sheet Information

Supplemental balance sheet information, the weighted average remaining lease term and weighted average discount rate related to leases were as follows:

	September 30, 2022			December 31, 2021
Right of use asset	$	3,292		$	4,530
Lease liability	$	3,629		$	4,976
Weighted average remaining lease term	1.95 years			2.42 years
Weighted average discount rate	6.04		%	6.33		%

Schedule of Future Maturities of Lease Liabilities

Future maturities of lease liabilities as of September 30, 2022 are as follows:

	Operating Leases
2022	$	621
2023	1,940
2024	1,064
2025	164
2026	44
Thereafter	2
Total lease payments	3,835
Less: imputed interest	(206)
Total lease liabilities	$	3,629

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table presents the calculation of basic and diluted EPS of common stock:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net income — basic and diluted	$	7,574	$	6,518	$	25,405	$	18,086
Weighted average number of shares outstanding — basic	51,216,869		51,171,416		51,197,296		51,157,726
Effect of dilutive securities:
Restricted stock units	136		—		186		14,876
Dilutive shares	136		—		186		14,876
Weighted average number of shares outstanding — diluted	51,217,005		51,171,416		51,197,482		51,172,602
Earnings per share:
Basic	$	0.15	$	0.13	$	0.50	$	0.35
Diluted	$	0.15	$	0.13	$	0.50	$	0.35

XML

Accumulated Other Comprehensive Income (Loss) (Tables)

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

Schedule of Accumulated Other Comprehensive Income

The following table presents the changes in accumulated other comprehensive income (loss) for unrealized gains and losses on available-for-sale securities:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Balance at beginning of period	$	(25,789)	$	8,470	$	4,384	$	13,426
Other comprehensive loss, net of tax:
Unrealized investment losses:
Unrealized investment losses arising during the period	(19,059)		(2,419)		(58,333)		(8,670)
Income tax benefit	(3,996)		(508)		(12,243)		(1,821)
Unrealized investment losses, net of tax	(15,063)		(1,911)		(46,090)		(6,849)
Less reclassification adjustments to:
Net realized investment gains (losses) included in net realized gains (losses)	21		49		(1,060)		72
Income tax expense (benefit)	4		10		(223)		15
Total reclassifications included in net income, net of tax	17		39		(837)		57
Other comprehensive loss	(15,080)		(1,950)		(45,253)		(6,906)
Balance at end of period	$	(40,869)	$	6,520	$	(40,869)	$	6,520

XML

Stock Compensation (Tables)

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

	Fiscal 2022	Fiscal 2021
Expected volatility	29.8%	29.8%
Expected term	6 years	6 years
Risk-free interest rate	1.92%	1.32%

Summary of Stock Option Activity

A summary of the status of the Company's stock option activity as of September 30, 2022 and changes during the nine-month period then ended are as follows:

	Stock Options	Weighted Average Exercise Price Per Share		Aggregate Intrinsic Value		Weighted Average Remaining Contract Term
Balance outstanding, December 31, 2021	120,187	$	16.06
Granted	64,694	$	7.04
Forfeited or cancelled	(20,158)	$	14.76
Balance outstanding, September 30, 2022	164,723	$	12.68	$	—	8.59 years
Balance vested and exercisable, September 30, 2022	53,956	$	15.68	$	—	7.98 years

Schedule of Share-based Payment Award, Restricted Stock Units, Valuation Assumptions

Grant date fair values were determined using a Monte Carlo valuation model based on the following assumptions:

	Fiscal 2022			Fiscal 2021
Total grant date fair value	$	391		$	845
Total grant date fair value per share	$	6.04		$	13.92
Expected volatility	40.0		%	35.0		%
Weighted average expected life	2.81 years			2.77 years
Risk-free interest rate	1.79		%	0.27		%

Summary of Share-based Payment Award, Total Shareholder Return

The percent of the target MSU that will be earned based on the Company’s TSR is as follows:

Cumulative TSR %
Fiscal 2022	Fiscal 2021	Percent of Units Vested
Below 29.2%	Below 25.1%	0%
29.2%	25.1%	50%
52.1%	47.2%	100%
74.9% and above	69.3% and above	200%

Summary of Nonvested Restricted Stock Unit Activity

A summary of the status of the Company’s non-vested restricted stock unit activity as of September 30, 2022 and changes during the nine-month period then ended is as follows:

	RSUs			MSUs			PSUs			Total
	Shares	Weighted Average Grant Date Fair Value		Shares	Weighted Average Grant Date Fair Value		Shares	Weighted Average Grant Date Fair Value		Shares	Weighted Average Grant Date Fair Value
Non-vested outstanding, December 31, 2021	117,109	$	15.53	50,861	$	13.92	101,748	$	17.50	269,718	$	15.97
Granted	97,808	$	6.67	64,709	$	6.04	64,693	$	7.04	227,210	$	6.60
Vested	(48,236)	$	15.05	—	$	—	—	$	—	(48,236)	$	15.05
Forfeited or cancelled	(17,129)	$	13.43	(9,854)	$	11.67	(16,895)	$	15.76	(43,878)	$	13.93
Non-vested outstanding, September 30, 2022	149,552	$	10.13	105,716	$	9.31	149,546	$	13.17	404,814	$	11.04

XML

Business and Basis of Presentation - Narrative (Details)	9 Months Ended
	Sep. 30, 2022 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Goodwill impairment	$ 0

XML

Acquisitions (Details) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
	Jul. 06, 2021	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill		$ 142,347	$ 142,347		$ 142,347
Finite-lived intangible assets, net		68,616	68,616		$ 73,114
Earn-out payment			$ 750	$ 0
Western Integrated Care, LLC
Business Acquisition [Line Items]
Percentage of voting interests acquired	100.00%
Consideration transferred	$ 5,500
Due to related parties	1,500
Goodwill	1,501
Finite-lived intangible assets, net	$ 3,624
Earn-out payment		$ 750

XML

Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	$ 530,118	$ 471,061
Equity securities	35,296	969
Total investments	565,414	472,030
Embedded derivatives on funds held under reinsurance agreements	(16,577)	271
Interest rate cap agreement	173
Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt	79,700	30,938
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	56,899	2,392
Embedded derivatives on funds held under reinsurance agreements	(2,103)	(4)
Interest rate cap agreement	0
Level 1 | Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	473,219	468,669
Embedded derivatives on funds held under reinsurance agreements	(14,474)	275
Interest rate cap agreement	173
Level 2 | Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt	79,700	30,938
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Embedded derivatives on funds held under reinsurance agreements	0	0
Interest rate cap agreement	0
Level 3 | Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt	0	0
Total investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total investments	565,414	472,030
Total investments | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total investments	69,079	2,392
Total investments | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total investments	496,335	469,638
Total investments | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total investments	0	0
U.S. government and government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	56,899	41,434
U.S. government and government securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	56,899	2,392
U.S. government and government securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	39,042
U.S. government and government securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	392	2,490
Foreign governments | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Foreign governments | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	392	2,490
Foreign governments | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
States, territories and possessions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	14,380	10,766
States, territories and possessions | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
States, territories and possessions | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	14,380	10,766
States, territories and possessions | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Political subdivisions of states territories and possessions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	33,863	40,002
Political subdivisions of states territories and possessions | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Political subdivisions of states territories and possessions | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	33,863	40,002
Political subdivisions of states territories and possessions | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Special revenue and special assessment obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	103,318	95,991
Special revenue and special assessment obligations | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Special revenue and special assessment obligations | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	103,318	95,991
Special revenue and special assessment obligations | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Industrial and public utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	118,252	103,257
Industrial and public utilities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Industrial and public utilities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	118,252	103,257
Industrial and public utilities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	123,478	118,218
Commercial mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Commercial mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	123,478	118,218
Commercial mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	24,171	17,368
Residential mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Residential mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	24,171	17,368
Residential mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Other loan-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	50,339	41,425
Other loan-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Other loan-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	50,339	41,425
Other loan-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Hybrid securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	5,026	110
Hybrid securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Hybrid securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	5,026	110
Hybrid securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities:	0	0
Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	35,296	969
Equity securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	12,180	0
Equity securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	23,116	969
Equity securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	$ 0	$ 0

XML

Investments - Schedule of Debt Securities, Available-for-sale (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Fixed maturities:
Cost or Amortized Cost	$ 581,935	$ 465,459
Gross Unrealized Gains	56	8,719
Gross Unrealized Losses	(51,873)	(3,117)
Fair Value	530,118	471,061
U.S. government and government securities
Fixed maturities:
Cost or Amortized Cost	59,974	41,490
Gross Unrealized Gains	14	113
Gross Unrealized Losses	(3,089)	(169)
Fair Value	56,899	41,434
Foreign governments
Fixed maturities:
Cost or Amortized Cost	400	2,500
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(8)	(10)
Fair Value	392	2,490
States, territories and possessions
Fixed maturities:
Cost or Amortized Cost	16,088	10,593
Gross Unrealized Gains	0	189
Gross Unrealized Losses	(1,708)	(16)
Fair Value	14,380	10,766
Political subdivisions of states, territories and possessions
Fixed maturities:
Cost or Amortized Cost	38,614	39,170
Gross Unrealized Gains	1	975
Gross Unrealized Losses	(4,752)	(143)
Fair Value	33,863	40,002
Special revenue and special assessment obligations
Fixed maturities:
Cost or Amortized Cost	116,311	93,664
Gross Unrealized Gains	5	2,920
Gross Unrealized Losses	(12,998)	(593)
Fair Value	103,318	95,991
Industrial and public utilities
Fixed maturities:
Cost or Amortized Cost	125,572	100,774
Gross Unrealized Gains	0	2,835
Gross Unrealized Losses	(7,320)	(352)
Fair Value	118,252	103,257
Commercial mortgage-backed securities
Fixed maturities:
Cost or Amortized Cost	141,552	119,378
Gross Unrealized Gains	20	591
Gross Unrealized Losses	(18,094)	(1,751)
Fair Value	123,478	118,218
Residential mortgage-backed securities
Fixed maturities:
Cost or Amortized Cost	25,769	16,549
Gross Unrealized Gains	16	843
Gross Unrealized Losses	(1,614)	(24)
Fair Value	24,171	17,368
Other loan-backed securities
Fixed maturities:
Cost or Amortized Cost	51,857	41,236
Gross Unrealized Gains	0	248
Gross Unrealized Losses	(1,518)	(59)
Fair Value	50,339	41,425
Hybrid securities
Fixed maturities:
Cost or Amortized Cost	5,798	105
Gross Unrealized Gains	0	5
Gross Unrealized Losses	(772)	0
Fair Value	$ 5,026	$ 110

XML

Investments - Schedule of Continuous Unrealized Loss Position (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, less than 12 months	$ 427,129	$ 200,252
Unrealized Loss, less than 12 months	(33,461)	(2,841)
Fair Value, 12 months or more	87,587	9,770
Unrealized Loss, 12 months or more	(18,412)	(276)
Fair Value	514,716	210,022
Unrealized Loss	(51,873)	(3,117)
U.S. government and government securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, less than 12 months	47,377	26,935
Unrealized Loss, less than 12 months	(2,691)	(168)
Fair Value, 12 months or more	4,623	23
Unrealized Loss, 12 months or more	(398)	(1)
Fair Value	52,000	26,958
Unrealized Loss	(3,089)	(169)
Foreign governments
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, less than 12 months	392	2,490
Unrealized Loss, less than 12 months	(8)	(10)
Fair Value, 12 months or more	0	0
Unrealized Loss, 12 months or more	0	0
Fair Value	392	2,490
Unrealized Loss	(8)	(10)
States, territories and possessions
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, less than 12 months	14,150	935
Unrealized Loss, less than 12 months	(1,612)	(16)
Fair Value, 12 months or more	229	0
Unrealized Loss, 12 months or more	(96)	0
Fair Value	14,379	935
Unrealized Loss	(1,708)	(16)
Political subdivisions of states, territories and possessions
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, less than 12 months	27,617	11,115
Unrealized Loss, less than 12 months	(3,574)	(143)
Fair Value, 12 months or more	5,725	0
Unrealized Loss, 12 months or more	(1,178)	0
Fair Value	33,342	11,115
Unrealized Loss	(4,752)	(143)
Special revenue and special assessment obligations
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, less than 12 months	86,592	29,917
Unrealized Loss, less than 12 months	(8,560)	(593)
Fair Value, 12 months or more	15,668	0
Unrealized Loss, 12 months or more	(4,438)	0
Fair Value	102,260	29,917
Unrealized Loss	(12,998)	(593)
Industrial and public utilities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, less than 12 months	107,179	24,042
Unrealized Loss, less than 12 months	(5,541)	(286)
Fair Value, 12 months or more	11,074	1,058
Unrealized Loss, 12 months or more	(1,779)	(66)
Fair Value	118,253	25,100
Unrealized Loss	(7,320)	(352)
Commercial mortgage-backed securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, less than 12 months	72,893	80,126
Unrealized Loss, less than 12 months	(7,836)	(1,565)
Fair Value, 12 months or more	44,600	6,212
Unrealized Loss, 12 months or more	(10,258)	(186)
Fair Value	117,493	86,338
Unrealized Loss	(18,094)	(1,751)
Residential mortgage-backed securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, less than 12 months	19,794	4,539
Unrealized Loss, less than 12 months	(1,551)	(24)
Fair Value, 12 months or more	1,437	0
Unrealized Loss, 12 months or more	(63)	0
Fair Value	21,231	4,539
Unrealized Loss	(1,614)	(24)
Other loan-backed securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, less than 12 months	46,109	20,153
Unrealized Loss, less than 12 months	(1,316)	(36)
Fair Value, 12 months or more	4,231	2,477
Unrealized Loss, 12 months or more	(202)	(23)
Fair Value	50,340	22,630
Unrealized Loss	(1,518)	(59)
Hybrid securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, less than 12 months	5,026	0
Unrealized Loss, less than 12 months	(772)	0
Fair Value, 12 months or more	0	0
Unrealized Loss, 12 months or more	0	0
Fair Value	5,026	0
Unrealized Loss	$ (772)	$ 0

XML

Investments - Summary of Investments by Contractual Maturity (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Cost or Amortized Cost
Due in one year or less	$ 31,666
Due after one year but before five years	162,478
Due after five years but before ten years	96,488
Due after ten years	72,125
Cost or Amortized Cost	581,935	$ 465,459
Fair Value
Due in one year or less	31,433
Due after one year but before five years	153,776
Due after five years but before ten years	86,189
Due after ten years	60,732
Fair Value	530,118	471,061
Commercial mortgage-backed securities
Cost or Amortized Cost
Cost or Amortized Cost	141,552	119,378
Fair Value
Fair Value	123,478	118,218
Residential mortgage-backed securities
Cost or Amortized Cost
Cost or Amortized Cost	25,769	16,549
Fair Value
Fair Value	24,171	17,368
Other loan-backed securities
Cost or Amortized Cost
Cost or Amortized Cost	51,857	41,236
Fair Value
Fair Value	$ 50,339	$ 41,425

XML

Investments - Summary of Realized Gain (Loss) on Investments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Fixed maturities:
Gains	$ 21	$ 52	$ 134	$ 150
Losses	0	0	(1,194)	(75)
Total fixed maturities	21	52	(1,060)	75
Funds held investments:
Gains	0	110	19	110
Losses	(12)	(1)	(29)	(1)
Total funds held investments	(12)	109	(10)	109
Equity securities:
Gains	0	0	1,400	0
Losses	0	(112)	(19)	(112)
Total equity securities	0	(112)	1,381	(112)
Total net realized gains	$ 9	$ 49	$ 311	$ 72

XML

Investments - Summary of Net Investment Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net Investment Income [Line Items]
Net investment income	$ 2,951	$ 2,187	$ 5,136	$ 6,562
Fixed maturities
Net Investment Income [Line Items]
Net investment income	2,628	1,597	6,189	4,734
Income on funds held investments
Net Investment Income [Line Items]
Net investment income	953	585	2,395	1,783
Equity securities
Net Investment Income [Line Items]
Net investment income	421	5	1,031	41
Unrealized losses on equity securities
Net Investment Income [Line Items]
Net investment income	(1,101)	0	(4,542)	0
Interest earned on cash and short-term investments
Net Investment Income [Line Items]
Net investment income	$ 50	$ 0	$ 63	$ 4

XML

Investments - Summary of Unrealized Gain (Loss) on Investments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Investments, Debt and Equity Securities [Abstract]
Net realized gains (losses) on sales of equity securities	$ 0	$ (112)	$ 1,381	$ (112)
Change in net unrealized gains (losses) of equity securities still held as of September 30, 2022 and 2021	(1,101)	(6)	(4,542)	11
Net realized and unrealized gains (losses) on equity securities	$ (1,101)	$ (118)	$ (3,161)	$ (101)

XML

Investments - Schedule of Funds Held Under Reinsurance Agreements (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Funds held under reinsurance agreements, at cost	$ 221,405	$ 199,139
Embedded derivatives, at fair value	(16,577)	271
Total funds held under reinsurance agreements	$ 204,828	$ 199,410

XML

Investments - Summary of Embedded Derivatives, Gain (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net Investment Income [Line Items]
Change in fair value of embedded derivatives	$ 5,812	$ 573	$ 16,848	$ 3,761
Effect of realized losses (gains) on funds held investments	12	(109)	10	(109)
Total gains (losses) on embedded derivatives	4,871	(121)	14,463	1,869
Income on funds held investments
Net Investment Income [Line Items]
Effect of net investment income on funds held investments	$ (953)	$ (585)	$ (2,395)	$ (1,783)

XML

Equity Method Investments (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Jan. 03, 2020	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Jan. 02, 2020
Gain (Loss) on Investments
Schedule of Equity Method Investments [Line Items]
Realized gain (loss) on sale		$ 1,400		$ 1,400
Trean Intermediaries
Schedule of Equity Method Investments [Line Items]
Ownership percentage sold	15.00%
Ownership percentage						25.00%
Proceeds from sale of equity method investments	$ 3,000		$ 1,888
Cumulative percentage ownership after all transactions	10.00%
Income from equity method investments		$ 0	50	$ 100	$ 150
Trean Intermediaries | Gain (Loss) on Investments
Schedule of Equity Method Investments [Line Items]
Realized gain (loss) on sale			$ (112)		$ (112)

XML

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Face Value	$ 79,700	$ 30,938
Unamortized Discount and Issuance Costs	(2,241)	(576)
Carrying Value	77,459	30,362
Secured credit facility
Debt Instrument [Line Items]
Face Value	29,700	30,938
Unamortized Discount and Issuance Costs	(449)	(576)
Carrying Value	29,251	30,362
Surplus notes
Debt Instrument [Line Items]
Face Value	50,000	0
Unamortized Discount and Issuance Costs	(1,792)	0
Carrying Value	$ 48,208	$ 0

XML

Debt - Secured Credit Facility (Details) - Secured credit facility - USD ($) $ in Thousands		1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 28, 2022	Jul. 31, 2020	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Amended and Restated Credit Agreement
Debt Instrument [Line Items]
Extension term		5 years
Increase (decrease) to term loan debt amount		$ 11,707
Amended and Restated Credit Agreement | Minimum
Debt Instrument [Line Items]
Quarterly installment payments					$ 206
Amended and Restated Credit Agreement | Maximum
Debt Instrument [Line Items]
Quarterly installment payments					$ 825
Term Loan
Debt Instrument [Line Items]
Maximum borrowing capacity		33,000
Second Amended And Restated Credit Agreement
Debt Instrument [Line Items]
Variable interest rate plus applicable margin					6.76%		4.64%
Eurodollar loans | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate	4.50%
Eurodollar loans | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Basis spread on variable rate	3.50%
ABR Loans | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate	3.50%
ABR Loans | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Basis spread on variable rate	2.50%
Revolving Credit Facility
Debt Instrument [Line Items]
Debt interest expense			$ 563	$ 419	$ 1,438	$ 1,271
Revolving Credit Facility | Amended and Restated Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 2,000

XML

Debt - Interest Rate Cap Agreement (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Debt Instrument [Line Items]
Payment for interest rate cap		$ 173	$ 0
Interest Rate Cap
Debt Instrument [Line Items]
Notional amount	$ 29,700	$ 29,700
Capped interest rate	5.00%	5.00%
Payment for interest rate cap	$ 173

XML

Debt - Surplus Notes (Details) - Notes Payable, Other Payables - Surplus notes - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
	Aug. 24, 2022	Sep. 30, 2022	Sep. 30, 2022
Debt Instrument [Line Items]
Face amount	$ 50,000
Interest rate, stated percentage	6.75%
Redemption period	10 years
Redemption price, percentage	100.00%
Covenant, indebtedness percentage of total surplus, maximum	35.00%
Debt interest expense		$ 368	$ 368

XML

Revenue from Contracts with Customers - Summary of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Total revenue from contracts with customers	$ 2,140	$ 2,799	$ 7,145	$ 8,683
Brokerage
Disaggregation of Revenue [Line Items]
Total revenue from contracts with customers	1,581	1,989	5,396	6,214
Managing general agent fees
Disaggregation of Revenue [Line Items]
Total revenue from contracts with customers	83	88	251	407
Third-party administrator fees
Disaggregation of Revenue [Line Items]
Total revenue from contracts with customers	266	437	838	1,191
Consulting and other fee-based revenue
Disaggregation of Revenue [Line Items]
Total revenue from contracts with customers	$ 210	$ 285	$ 660	$ 871

XML

Revenue from Contracts with Customers - Schedule of Contract with Customer, Contract Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Contract assets	$ 4,878	$ 3,353

XML

Income Taxes (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Effective income tax rate, percent	21.00%	24.20%	21.00%	22.00%

XML

Liability for Unpaid Losses and Loss Adjustment Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Unpaid losses and LAE reserves at beginning of period	$ 577,686	$ 502,560	$ 544,320	$ 457,817
Less losses ceded through reinsurance	(379,274)	(358,601)	(369,008)	(335,655)
Net unpaid losses and LAE at beginning of period	198,412	143,959	175,312	122,162
Incurred losses and LAE related to:
Current period	45,673	32,947	126,545	88,032
Prior period	(26)	(818)	(818)	(1,297)
Total incurred losses and LAE	45,647	32,129	125,727	86,735
Paid losses and LAE, net of reinsurance, related to:
Current period	19,570	12,638	41,268	25,111
Prior period	12,859	7,092	48,141	27,428
Total paid losses and LAE	32,429	19,730	89,409	52,539
Net unpaid losses and LAE at end of period	211,630	156,358	211,630	156,358
Plus losses ceded through reinsurance	367,121	354,434	367,121	354,434
Unpaid losses and LAE reserves at end of period	$ 578,751	$ 510,792	$ 578,751	$ 510,792

XML

Liability for Unpaid Losses and Loss Adjustment Expense - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Insurance [Abstract]
Prior year claims and claims adjustment expense	$ (26)	$ (818)	$ (818)	$ (1,297)

XML

Reinsurance (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Written premiums
Gross	$ 160,505	$ 175,516	$ 470,391	$ 473,463
Assumed	1,678	2,108	7,384	7,442
Ceded	(93,790)	(114,374)	(265,234)	(305,164)
Net written premiums	68,393	63,250	212,541	175,741
Earned premiums
Gross	158,643	146,170	469,403	408,936
Assumed	2,479	2,976	7,400	7,133
Ceded	(89,741)	(97,191)	(275,235)	(275,037)
Net earned premiums	$ 71,381	$ 51,955	$ 201,568	$ 141,032

XML

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Lessee, Lease, Description [Line Items]
Renewal term	60 months		60 months
Lease expense	$ 615	$ 626	$ 1,855	$ 1,831
Variable lease expense	17	29	68	56
Sublease income	$ 27	$ 33	$ 70	$ 74
Minimum
Lessee, Lease, Description [Line Items]
Term of contract	1 month		1 month
Maximum
Lessee, Lease, Description [Line Items]
Term of contract	57 months		57 months

XML

Leases - Schedule of Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Leases [Abstract]
Right of use asset	$ 3,292	$ 4,530
Lease liability	$ 3,629	$ 4,976
Weighted average remaining lease term	1 year 11 months 12 days	2 years 5 months 1 day
Weighted average discount rate	6.04%	6.33%

XML

Leases - Schedule of Future Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Leases [Abstract]
2022	$ 621
2023	1,940
2024	1,064
2025	164
2026	44
Thereafter	2
Total lease payments	3,835
Less: imputed interest	(206)
Total lease liabilities	$ 3,629	$ 4,976

XML

Equity (Details) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Equity [Abstract]
Common stock, authorized (in shares)	600,000,000	600,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, issued (in shares)	51,220,485	51,176,887
Common stock, outstanding (in shares)	51,220,485	51,176,887

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income — basic and diluted	$ 7,574	$ 6,518	$ 25,405	$ 18,086
Weighted average number of shares outstanding — basic
Weighted average number of shares outstanding - basic (in shares)	51,216,869	51,171,416	51,197,296	51,157,726
Effect of dilutive securities:
Dilutive securities (in shares)	136	0	186	14,876
Weighted average number of shares outstanding — diluted
Weighted average number of shares outstanding - diluted (in shares)	51,217,005	51,171,416	51,197,482	51,172,602
Earnings per share:
Basic (in dollars per share)	$ 0.15	$ 0.13	$ 0.50	$ 0.35
Diluted (in dollars per share)	$ 0.15	$ 0.13	$ 0.50	$ 0.35
Excluded: Antidilutive common stock equivalents (in shares)			561,537	396,044
Restricted stock units (RSUs) (in shares)
Effect of dilutive securities:
Dilutive securities (in shares)	136	0	186	14,876

XML

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Shareholders' equity beginning balance	$ 410,118	$ 417,343	$ 421,909	$ 410,107
Less reclassification adjustments to:
Other comprehensive loss	(15,080)	(1,950)	(45,253)	(6,906)
Shareholders' equity ending balance	403,056	422,292	403,056	422,292
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Shareholders' equity beginning balance	(25,789)	8,470	4,384	13,426
Less reclassification adjustments to:
Other comprehensive loss	(15,080)	(1,950)	(45,253)	(6,906)
Shareholders' equity ending balance	(40,869)	6,520	(40,869)	6,520
Unrealized investment gain (loss)
Unrealized investment losses:
Unrealized investment losses arising during the period	(19,059)	(2,419)	(58,333)	(8,670)
Income tax benefit	(3,996)	(508)	(12,243)	(1,821)
Unrealized investment losses, net of tax	(15,063)	(1,911)	(46,090)	(6,849)
Less reclassification adjustments to:
Net realized investment gains (losses) included in net realized gains (losses)	21	49	(1,060)	72
Income tax expense (benefit)	4	10	(223)	15
Total reclassifications included in net income, net of tax	17	39	(837)	57
Other comprehensive loss	$ (15,080)	$ (1,950)	$ (45,253)	$ (6,906)

XML

Stock Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense			$ 1,019	$ 1,098
Cost not yet recognized, weighted average period for recognition			8 years 7 months 2 days
2020 Omnibus Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized (in shares)	5,058,085		5,058,085
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense	$ 53	$ 49	$ 149	$ 118
Weighted average grant-date fair value of options granted (in dollars per share)			$ 2.30	$ 5.49
Unrecognized compensation cost related to stock options	304		$ 304
Cost not yet recognized, weighted average period for recognition			1 year
Stock Options | Share-based Payment Arrangement, Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)			3 years
Contractual term from date of grant (in years)			10 years
Stock Options | Share-based Payment Arrangement, Employee | Share-based payment arrangement, tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			33.33%
Stock Options | Share-based Payment Arrangement, Employee | Share-based payment arrangement, tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			33.33%
Stock Options | Share-based Payment Arrangement, Employee | Share-based payment arrangement, tranche three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			33.33%
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense	407	419	$ 870	$ 980
Vesting period (in years)			3 years
Cost not yet recognized, weighted average period for recognition			1 year 8 months 12 days
Non-vested non-option stock-based compensation expense	2,453		$ 2,453
Fair value of restricted stock units vested	$ 113	$ 342	$ 257	$ 478
Restricted Stock Units (RSUs) | Share-based payment arrangement, tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			33.33%
Restricted Stock Units (RSUs) | Share-based payment arrangement, tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			33.33%
Restricted Stock Units (RSUs) | Share-based payment arrangement, tranche three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			33.33%
Performance Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)			3 years
Performance Stock Units | Minimum | Share-based payment arrangement, tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payout rate (percentage)	0.00%		0.00%
Performance Stock Units | Minimum | Share-based payment arrangement, tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payout rate (percentage)	50.00%		50.00%
Performance Stock Units | Maximum | Share-based payment arrangement, tranche four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payout rate (percentage)	200.00%		200.00%
Market-Based Stock Units (MSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period (in years)			3 years
Market-Based Stock Units (MSUs) | Share-based payment arrangement, tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			0.00%
Market-Based Stock Units (MSUs) | Share-based payment arrangement, tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			50.00%
Market-Based Stock Units (MSUs) | Share-based payment arrangement, tranche three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			100.00%
Market-Based Stock Units (MSUs) | Share-based payment arrangement, tranche four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage			200.00%

XML

Stock Compensation - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) - Stock Options	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	29.80%	29.80%
Expected term	6 years	6 years
Risk-free interest rate	1.92%	1.32%

XML

Stock Compensation - Summary of Stock Option Activity (Details) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares
Stock Options
Options outstanding, beginning balance (in shares) | shares	120,187
Granted (in shares) | shares	64,694
Forfeited or cancelled (in shares) | shares	(20,158)
Options outstanding, ending balance (in shares) | shares	164,723
Options exercisable (in shares) | shares	53,956
Weighted Average Exercise Price Per Share
Options outstanding, weighted average exercise price, beginning balance (in dollars per share) | $ / shares	$ 16.06
Grants in period, weighted average exercise price (in dollars per share) | $ / shares	7.04
Forfeited or cancelled in period, weighted average exercise price (in dollars per share) | $ / shares	14.76
Options outstanding, weighted average exercise price, ending balance (in dollars per share) | $ / shares	12.68
Options exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 15.68
Options outstanding, aggregate intrinsic value | $	$ 0
Options vested or expected to vest, aggregate intrinsic value | $	$ 0
Options outstanding, weighted average outstanding (in years)	8 years 7 months 2 days
Options vested or expected to vest, weighted average remaining (in years)	7 years 11 months 23 days

XML

Stock Compensation - Schedule of Share-based Payment Award, Restricted Stock Units, Valuation Assumptions (Details) - Restricted Stock Units (RSUs) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total grant date fair value	$ 391	$ 845
Total grant date fair value per share (in dollars per share)	$ 6.04	$ 13.92
Expected volatility	40.00%	35.00%
Weighted average expected life	2 years 9 months 21 days	2 years 9 months 7 days
Risk-free interest rate	1.79%	0.27%

XML

Stock Compensation - Summary of Share-based Payment Award, Total Shareholder Return (Details) - Market-Based Stock Units (MSUs)	3 Months Ended	9 Months Ended
	Mar. 31, 2022	Sep. 30, 2022
Share-based payment arrangement, tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cumulative TSR %	25.10%	29.20%
Percent of Units Vested		0.00%
Share-based payment arrangement, tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cumulative TSR %	25.10%	29.20%
Percent of Units Vested		50.00%
Share-based payment arrangement, tranche three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cumulative TSR %	47.20%	52.10%
Percent of Units Vested		100.00%
Share-based payment arrangement, tranche four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cumulative TSR %	69.30%	74.90%
Percent of Units Vested		200.00%

XML

Stock Compensation - Summary of Nonvested Restricted Stock Unit Activity (Details)	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Shares
Non-vested outstanding, beginning balance (in shares) | shares	269,718
Granted (in shares) | shares	227,210
Vested (in shares) | shares	(48,236)
Forfeited or cancelled (in shares) | shares	(43,878)
Non-vested outstanding, ending balance (in shares) | shares	404,814
Weighted Average Grant Date Fair Value
Non-vested outstanding, weighted average grant date fair value, beginning balance (in dollars per share) | $ / shares	$ 15.97
Grants in period, weighted average exercise price (in dollars per share) | $ / shares	6.60
Vested in period, weighted average exercise price (in dollars per share) | $ / shares	15.05
Forfeited or cancelled in period, weighted average exercise price (in dollars per share) | $ / shares	13.93
Non-vested outstanding, weighted average grant date fair value, ending balance (in dollars per share) | $ / shares	$ 11.04
Restricted Stock Units (RSUs)
Shares
Non-vested outstanding, beginning balance (in shares) | shares	117,109
Granted (in shares) | shares	97,808
Vested (in shares) | shares	(48,236)
Forfeited or cancelled (in shares) | shares	(17,129)
Non-vested outstanding, ending balance (in shares) | shares	149,552
Weighted Average Grant Date Fair Value
Non-vested outstanding, weighted average grant date fair value, beginning balance (in dollars per share) | $ / shares	$ 15.53
Grants in period, weighted average exercise price (in dollars per share) | $ / shares	6.67
Vested in period, weighted average exercise price (in dollars per share) | $ / shares	15.05
Forfeited or cancelled in period, weighted average exercise price (in dollars per share) | $ / shares	13.43
Non-vested outstanding, weighted average grant date fair value, ending balance (in dollars per share) | $ / shares	$ 10.13
Market-Based Stock Units (MSUs)
Shares
Non-vested outstanding, beginning balance (in shares) | shares	50,861
Granted (in shares) | shares	64,709
Vested (in shares) | shares	0
Forfeited or cancelled (in shares) | shares	(9,854)
Non-vested outstanding, ending balance (in shares) | shares	105,716
Weighted Average Grant Date Fair Value
Non-vested outstanding, weighted average grant date fair value, beginning balance (in dollars per share) | $ / shares	$ 13.92
Grants in period, weighted average exercise price (in dollars per share) | $ / shares	6.04
Vested in period, weighted average exercise price (in dollars per share) | $ / shares	0
Forfeited or cancelled in period, weighted average exercise price (in dollars per share) | $ / shares	11.67
Non-vested outstanding, weighted average grant date fair value, ending balance (in dollars per share) | $ / shares	$ 9.31
Performance Stock Units (PSUs)
Shares
Non-vested outstanding, beginning balance (in shares) | shares	101,748
Granted (in shares) | shares	64,693
Vested (in shares) | shares	0
Forfeited or cancelled (in shares) | shares	(16,895)
Non-vested outstanding, ending balance (in shares) | shares	149,546
Weighted Average Grant Date Fair Value
Non-vested outstanding, weighted average grant date fair value, beginning balance (in dollars per share) | $ / shares	$ 17.50
Grants in period, weighted average exercise price (in dollars per share) | $ / shares	7.04
Vested in period, weighted average exercise price (in dollars per share) | $ / shares	0
Forfeited or cancelled in period, weighted average exercise price (in dollars per share) | $ / shares	15.76
Non-vested outstanding, weighted average grant date fair value, ending balance (in dollars per share) | $ / shares	$ 13.17